WO2017155055A1 - Method for manufacturing culture product liquid - Google Patents

Method for manufacturing culture product liquid Download PDF

Info

Publication number
WO2017155055A1
WO2017155055A1 PCT/JP2017/009546 JP2017009546W WO2017155055A1 WO 2017155055 A1 WO2017155055 A1 WO 2017155055A1 JP 2017009546 W JP2017009546 W JP 2017009546W WO 2017155055 A1 WO2017155055 A1 WO 2017155055A1
Authority
WO
WIPO (PCT)
Prior art keywords
culture
stem cell
stem cells
culture vessel
bone marrow
Prior art date
Application number
PCT/JP2017/009546
Other languages
French (fr)
Japanese (ja)
Inventor
アレクセイ グラドコフ
Original Assignee
株式会社Cells Power
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社Cells Power filed Critical 株式会社Cells Power
Priority to RU2018131756A priority Critical patent/RU2751239C2/en
Priority to US16/073,352 priority patent/US20190032019A1/en
Priority to EP17763395.5A priority patent/EP3428272A4/en
Priority to SG11201806410PA priority patent/SG11201806410PA/en
Priority to CN201780015560.6A priority patent/CN108699516A/en
Priority to MYPI2018702704A priority patent/MY185820A/en
Priority claimed from JP2017044698A external-priority patent/JP6345826B2/en
Publication of WO2017155055A1 publication Critical patent/WO2017155055A1/en
Priority to PH12018501576A priority patent/PH12018501576A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology

Definitions

  • the present invention relates to a culture product production method for producing a culture product solution using stem cells made from bone marrow fluid collected from a donor.
  • a stem cell culture comprising a culture tub, a culture solution filling the culture tub, and a carrier having a height portion on its surface and coated with a stem cell adhesion substance, wherein there are a plurality of low portions that form a height on the carrier surface.
  • An apparatus is disclosed (see Patent Document 1). In this stem cell culture apparatus, the carrier is suspended in the culture solution, and the stem cells attached in a dispersed state to the carrier surface via the stem cell adhesion substance are proliferated without being detached from the carrier surface.
  • the culture solution after culturing the stem cells is discarded.
  • the culture solution after culturing the stem cells contains a metabolite secreted from the stem cells, and the culture solution can be used for treatment of various diseases and beauty.
  • various stem cells are present in the tissue or cells collected from the donor, the various stem cells proliferate even if the stem cells present in the tissue or cells collected from the donor are cultured. Since various kinds of metabolites secreted from the culture medium are contained in the culture solution, it is difficult to produce a culture product solution having only a specific effect on various diseases and various cosmetics.
  • An object of the present invention is to provide a culture product production method capable of producing a culture product solution containing a predetermined metabolite secreted from a single type of stem cell and having a single specific effect on various diseases and various cosmetics. It is to provide.
  • the premise of the present invention for solving the above problems is a culture product production method for producing a culture product using stem cells made from bone marrow fluid collected from a donor.
  • the method for producing a culture solution includes a bone marrow fluid separation step in which bone marrow fluid collected from a donor is separated into layers, and an intermediate layer of the bone marrow fluid separated in layers by the bone marrow fluid separation step.
  • a bone marrow fluid extraction step for extracting the located intermediate layer bone marrow fluid, and the intermediate layer bone marrow fluid extracted by the bone marrow fluid extraction step and a predetermined culture solution are injected into a first culture vessel having a predetermined volume and a predetermined area bottom surface,
  • the first culture cell is left statically for a predetermined time, and the first stem cell is fixed by the stem cell first fixing step for fixing the first stem cell contained in the intermediate layer bone marrow fluid to the bottom surface of the first culture container, and the stem cell first fixing step.
  • a new culture solution is poured into the first culture vessel while discharging the culture solution in the first culture vessel, and the first culture vessel is left statically for a predetermined time.
  • the total planar area of the first stem cells is A first stem cell collection step for collecting the first stem cells from the first culture container when the first target ratio is reached, a stem cell separation step for centrifuging the first stem cells collected in the first stem cell collection step, and a stem cell
  • the second stem cell collecting step for collecting the second stem cell located in the lowermost layer of the first stem cells separated in a layered manner by the separating step, the second stem cell collected by the second stem cell collecting step, and a predetermined culture solution Pour into a second culture container having a larger volume and a larger bottom area than the one culture container, and leave the second culture container statically for a predetermined time to fix the second stem cells to the bottom surface of the second culture container.
  • the stem cell second fixing step and the stem cell second fixing step fix the second stem cell on the bottom surface of the second culture vessel, and then discharge the culture solution in the second culture vessel to the second culture.
  • culturing when the total planar area of the second stem cells reaches the second target ratio, culturing includes a predetermined metabolite secreted from the single stem cell that has proliferated. And having a culture product solution first extraction step of extracting the product solution from the second culture vessel.
  • the first culture vessel in the stem cell first fixing step and the stem cell first culturing step, is allowed to stand statically for a predetermined time in a state where the first culture vessel is inclined at a predetermined angle, thereby stem cell second fixing.
  • the second culture vessel in the step and the stem cell second culture step, is statically left for a predetermined time in a state where the second culture vessel is inclined at a predetermined angle.
  • the culture product production method extracts the culture product solution from the second culture vessel in the culture product solution first extraction step, and then extracts the culture product solution from the second culture vessel.
  • a culture product solution second extraction step of extracting a culture product solution containing a predetermined metabolite secreted from the proliferated single species of second stem cells from the third culture vessel is included.
  • the third culture vessel is statically left for a predetermined time in a state where the third culture vessel is inclined at a predetermined angle.
  • the bone marrow fluid separation step collects 2 to 3 cc of bone marrow from a donor, and injects 2 to 3 cc of bone marrow into a separation container extending vertically.
  • the separation container is statically left at a temperature substantially the same as the body temperature for a predetermined time to separate the bone marrow fluid into layers in the vertical direction in the separation container, and the bone marrow fluid extraction step is performed to remove the bone marrow fluid separated into layers in the separation container.
  • the middle layer bone marrow fluid located in the middle layer is extracted.
  • the capacity of the first culture vessel is about 20 to 30 cc
  • the initial planar shape of the first stem cells is substantially circular
  • the first stem cells are deformed.
  • the planar shape is a flat shape in which the first stem cells are indefinitely elongated in one direction with a substantially circular nucleus, and in the first stem cell fixing step, the first culture vessel is kept at a temperature substantially the same as the body temperature for 12 to 24 hours. While standing statically, the deformation of the first stem cells in the first culture vessel from the initial planar shape is observed at intervals of about 1 to 2 hours during 12 to 24 hours. When deformed into a regular flat shape, it is determined that the first stem cells have settled on the bottom surface of the first culture vessel.
  • the first culture container in the first stem cell collection step, is statically allowed to stand for 36 to 48 hours at a temperature substantially the same as the body temperature for 36 to 48 hours.
  • the total planar area of the first stem cells that have settled on the bottom surface of the first culture vessel at about 1 to 2 hours is observed with respect to the bottom surface area of the first culture vessel.
  • the first target ratio of the total planar area of the first stem cells to the bottom area of the first culture vessel is 70 to 80%.
  • the stem cell separation step injects the first stem cells into a separation container, sets the separation container in a centrifuge, and centrifuges the first stem cells.
  • 1 collection process collect
  • the capacity of the second culture container is about 40-60 cc
  • the capacity of the third culture container is about 70-80 cc
  • the initial planar shape of the second stem cell Is substantially flat
  • the planar shape of the second stem cell after deformation is a flat shape in which the second stem cell is indefinitely elongated in one direction with the substantially circular shape as a nucleus.
  • the second and third culture containers are allowed to stand for 36 to 48 hours statically at the same temperature as the body temperature for 36 to 48 hours while the second and third culture containers are spaced at about 1 to 2 hours between 36 and 48 hours.
  • the second culture vessel and the third culture vessel are statically kept at a temperature substantially the same as the body temperature for 36 to 48 hours.
  • the total planar area of the second stem cells established on the bottom surfaces of the second and third culture vessels at intervals of about 1 to 2 hours during 36 to 48 hours with respect to the bottom surface areas of the second and third culture vessels Observe.
  • the second target ratio of the total planar area of the second stem cells to the bottom area of the second culture container is 88 to 92%
  • the bottom area of the third culture container The third target ratio of the total planar area of the second stem cells is 88-92%.
  • the first and second stem cells are mesenchymal stem cells.
  • the intermediate layer bone marrow fluid located in the intermediate layer of the bone marrow fluid separated into layers is extracted, and the intermediate layer bone marrow fluid is cultured with the culture solution to obtain the first stem cells.
  • the total planar area of the first stem cells reaches the first target ratio with respect to the bottom area of the first culture container while culturing the first stem cells while being fixed on the bottom surface of the first culture container, Collecting one stem cell and collecting the second stem cell located in the lowermost layer of the first stem cells separated into layers, culturing the second stem cell together with a culture solution, and cultivating the second stem cell to the bottom surface of the second culture vessel
  • the total planar area of the second stem cells reached the second target ratio with respect to the bottom area of the second culture vessel while injecting a new culture solution into the second culture vessel and culturing the second stem cells.
  • the product liquid can be made.
  • a culture product solution is produced using pure second stem cells from which unnecessary stem cells have been removed, and a predetermined kind of secreted from a single kind of second stem cells is produced in the culture product solution. Since it can contain only metabolites, it has a high therapeutic effect on a given disease, can make a culture product that has a high probability of completely curing the disease, and has a high effect on a given beauty.
  • a culture product solution can be made.
  • the first culture vessel is statically left for a predetermined time in a state inclined at a predetermined angle
  • the second culture is performed in the stem cell second fixing step and the stem cell second culturing step.
  • the method of producing a culture product solution in which the container is statically left for a predetermined time in a state where the container is inclined at a predetermined angle is obtained in a state where the first culture container is inclined at a predetermined angle in the stem cell first fixing step and the stem cell first culture step.
  • the method for producing a culture product includes the step of statically leaving the second culture vessel tilted at a predetermined angle for a predetermined time in the second stem cell fixing step and the second stem cell culture step, so that the bottom of the second culture vessel The second stem cell can be firmly established, and the proliferation of the second stem cell can be surely promoted.
  • the second stem cells are collected from the second culture vessel, the second stem cells are cultured with the culture solution, and the second stem cells have a larger capacity and a larger bottom surface than the second culture vessel.
  • the bottom surface of the third culture vessel is fixed to the bottom surface of the third culture vessel having a bottom surface area, a new culture solution is injected into the third culture vessel, and the second stem cells are cultured while the total planar area of the second stem cells is the bottom surface of the third culture vessel.
  • a culture product solution containing a predetermined metabolite secreted from a single type of second stem cell grown in the culture process of the second stem cell is extracted from the third culture vessel.
  • the second stem cells are further cultured in the third culture container, and when the total planar area of the second stem cells reaches the third target ratio with respect to the bottom area of the third culture container, Single species grown during the culture process Since the culture product solution containing a predetermined metabolite secreted from the second stem cell is extracted from the third culture vessel, the various stem cells are not cultured in the stem cell culturing process and are secreted from the various stem cells.
  • a variety of metabolites that contain only a specific metabolite secreted from a single type of second stem cell, and that produce a specific effect on a specific disease or a specific beauty
  • the culture product production method can produce a large amount of culture product at a time by using a third culture vessel having a larger capacity than the second culture vessel.
  • the method for producing a culture product solution in which the third culture vessel is statically left for a predetermined time in a state where the third culture vessel is inclined at a predetermined angle includes the stem cell third fixing step and the stem cell third culture.
  • the second stem cells can be reliably fixed on the bottom surface of the second culture container by allowing the third culture container to stand statically for a predetermined time in a state where the third culture container is inclined at a predetermined angle. Can be surely promoted.
  • bone marrow fluid separation step 2 to 3 cc of bone marrow fluid is collected from the donor, and 2 to 3 cc of bone marrow fluid is injected into a separation container extending in the vertical direction, and the separation container is statically fixed at a temperature substantially equal to the body temperature for a predetermined time. Culturing the bone marrow fluid by separating it into layers in the vertical direction in the separation container and extracting the intermediate layer bone marrow fluid located in the middle layer of the bone marrow fluid separated into layers in the separation container in the bone marrow fluid extraction step In the production method, bone marrow fluid containing various stem cells is statically left for a predetermined time at approximately the same temperature as the body temperature and separated into layers in the vertical direction.
  • the capacity of the first culture vessel is about 20-30 cc, the initial planar shape of the first stem cells is substantially circular, and the first stem cells are deformed in one direction with the deformed planar shape of the first stem cells as a nucleus.
  • the first culture vessel is statically left at a temperature substantially the same as the body temperature for 12 to 24 hours, and is about 1-2 for 12 to 24 hours.
  • the capacity of the first culture container exceeds 30 cc
  • the first stem cells are difficult to settle on the bottom surface of the first culture container and the growth of the first stem cells is slowed.
  • the first stem cells quickly and easily settle on the bottom surface of the first culture container, and the first stem cells proliferate quickly in the first culture container, so that a single type of stem cells can be made in a short period of time and unnecessary.
  • a large amount of a culture product solution containing only a predetermined metabolite secreted from a single kind of stem cell from which various stem cells have been removed can be produced in a short period of time.
  • the method for producing a culture product solution comprises the first culture container being left to stand for 12 to 24 hours at a temperature substantially the same as the body temperature, and the first culture container in the first culture container at intervals of about 1 to 2 hours during 12 to 24 hours.
  • the first stem cell was fixed on the bottom surface of the first culture vessel. Therefore, it is possible to accurately grasp the fixation of the first stem cell to the bottom surface of the first culture container by the change in the planar shape of the first stem cell without missing the fixation of the first stem cell to the bottom surface of the first culture container.
  • the bottom surface of the first culture container is left at about 1 to 2 hours between 36 and 48 hours while the first culture container is statically left at a temperature substantially the same as the body temperature for 36 to 48 hours.
  • the culture product producing method for observing the total planar area of the first stem cells settled on the first culture vessel with respect to the bottom area of the first culture vessel observes the total planar area at intervals of about 1 to 2 hours.
  • the total plane area relative to the bottom area of the culture vessel can be accurately confirmed, and the total plane area of the first stem cells has reached the first target ratio with respect to the bottom area of the first culture container.
  • the first stem cell can be collected from the first culture container while maintaining the activity of the first stem cell without mistaking the timing of collecting the first stem cell from the first culture container. Using a single species of trunk It can be made to ensure the culture product liquor containing only a predetermined metabolites secreted from cells.
  • the total planar area of the first stem cells relative to the bottom area of the first culture container is When the first stem cells proliferate in excess of 80%, the activity of the first stem cells is gradually lost, but when the total planar area of the first stem cells grows to 70-80% with respect to the bottom area of the first culture vessel.
  • the first stem cells since the first stem cells are collected from the first culture vessel, the activity of the first stem cells can be maintained, the first stem cells can be propagated while maintaining the activity, and the first stem cells are used.
  • a culture product solution containing only a predetermined metabolite secreted from a single kind of stem cell can be reliably produced.
  • the first stem cells are injected into a separation container, the separation container is placed in a centrifuge and the first stem cells are centrifuged.
  • the first stem cell collection step the first stem cells are centrifuged in layers in the separation container.
  • a method for producing a culture product solution for collecting second stem cells located in the lowermost layer of one stem cell includes separating first stem cells containing unnecessary stem cells into layers by centrifugation, and centrifuging the first stem cells into layers. By collecting the second stem cells located in the lowermost layer, specific second stem cells can be reliably extracted from the first stem cells, and unnecessary stem cells can be removed from the first stem cells.
  • the culture product production method can culture only a specific type of second stem cells to be cultured, and includes only a predetermined metabolite secreted from a single type of stem cell using the first stem cells. Can be made reliably.
  • the capacity of the second culture vessel is about 40 to 60 cc
  • the capacity of the third culture vessel is about 70 to 80 cc
  • the initial planar shape of the second stem cell is substantially circular
  • the planar shape after deformation of the second stem cell Is a flat shape in which the second stem cell is indefinitely elongated in one direction with a substantially circular nucleus
  • the second culture vessel and the third culture vessel are substantially the same as the body temperature in the second stem cell fixing step and the third stem cell fixing step. While standing statically for 36 to 48 hours at a temperature of 36 to 48 hours, the deformation from the initial planar shape of the second stem cells in the second and third culture vessels was observed at intervals of about 1 to 2 hours during 36 to 48 hours.
  • the culture product producing method for determining that the second stem cell has settled on the bottom surfaces of the second and third culture vessels Volume exceeds 60cc, 3rd culture
  • the capacity of the vessel exceeds 80 cc
  • the second stem cells are difficult to settle on the bottom surfaces of the second and third culture vessels and the growth of the second stem cells is slow, but the second and third culture vessels having the above-mentioned capacities are used.
  • the second stem cells are quickly and easily fixed on the bottom surfaces of the second and third culture vessels, and the second stem cells proliferate quickly in the second and third culture vessels.
  • a large amount of a culture product containing only a predetermined metabolite secreted from a single type of second stem cell from which unnecessary stem cells have been removed can be produced in a short period of time.
  • the production method of the culture product comprises the second and third culture vessels statically left at a temperature substantially the same as the body temperature for 36 to 48 hours, while the second and third culture containers are spaced at intervals of about 1 to 2 hours between 36 and 48 hours.
  • the second stem cell is second By determining that the second stem cells have settled on the bottom surface of the third culture container, the second stem cells are not missed by the second stem cells due to the change in the planar shape of the second stem cells.
  • the second and third culture vessels can be accurately fixed on the bottom surfaces of the second and third culture vessels, and the second stem cells are confirmed to be fixed on the bottom surfaces of the second and third culture vessels.
  • New medium while draining By injecting the nutrient solution into the second and third culture vessels, the proliferation of the second stem cell can be surely promoted, and a predetermined secreted from a single type of second stem cell using the second stem cell. A culture product containing only metabolites can be produced reliably.
  • the second and third culture vessels are statically left at the same temperature as the body temperature for 36 to 48 hours, and between about 36 and 48 hours, about 1-2 hours.
  • the method for producing a culture solution for observing the total planar area of the second stem cells fixed on the bottom surfaces of the second and third culture vessels with respect to the bottom surface area of the second and third culture vessels at intervals of about 1 to 2 hours By observing the planar area, the total planar area with respect to the bottom area of the second and third culture vessels of the second stem cells can be confirmed accurately, and the second stem cell is compared with the bottom areas of the second and third culture vessels.
  • the second stem cells can be collected from the second and third culture vessels without mistaking the timing. Retains stem cell activity
  • the second stem cells can be collected from the second and third culture vessels while the second stem cells are used to reliably produce a culture solution containing only a predetermined metabolite secreted from a single kind of stem cells. Can do.
  • the second target ratio of the total planar area of the second stem cells to the bottom area of the second culture container is 88 to 92%
  • the third target ratio of the total planar area of the second stem cells to the bottom area of the third culture container is 88.
  • the activity of the second stem cells is increased when the total planar area of the second stem cells with respect to the bottom area of the second and third culture vessels exceeds 92% and the second stem cells proliferate.
  • the second stem cells are collected from the second and third culture vessels when the total planar area of the second stem cells grows to 88-92% with respect to the bottom area of the second and third culture vessels.
  • the second stem cell can retain the activity, and the second stem cell can be proliferated while retaining the activity, and the second stem cell is used to secrete the second stem cell from a single type of second stem cell. Contains only the metabolites of Nutrient product solution can be made to ensure.
  • the method for producing a culture product in which the first and second stem cells are mesenchymal stem cells uses a variety of mesenchymal stem cells that are secreted from a variety of mesenchymal stem cells by using a single type of cultured second mesenchymal stem cells. It does not contain a variety of metabolites, contains only certain metabolites secreted from a single type of second mesenchymal stem cell, and is used for certain diseases such as skin care, hair care, and body care. It is possible to make a culture product solution that exhibits only a specific effect, to make a culture product solution that can be used effectively for treatment of a given disease, and to be used effectively for a given beauty. Possible culture products can be made.
  • a culture product solution is made using pure second mesenchymal stem cells from which unnecessary stem cells have been removed, and a single type of second mesenchymal stem cells is used as the culture product solution. Because it can contain only certain metabolites secreted from, it can produce a culture product that has a high therapeutic effect on a given disease and is highly established to completely cure the disease. It is possible to produce a culture product solution having a high effect on the above.
  • Explanatory drawing which shows an example of a bone marrow fluid separation process.
  • Explanatory drawing of the bone marrow fluid separation process continued from FIG.
  • Explanatory drawing which shows an example of a stem cell 1st observation process.
  • the partial enlarged view which shows an example of the planar shape of a 1st mesenchymal stem cell.
  • the elements on larger scale which show another example of the planar shape of a 1st mesenchymal stem cell.
  • the elements on larger scale which show another example of the planar shape of a 1st mesenchymal stem cell.
  • Explanatory drawing which shows an example of a stem cell isolation
  • Explanatory drawing which shows an example of a stem cell 2nd extraction process.
  • Explanatory drawing which shows an example of a stem cell 3rd observation process.
  • the elements on larger scale which show an example of the planar shape of a 2nd mesenchymal stem cell.
  • the elements on larger scale which show another example of the planar shape of a 2nd mesenchymal stem cell.
  • the elements on larger scale which show another example of the planar shape of a 2nd mesenchymal stem cell.
  • Explanatory drawing which shows an example of a stem cell 5th observation process.
  • FIG. 1 is a schematic configuration diagram of the culture product production system 10 shown as an example.
  • 2 is an explanatory view showing an example of the bone marrow fluid separation step
  • FIG. 3 is an explanatory view of the bone marrow fluid separation step continued from FIG.
  • FIG. 4 is an explanatory diagram of a bone marrow fluid separation process continued from FIG.
  • the culture product production method is a method of culturing a specific type of single mesenchymal stem cell (single seed stem cell) from a plurality of types of mesenchymal stem cells contained in bone marrow fluid, A culture product containing a secreted predetermined metabolite is produced.
  • bone marrow fluid raw material bone marrow fluid
  • bone marrow fluid extraction step stem cell first using the culture product production system 10.
  • a stem cell first culturing process a stem cell first collecting process, a stem cell separating process, a stem cell second collecting process, a stem cell second fixing process, a stem cell second culturing process, and a culture product solution first extracting process.
  • the stem cell first fixing step includes a stem cell first observation step
  • the stem cell second collection step includes a stem cell second observation step.
  • the stem cell second fixing step includes a stem cell third observation step
  • the culture product solution first extraction step includes a stem cell fourth observation step.
  • the stem cell third fixing step includes a stem cell fifth observation step
  • the culture product solution second extraction step includes a stem cell sixth observation step.
  • the culture product production system 10 includes a computer 11, a barcode reader 12, and an electron microscope 13.
  • the computer 11 includes a central processing unit (CPU or virtual CPU), a storage device (memory or virtual memory), and a large-capacity storage area (hard disk, virtual hard disk, etc.), and a physical OS (operating system) or virtual OS ( Virtual operating system).
  • An input device such as a keyboard 14 and a mouse 15 and an output device such as a display 16 and a printer (not shown) are connected to the computer 11 via an interface (wireless or wired).
  • donor data is managed using a QR code (registered trademark).
  • Donor data includes the donor's name, address, telephone number, date of birth, sex, blood type, height, weight, email address, and the like.
  • a QR code is used as a two-dimensional code, but in addition to the QR code, a matrix type SP code, VeriCode (MaxiCode), CP code, DataMatrix, Code1, AztecCode, Intercode Kuta code and card e can be used.
  • the two-dimensional code used in the system 10 includes all that will be developed in the future.
  • the bone marrow fluid 18 collected from the donor is separated into layers.
  • 2 to 3 cc (2 to 3 ml) of bone marrow fluid 18 is collected from the sternum or iliac bone (pelvis) of these donors.
  • the bone marrow fluid 18 is collected by “bone marrow puncture” (Marc), in which the donor is locally anesthetized and then the bone marrow is punctured to suck the bone marrow fluid (bone marrow blood).
  • a doctor, nurse, researcher, or other person in charge starts up the system 10 in the computer 11 simultaneously with the collection of the bone marrow fluid 18 and inputs donor data into the computer 11 using an input device such as a keyboard 14 or a mouse 15. To do.
  • the computer 11 generates a unique donor identifier that identifies each donor each time donor data is input (every time the bone marrow fluid 18 is collected from the donor), and stores the storage area in a state in which the donor data is associated with the donor identifier. (Donor data storage step).
  • the computer 11 converts the inputted donor data into a QR code (two-dimensional code) by a two-dimensional code writer function (two-dimensional code (QR code) conversion means), and the first code sheet 17 on which the QR code is printed
  • the QR code is stored (stored) in a storage area in association with a donor identifier that identifies each donor (two-dimensional code (QR code) storage step).
  • the second donor data is input, the second code sheet on which the QR code is printed is output.
  • the third code sheet on which the QR code is printed is output.
  • the first to nth code sheets are output according to different donors.
  • the QR code printed on the first code sheet 17 printed with NO1 includes a bone marrow fluid separation step, a bone marrow fluid extraction step, a stem cell first observation step, a stem cell first colonization step, a stem cell first culture step, a stem cell.
  • Second observation step stem cell first collection step, stem cell separation step, stem cell second collection step, stem cell third observation step, stem cell second colonization step, stem cell second culture step, stem cell fourth observation step, culture product solution first Extraction step, stem cell second collection step, stem cell third colonization step, stem cell third culture step, culture product solution second extraction step, stem cell second collection step, stem cell fifth observation step, stem cell third colonization step, stem cell third
  • the number 1 indicating the culture step, the sixth stem cell observation step, and the culture product second extraction step is stored.
  • the computer 11 stores the donor data stored in the storage area and the donor data indicated by the QR code read by the barcode reader 12. Compare.
  • cc of bone marrow fluid 18 collected from the donor is injected (accommodated) into a glass test tube 19 (separation container) extending vertically.
  • the 2-3 cc bone marrow fluid 18 contains 0.5 to 1 ml (about 5 ⁇ 10 7 (cells / ml)) of a plurality of types of mesenchymal stem cells.
  • a first code sheet 17 is attached to the outer peripheral surface of the glass test tube 19 into which the bone marrow fluid 18 is injected.
  • the glass test tube 19 into which the bone marrow fluid 18 has been injected is set in a test tube stand 20 and accommodated in a thermostatic chamber 21 together with the test tube stand 20.
  • a person in charge such as a doctor, nurse, researcher or the like attaches the first code sheet 17 on which the QR code is printed on the outer peripheral surface of the glass test tube 19, and then attaches the QR code of the glass test tube 19 to the barcode reader 12. Let me read.
  • the barcode reader 12 is connected to the computer 11 via an interface (wired or wireless).
  • the bar code reader 12 transmits the read QR code to the computer 11.
  • the computer 11 extracts the number 1 and the donor data indicated by the QR code transmitted from the barcode reader 12 from the storage area and reads them into the cache memory, and displays a process first display screen (not shown) on the display 16. .
  • a process first display screen On the process first display screen, number 1 and donor data are displayed, and a bone marrow fluid separation button, a bone marrow fluid extraction button, a stem cell first observation button, a stem cell second observation button, a stem cell first collection button, and a logout button Is displayed.
  • the logout button is clicked, the system 10 stops in the computer 11.
  • the person in charge clicks the bone marrow fluid separation button displayed on the display 16, injects the bone marrow fluid 18 into the glass test tube 19 from the syringe, and inserts the glass test tube 19 into which the bone marrow fluid 18 is injected into the test tube stand 20.
  • the person in charge accommodates the test tube stand 20 in a thermostatic chamber 21 and statically leaves the glass test tube 19 into which the bone marrow fluid 18 has been injected in the thermostatic chamber 21 for a predetermined time (about 2 hours). (Leave quietly without moving).
  • the temperature in the thermostatic chamber 21 is maintained at about 36 to 37 ° C., which is substantially the same as the body temperature.
  • the computer 11 displays the number 1 and the donor data indicated by the QR code printed on the first code sheet 17 on the display 16, and displays a bone marrow fluid separation in progress message and a bone marrow fluid separation end button on the display 16.
  • the bone marrow fluid 18 injected into the test tube 20 is vertically moved in the test tube 20 as shown in FIG. Separated into several layers (bone marrow fluid separation step).
  • Stem cell culture usually requires 150 to 200 cc (150 to 200 ml) of bone marrow fluid, but the production method of the culture product is based on a single type of stem cell from a small amount of 2 to 3 cc of bone marrow fluid 18 collected from a donor. Therefore, a small amount of 2 to 3 cc of bone marrow fluid 18 may be collected from the donor, and the burden on the donor when collecting bone marrow fluid 18 can be minimized.
  • the bone marrow fluid extraction step is performed after the bone marrow fluid separation step in which the bone marrow fluid 18 is separated into layers.
  • the intermediate layer bone marrow fluid 22 is extracted from the bone marrow fluid 18 separated into layers.
  • the person in charge confirms that the bone marrow fluid 18 has been separated into layers, and then clicks the bone marrow fluid separation end button displayed on the display 16.
  • the computer 11 displays a process second display screen (not shown) on the display 16.
  • number 1 and donor data are displayed, and a bone marrow fluid separation end message, a bone marrow fluid extraction button, a stem cell first observation button, a stem cell second observation button, and a stem cell first collection button are displayed.
  • the person in charge clicks the bone marrow fluid extraction button on the process second display screen, and causes the barcode reader 12 to read the QR code of the glass test tube 19.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16 and a bone marrow fluid separation end message, a bone marrow fluid extraction in progress message, and a bone marrow fluid extraction end button are displayed on the display. .
  • the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge takes out the test tube stand 20 from the thermostatic chamber 21, pulls out the glass test tube 19 from the test tube stand 20, and extracts the intermediate layer bone marrow fluid 22 existing in a specific layer of the bone marrow fluid 18 separated into layers. (Bone marrow fluid extraction process).
  • the person in charge extracts (suctions) the intermediate layer bone marrow fluid 22 having a layer thickness of 2 to 4 mm located in the intermediate layer of the bone marrow fluid 18 separated into layers using a syringe (not shown).
  • the intermediate layer bone marrow fluid 22 having a layer thickness of 2 to 4 mm located in the intermediate layer of the bone marrow fluid 18 separated into layers using a pipette (not shown) is extracted (suctioned).
  • bone marrow fluid 18 containing various mesenchymal stem cells is separated into layers in the vertical direction, and then a specific intermediate layer bone marrow fluid 22 is obtained from bone marrow fluid 18 by using a syringe or pipette. Can be reliably extracted, and unnecessary mesenchymal stem cells contained in the bone marrow fluid 18 can be removed.
  • FIG. 5 is an explanatory view showing an example of the first stem cell observation step
  • FIG. 6 is a side view of the first flat culture vessel
  • FIG. 7 is a partially enlarged view showing an example of the planar shape of the first mesenchymal stem cell 26
  • FIG. 8 is a partially enlarged view showing another example of the planar shape of the first mesenchymal stem cell 26. 7 and 8 show enlarged images of the planar shape of the first mesenchymal stem cell 26 taken by the electron microscope 13.
  • the stem cell first observation step is performed after the bone marrow fluid extraction step of extracting a specific middle layer bone marrow fluid 22 located in the middle layer from the bone marrow fluid 18.
  • the intermediate layer bone marrow fluid 22 and the culture solution 23 are injected (contained) into the first flat culture vessel 24 (first culture vessel), and the temperature inside the culture vessel 24 is substantially the same as the body temperature (about 36).
  • the culture vessel 24 is statically left for 12 to 24 hours (slowly left unmoved) while being held at 37 ° C).
  • a person in charge such as a doctor, nurse, or researcher extracts a specific intermediate layer bone marrow fluid 22 from the bone marrow fluid 18 and then clicks a bone marrow fluid extraction end button displayed on the display 16.
  • the computer 11 displays a process third display screen (not shown) on the display 16.
  • process third display screen On the process third display screen, number 1 and donor data are displayed, and a bone marrow separation end message, a bone marrow extraction end message, a stem cell first observation button, a stem cell second observation button, and a stem cell first collection button are displayed. Is done.
  • the person in charge attaches the first code sheet 17 on which the QR code is printed to the bottom surface 27 (the outer surface of the bottom wall) of the first flat culture vessel 24.
  • the stem cell first observation button on the process third display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 24.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. If the donor data match, the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation in progress message, stem cell first Display the observation end button on the display. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge injects (accommodates) the intermediate layer bone marrow fluid 22 sucked into the syringe or pipette into the culture container 24 and injects (accommodates) the culture medium 23 into the culture container 24 using the syringe or pipette.
  • the first flat culture vessel 24 (first culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 with a small capacity and a predetermined area and having a substantially square shape.
  • the first flat culture vessel 24 has a top 40 and a bottom 38 and an inlet 41 formed in the top 40.
  • the injection port 41 is watertightly closed by a lid 42.
  • the first flat culture container 24 As the first flat culture container 24, a flat container having a small volume and a bottom surface 27 having a predetermined area and having a circular or elliptical planar shape may be used.
  • the first flat culture vessel 24 used in the first stem cell observation means has a capacity of about 20-30 cc (preferably 25 cc) and a bottom area of about 25-36 mm 2 .
  • the culture container 24 has a side length of 5 to 6 mm.
  • the culture solution 23 is a mineral salt to which penicillin (about 100 U / ml), amphotericin (about 100 ng / ml), streptomycin (about 100 mg / ml), L-glutamine (about 2 to 4 ml) and 20% fetal bovine serum are added. Solutions and amino acids are included.
  • the first mesenchymal stem cells 26 contained in the intermediate layer bone marrow fluid 22 injected into the culture vessel 24 are cultured in the culture solution 23 while being fixed on the bottom surface 27 of the culture vessel 24 over time. It gradually grows (differentiates) on the bottom surface 27 to form a colony.
  • Dulbecco's Modified a Eagle's Medium DMEM
  • GMEM Grasgo Minimum Essential Medium
  • RPMI 640 RPMI 640
  • insulin transferrin, ethanolamine, selenium, 2-mercaptoethanol, L-alanyl-L-glutamine, sodium pyruvate, L-alanine, L-asparagine, L-aspartic acid, glycine, L-proline L-serine or the like can also be added.
  • the person in charge injects the intermediate layer bone marrow fluid 22 and the culture solution 23 into the first flat culture vessel 24 and then installs (sets) the culture vessel 24 in the sample holder of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 38 of the first flat culture vessel 24, and the bottom portion 38 of the culture vessel 24 is held in a state of being lifted by the spacer 39.
  • the culture vessel 24 is held at a predetermined angle so that the bottom 38 of the vessel 24 is on top and the top 40 (inlet 41) of the culture vessel 24 is on the bottom.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 40 of the first flat culture vessel 24, and the top 40 of the culture vessel 24 is held in a state of being lifted by the spacer 39.
  • the inclination angle ⁇ 1 of the first flat culture vessel 24 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the first flat culture vessel 24 is inclined at the inclination angle with respect to the upper surface 37 of the sample holder 36 so that the intermediate bone marrow fluid 22 and the culture solution 23 are contained in the culture vessel 24 in the culture vessel 24.
  • the first mesenchymal system is biased toward the top 40 (or the bottom 38), and the water pressure between the intermediate bone marrow fluid 22 and the culture fluid 23 increases on the top 49 side (or the bottom 38 side) of the culture vessel 24.
  • the stem cells 26 are concentrated on the bottom 38 side of the culture vessel 24, thereby increasing the activity of the first mesenchymal stem cells 26, and the first mesenchymal stem cells 26 are easily and quickly fixed on the bottom surface 27 of the culture vessel 24. Can be made.
  • the electron microscope 13 is connected to the computer 11 via an interface (wired or wireless).
  • the electron microscope 13 has an image capturing function for capturing an enlarged image of a subject using an image sensor, and also has an image transmission function for transmitting the enlarged image to the computer 11.
  • the electron microscope 13 takes magnified images of the planar shape of the first mesenchymal stem cells 26 contained in the intermediate layer bone marrow fluid 22 injected into the culture vessel 24 at intervals of about 1 to 2 hours, and the planar surface of the photographed stem cells 26 is taken.
  • the enlarged image of the shape is transmitted to the computer 11 at intervals of about 1 to 2 hours.
  • the image capturing interval and the image transmission interval in the electron microscope 13 can be freely set within 1 to 2 hours by an input device such as a keyboard 14 or a mouse 15.
  • the computer 11 stores (stores) the enlarged image of the planar shape of the first mesenchymal stem cell 26 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (first storage of the stem cell image) Process).
  • the computer 11 displays on the display 16 an enlarged image of the planar shape of the stem cell 28 transmitted from the electron microscope 13 and the imaging time.
  • the person in charge confirms (views) the enlarged image of the planar shape of the stem cell 26 displayed on the display 16 at intervals of about 1 to 2 hours during 12 to 24 hours, and determines the stem cells 26 contained in the intermediate layer bone marrow fluid 22.
  • a change in planar shape is observed (stem cell first observation step).
  • the person in charge may directly observe the change in the planar shape of the first mesenchymal stem cell 26 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 12 to 24 hours.
  • the first mesenchymal stem cell 26 is fixed to the bottom surface 27 of the first flat culture vessel 24 (first culture vessel) while culturing the first mesenchymal stem cell 26 contained in the intermediate layer bone marrow fluid. (Stem cell first fixing step).
  • the initial planar shape of the first mesenchymal stem cell 26 is substantially circular.
  • the stem cell 26 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24, and the stem cell. 26 has not started to proliferate (differentiate).
  • the planar shape after the deformation of the first mesenchymal stem cell 26 is a flat shape in which the stem cell 26 is stretched (expanded) in one direction (predetermined direction) with a substantially circular shape before fixing as a nucleus, and the stem cell 26 is a culture vessel. 24 has settled on the bottom surface 27 (inner surface of the bottom wall), and the stem cells 26 have started to grow (differentiate).
  • the person in charge As a result of the observation in the first stem cell observation step, the person in charge, as shown in FIG. 6, when the enlarged image of the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 is observed in a substantially circular shape, It is determined that the stem cells 26 are not settled on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24, and the change in the planar shape of the stem cells 26 is continuously observed at intervals of about 1 to 2 hours.
  • the person in charge As a result of the observation in the first stem cell observation step, the person in charge, as shown in FIG. 7, has a flat shape in which the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 is from an approximately circular shape to an approximately circular shape. When the shape is deformed, it is determined that the stem cell 26 has settled on the bottom surface 27 of the culture vessel 24.
  • the stem cell 26 becomes difficult to settle on the bottom face of the container and the proliferation of the stem cell 26 is slow.
  • the stem cell 26 can be easily fixed on the bottom surface 27 of the culture container 24 by using the first flat culture container 24 having the above-described capacity and the bottom surface area. The stem cell 26 can be rapidly proliferated.
  • the culture product producing method is such that the culture container 24 is left to stand at a temperature substantially the same as the body temperature for 12 to 24 hours, and the first interval in the culture container 24 is about 1 to 2 hours between 12 and 24 hours. Since the deformation of the leaf stem cells 26 from the initial planar shape is observed, the deformation of the stem cells 26 is not missed, and the establishment of the stem cells 26 on the bottom surface 27 of the culture vessel 24 can be confirmed accurately.
  • FIG. 9 is a partially enlarged view showing another example of the planar shape of the first mesenchymal stem cell 26.
  • FIG. 9 shows an enlarged image of the planar shape of the first mesenchymal stem cell 26 photographed by the electron microscope 13.
  • the first mesenchymal stem cell 26 (first stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with a substantially circular shape as a nucleus, and the first stem cell 26 has a first shape.
  • the stem cell first fixing step in which the fixation on the bottom surface 27 of the flat culture vessel 24 (first culture vessel) is confirmed, the stem cell first culturing step and the stem cell second observation step are performed.
  • the culture solution 23 injected into the culture vessel 24 is discharged (discarded) from the culture vessel 24, and a new culture solution 23 is injected (accommodated) into the culture vessel 24.
  • the culture vessel 24 is statically left (i.e., silently left unmoved) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the first mesenchyme relative to the bottom surface area of the culture vessel 24 is left.
  • the stem cells 26 are cultured until the total planar area of the stem cells 26 reaches the first target ratio (stem cell first culture step).
  • the total planar area of the first mesenchymal stem cells 26 fixed to the bottom surface 27 of the culture vessel 24 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 24. It is determined whether or not the total planar area of the stem cells 26 has reached the first target ratio with respect to the bottom area of the culture vessel 24.
  • the first target ratio of the total planar area of the first mesenchymal stem cell 26 to the bottom surface area of the culture vessel 24 is 70 to 80% (70 to 80% confluent).
  • the computer 11 displays a process fourth display screen (not shown) on the display 16.
  • number 1 and donor data are displayed, and a bone marrow fluid separation end message, a bone marrow fluid extraction end message, a stem cell first observation end message, a stem cell second observation button, and a stem cell first collection button are displayed. Is displayed.
  • the person in charge clicks the stem cell second observation button on the process fourth display screen, removes the culture container 24 from the sample holder of the electron microscope 16, and causes the barcode reader 12 to read the QR code of the culture container 24.
  • the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation An ongoing message and a stem cell second observation end button are displayed on the display 16.
  • the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge discharges (discards) the culture solution 23 injected into the culture vessel 24 in the stem cell first observation step from the culture vessel 24 and injects (accommodates) the new culture solution 23 into the culture vessel 24.
  • the new culture solution 23 is the same as that injected in the stem cell first observation step.
  • the person in charge injects a new culture solution 23 into the culture vessel 24 and then installs (sets) the culture vessel 24 in the sample holder of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 38 of the first flat culture vessel 24, and the bottom portion 38 of the culture vessel 24 is held in a state of being lifted by the spacer 39.
  • the culture vessel 24 is held at a predetermined angle so that the bottom 38 of the vessel 24 is on top and the top 40 (inlet 41) of the culture vessel 24 is on the bottom (see FIG. 6).
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 40 of the first flat culture vessel 24, and the top 40 of the culture vessel 24 is held in a state of being lifted by the spacer 39.
  • the inclination angle ⁇ 1 of the first flat culture vessel 24 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the culture product production method injects a new culture solution 23 into the culture vessel 24 while discharging the culture solution 23 in the culture vessel 24. Proliferation can be reliably promoted.
  • the first mesenchymal stem cell 26 and the culture solution 23 are cultured in the culture vessel 24 by inclining the first flat culture vessel 24 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 40 side (or the bottom 38 side) of the container 24, and the water pressure between the first mesenchymal stem cell 26 and the culture solution 23 increases on the top 40 side (or the bottom 38 side) of the culture container 24.
  • the first mesenchymal stem cells 26 concentrate on the bottom 38 side of the culture vessel 24, thereby increasing the activity of the first mesenchymal stem cells 26, and the first mesenchymal stem cells 26 are formed on the bottom surface 27 of the culture vessel 24. Can be propagated (differentiated) easily and rapidly.
  • the electron microscope 13 takes an enlarged image of the planar shape of the first mesenchymal stem cell 26 in the culture vessel 24 at intervals of about 1 to 2 hours, and takes an enlarged image of the planar shape of the photographed stem cell 26 for about 1 to 2 hours. It transmits to the computer 11 at intervals.
  • the computer 11 stores (stores) the enlarged image of the planar shape of the stem cell 26 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image second storage step).
  • the computer 11 displays the enlarged image of the planar shape of the stem cell 26 transmitted from the electron microscope 13 and the imaging time on the display 16.
  • the person in charge confirms (views) the enlarged image of the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours. While observing the total planar area of the stem cells 26 settled on the bottom surface area of the culture container 24, the total planar area of the stem cells 26 reaches the first target ratio (70 to 80% confluent) with respect to the bottom surface area of the culture container 24. It is determined whether or not (stem cell second observation step). The person in charge directly observes the total planar area of the first mesenchymal stem cell 26 with respect to the bottom surface area of the culture vessel 24 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total planar area of 26 has reached the first target ratio (70 to 80% confluent) with respect to the bottom area of the culture vessel 24.
  • the person in charge shows that the total planar area with respect to the bottom area of the culture vessel 24 of the first mesenchymal stem cell 26 displayed on the display 16 is the first target ratio as shown in FIG. If it has not reached (70 to 80% confluence), the total planar area of the stem cells 26 relative to the bottom area of the culture vessel 24 is continuously observed at intervals of about 1 to 2 hours.
  • the total plane area of the first mesenchymal stem cell 26 reaches the first target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 24 of the stem cell 26 It is assumed that the area has reached the first target ratio.
  • the first mesenchymal stem cell 26 grows on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24 to form a colony, and the planar shape of the stem cell 26 expands.
  • the first target ratio 70 to 80% confluent
  • the first mesenchymal stem cells 26 grown (differentiated) in the culture vessel 24 are cultured in the culture vessel 24. Taken from.
  • a person in charge such as a doctor, nurse, or researcher, confirms that the total planar area of the first mesenchymal stem cell 26 relative to the bottom area of the culture vessel 24 has reached the first target ratio, and then is displayed on the display 16. Click the button for ending stem cell second observation.
  • the computer 11 displays a process fifth display screen (not shown) on the display 16.
  • process fifth display screen number 1 and donor data are displayed, bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation end message, stem cell first collection button Is displayed.
  • the person in charge clicks the stem cell first collection button on the process fifth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 24.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation An end message, a stem cell first collection execution message, and a stem cell first collection end button are displayed on the display 16.
  • the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge discharges (discards) the culture solution 23 in the second observation of the stem cells injected into the culture vessel 24 from the culture vessel 24 using a syringe or pipette, and after washing the inside of the culture vessel 24 with PBS, The trypsin solution sucked into the syringe or pipette is injected into the culture container 24.
  • the trypsin solution is injected into the culture vessel 24
  • the first mesenchymal stem cells 26 fixed on the bottom surface 27 of the culture vessel 24 are detached from the bottom surface 27 by the trypsin solution and float on the water surface of the trypsin solution.
  • the person in charge collects (suctions) the stem cells 26 using a pipette, and stores the stem cells 26 in the pipette (stem cell first collection step).
  • the culture product production method can accurately confirm the total planar area with respect to the bottom area of the culture vessel 24 of the first mesenchymal stem cell 26, It can be ascertained that the total planar area of the stem cells 26 has reached the first target ratio with respect to the bottom surface area of the culture vessel 24.
  • FIG. 10 is an explanatory diagram showing an example of the stem cell separation step.
  • a stem cell separation step is performed.
  • the first mesenchymal stem cells 26 collected by the first collection means are centrifuged in layers by the centrifuge 28.
  • a person in charge, such as a doctor, nurse, or researcher aspirates the first mesenchymal stem cell 26 from the culture vessel 24 into the pipette, and then clicks the stem cell first collection end button displayed on the display 16.
  • the computer 11 displays a process sixth display screen (not shown) on the display 16.
  • a process sixth display screen On the process sixth display screen, number 1 and donor data are displayed, and a stem cell separation button, a stem cell second extraction button, a stem cell third observation button, a stem cell fourth observation button, and a first extraction button are displayed.
  • the person in charge affixes the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the glass test tube 29 into which the first mesenchymal stem cells 26 are injected.
  • the stem cell separation button on the process sixth display screen is clicked, and the QR code of the glass test tube 29 is read by the barcode reader 12.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and a stem cell separation in progress message and a stem cell separation end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge injects (accommodates) the first mesenchymal stem cell 26 in the pipette into the glass test tube 29 and installs (sets) the glass test tube 29 in the centrifuge 28.
  • the person in charge centrifuges the stem cells 26 with the centrifuge 28 for a predetermined time, and then removes the glass test tube 29 from the centrifuge 28.
  • the first mesenchymal stem cells 26 in the glass test tube 29 are separated into several layers in the vertical direction by the centrifuge 28 (stem cell separation step).
  • FIG. 11 is an explanatory diagram showing an example of the second stem cell collection step.
  • a stem cell second collection step is performed.
  • second mesenchymal stem cells 30 located in the lower layer (lowermost layer) are collected from the first mesenchymal stem cells 26 separated into layers.
  • a doctor, nurse, researcher, or other person in charge uses the centrifuge 28 to separate the first mesenchymal stem cells 26 in layers in the vertical direction, and then removes the glass test tube 29 from the centrifuge 28 and displays the display 16. Click the stem cell separation end button displayed in.
  • the computer 11 displays a process seventh display screen (not shown) on the display 16.
  • a process seventh display screen (not shown) on the display 16.
  • number 1 and donor data are displayed, and a stem cell separation end message, a stem cell second collection button, a stem cell third observation button, a stem cell fourth observation button, and a culture product solution first extraction button are displayed. Is displayed.
  • the person in charge clicks the stem cell second collection button on the process seventh display screen, and causes the barcode reader 12 to read the QR code of the glass test tube 29.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and a stem cell separation end message, a stem cell second collection in progress message, and a stem cell second collection end button are displayed on the display 16. indicate. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge collects the second mesenchymal stem cell 30 present in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers in the glass test tube 29 (second stem cell collecting step).
  • the person in charge collects (sucks) the second mesenchymal stem cells 30 located in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers using a syringe.
  • the second mesenchymal stem cells 30 located in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers using a pipette are collected (sucked).
  • the production method of the culture product is obtained by centrifuging the first mesenchymal stem cells 26 containing unnecessary stem cells with a centrifuge 28 and separating them in layers in the vertical direction.
  • a specific second mesenchymal stem cell 30 can be reliably collected from the stem cell 26, and unnecessary mesenchymal stem cells are removed from the stem cell 26. can do.
  • the stem cell 26 When the total planar area of the first mesenchymal stem cell 26 with respect to the bottom surface area of the first flat culture vessel 24 (first culture vessel) exceeds 80% and the stem cell 26 proliferates, Although the activity is gradually lost, the stem cell 26 is collected from the culture vessel 24 when the total planar area of the stem cell 26 grows to 70 to 80% of the bottom surface area of the culture vessel 24, so that the activity of the stem cell 26 is retained.
  • the stem cells 26 can be proliferated while maintaining the activity, and the second mesenchymal stem cells 30 having activity can be collected from the stem cells 26.
  • FIG. 12 is an explanatory view showing an example of the third observation process of stem cells included in the second fixing means
  • FIG. 13 is a side view of the second flat culture vessel
  • FIG. 14 is a partially enlarged view showing an example of the planar shape of the second mesenchymal stem cell 30,
  • FIG. 15 is a partially enlarged view showing another example of the planar shape of the second mesenchymal stem cell 30. 14 and 15 show enlarged images of the planar shape of the second mesenchymal stem cell 30 photographed by the electron microscope 13.
  • the stem cell third observation step and the stem cell second colonization step are performed after the stem cell second collection step in which specific second mesenchymal stem cells 30 located in the lower layer (lowermost layer) are collected from the first mesenchymal stem cell 26. .
  • the second mesenchymal stem cell 30 and the culture solution 23 are injected (contained) into the second flat culture vessel 25 (second culture vessel), and the culture vessel 25 is heated to the body temperature. It is left to stand statically (without moving) for 36 to 48 hours at substantially the same temperature (about 36 to 37 ° C.).
  • Deformation from the initial planar shape of the second mesenchymal stem cell 30 (second stem cell) in the culture vessel 25 is observed with the electron microscope 13 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours. It is determined whether or not the bottom surface 27 of the culture vessel 25 is fixed.
  • a first code sheet 17 on which a QR code specifying a donor is printed is attached to the bottom surface 27 (outer surface of the bottom wall) of the culture vessel 25 into which the second mesenchymal stem cells 30 and the culture solution 23 are injected.
  • a person in charge such as a doctor, a nurse, or a researcher collects a specific second mesenchymal stem cell 30 from the first mesenchymal stem cell 26 and then clicks a stem cell second collection end button displayed on the display 16. .
  • the computer 11 displays a process eighth display screen (not shown) on the display 16.
  • process eighth display screen number 1 and donor data are displayed, a stem cell separation end message, a stem cell second collection end message, a stem cell third observation button, a stem cell fourth observation button, and a culture solution first extraction button Is displayed.
  • the person in charge attaches the first code sheet 17 on which the QR code is printed to the bottom surface 27 (outer surface of the bottom wall) of the second flat culture vessel 25.
  • the third stem cell observation button on the process eighth display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 25.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation in progress message, the stem cell third An observation end button is displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge injects (accommodates) the second mesenchymal stem cell 30 sucked into the syringe or pipette into the culture container 25 and injects (accommodates) the culture solution 23 into the culture container 25.
  • the second flat culture vessel 25 (second culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 having a predetermined capacity and a predetermined area and having a substantially square shape. The area is about twice that of the first flat culture vessel 24 (first culture vessel).
  • the second flat culture vessel 25 has a top portion 43 and a bottom portion 44 and an injection port 45 formed in the top portion 43.
  • the injection port 45 is watertightly closed by a lid 46.
  • a flat vessel having a circular shape or an elliptical shape having a bottom surface 27 having a predetermined capacity and a predetermined area may be used.
  • the second flat culture vessel 25 (second culture vessel) used in the third stem cell observation step has a capacity of about 40 to 60 cc (preferably 50 cc) and a bottom area of about 50 to 72 mm 2 . .
  • the culture container 25 has a side length of about 7 to 8.5 mm.
  • the culture solution 23 is the same as that injected in the first observation of stem cells.
  • the second mesenchymal stem cells 30 injected into the culture vessel 25 are cultured with the culture solution 23 while being fixed on the bottom surface 27 of the culture vessel 25 as time passes, and gradually grow (differentiate) on the bottom surface 27 of the culture vessel 25. To form colonies.
  • the person in charge injects the second mesenchymal stem cell 30 and the culture solution 23 into the second flat culture vessel 25 and then installs (sets) the culture vessel 25 in the sample holder 36 of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 44 of the second flat culture vessel 25, and the bottom portion 44 of the culture vessel 25 is held in a state lifted by the spacer 39.
  • the culture vessel 25 is held in a state inclined at a predetermined angle such that the bottom portion 44 of the culture vessel is on the top and the top portion 43 (injection port 45) of the culture vessel 25 is on the bottom.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 43 of the second flat culture vessel 25, and the top 43 of the culture vessel 25 is held in a state lifted by the spacer 39.
  • the inclination angle ⁇ 2 of the second flat culture vessel 25 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 25 by inclining the second flat culture vessel 25 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 43 side (or the bottom 44 side) of the container 25, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 43 side (or the bottom 44 side) of the culture container 25.
  • the second mesenchymal stem cells 30 are concentrated on the bottom 44 side of the culture vessel 25, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 on the bottom surface 27 of the culture vessel 25. Can be fixed easily and quickly.
  • the electron microscope 13 takes a magnified image of the planar shape of the second mesenchymal stem cell 30 injected into the culture vessel 25 at intervals of about 1 to 2 hours, and the magnified image of the planar shape of the photographed stem cell 30 is approximately 1 to 2 times. It transmits to the computer 11 at intervals of 2 hours.
  • the computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in a storage area in a state associated with the donor identifier (stem cell image third memory). Process).
  • the computer 11 displays the enlarged image of the planar shape of the stem cell 30 and the imaging time transmitted from the electron microscope 13 on the display 16.
  • the person in charge checks (views) the enlarged image of the planar shape of the stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours, and observes the change in the planar shape of the stem cell 30 ( Stem cell third observation step).
  • the person in charge may directly observe the change in the planar shape of the stem cell 30 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours.
  • the initial planar shape of the second mesenchymal stem cell 30 is substantially circular.
  • the stem cell 30 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 25, and the stem cell. 30 has not started to proliferate (differentiate).
  • the planar shape after deformation of the second mesenchymal stem cell 30 is a flat shape in which the stem cell 30 extends in an indefinite shape in one direction with a substantially circular shape before fixation as a nucleus, and the stem cell 30 is a bottom surface 27 (bottom wall) of the culture vessel 25.
  • the stem cell 30 has started to proliferate (differentiate).
  • the person in charge looks at the stem cell 30 when the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 remains substantially circular as shown in FIG. It is determined that the bottom surface 27 (inner wall inner surface) of the culture vessel 25 has not settled, and the change in the planar shape of the stem cell 30 is continuously observed at intervals of about 1 to 2 hours.
  • the person in charge has an irregular flat shape in which the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 is from a substantially circular shape to a substantially circular shape as a nucleus. When the shape is deformed, it is determined that the stem cell 30 has settled on the bottom surface 27 of the culture vessel 25 (stem cell second fixing step).
  • the stem cell 30 becomes difficult to settle on the bottom surface of the container and the proliferation of the stem cell 30 is slow.
  • the stem cell 30 can be easily fixed on the bottom surface 27 of the culture container 25 by using the second flat culture container 25 having the above-mentioned capacity and the bottom surface area. The stem cell 30 can be rapidly proliferated.
  • the method for producing a culture product solution is to leave the culture vessel 25 statically at a temperature substantially the same as the body temperature for 36 to 48 hours, and at intervals of about 1 to 2 hours between 36 and 48 hours. Since the deformation of the leaf stem cells 30 from the initial planar shape is observed, the deformation of the stem cells 30 is not overlooked, and the establishment of the stem cells 30 on the bottom surface 27 of the culture vessel 25 can be confirmed accurately.
  • FIG. 16 is a partially enlarged view showing another example of the planar shape of the second mesenchymal stem cell 30, and FIG. 17 shows an example of preservation of the extracted culture product solution 31 and the second mesenchymal stem cell 30.
  • FIG. FIG. 16 shows an enlarged image of the planar shape of the second mesenchymal stem cell 30 photographed by the electron microscope 13.
  • the second mesenchymal stem cell 30 (second stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with a substantially circular shape as a nucleus, and the second stem cell 30
  • the stem cell second culture step and the stem cell fourth observation step are performed after the stem cell third observation step in which the fixation to the bottom surface 27 of the flat culture vessel 25 (second culture vessel) is confirmed.
  • the culture solution 23 injected into the culture vessel 25 is discharged (discarded) from the culture vessel 25, and a new culture solution 23 is injected (accommodated) into the culture vessel 25. Is done.
  • the culture vessel 25 is left to stand statically (without moving) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the second mesenchymal stem cell 30 is cultured in the culture vessel 25. (Stem cell second culture step).
  • the total planar area of the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 25 at intervals of about 1 to 2 hours in the standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 25; It is determined whether or not the total planar area of the stem cells 30 has reached the second target ratio with respect to the bottom area of the culture vessel 25.
  • the second target ratio of the total planar area of the second mesenchymal stem cell 30 to the bottom surface area of the culture vessel 25 is 88 to 92% (88 to 92% confluent).
  • a person in charge such as a doctor, nurse, or researcher, confirms that the second mesenchymal stem cell 30 has settled on the bottom surface 27 of the culture vessel 25, and then clicks the stem cell third observation end button displayed on the display 16.
  • the computer 11 displays a process eighth display screen (not shown) on the display 16.
  • process eighth display screen number 1 and donor data are displayed, a stem cell separation end message, a stem cell second collection end message, a stem cell third observation end message, a stem cell fourth observation button, and a culture product solution first extraction A button is displayed.
  • the person in charge clicks the stem cell fourth observation button on the process eighth display screen, removes the culture vessel 25 from the sample holder of the electron microscope 13, and causes the barcode reader 12 to read the QR code of the culture vessel 25.
  • the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data displayed on the display 16 (donor data read into the memory) and the donor data indicated by the QR code read by the barcode reader.
  • the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation are performed.
  • a middle message and a stem cell fourth observation end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge discharges (discards) the culture solution 23 injected into the culture vessel 25 in the stem cell second culture step and the stem cell fourth observation step, and injects (accommodates) the new culture solution 23 into the culture vessel 25.
  • the new culture solution 23 is the same as that injected in the stem cell first observation means.
  • the person in charge injects a new culture solution 23 into the culture vessel 25 and then installs (sets) the culture vessel 25 on the sample holder of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 44 of the second flat culture vessel 25, and the bottom portion 44 of the culture vessel 25 is held in a state lifted by the spacer 39.
  • the culture vessel 25 is held in a state inclined at a predetermined angle such that the bottom portion 44 of the culture vessel is on the top and the top 43 (injection port 45) of the culture vessel 25 is on the bottom.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 43 of the second flat culture vessel 25, and the top 43 of the culture vessel 25 is held in a state lifted by the spacer 39.
  • the inclination angle ⁇ 2 of the second flat culture vessel 25 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the culture product production method is configured to inject a new culture solution 23 into the culture vessel 25 while discharging the culture solution 23 in the culture vessel 25.
  • the proliferation of the mesenchymal stem cell 30 can be surely promoted.
  • the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 25 by inclining the second flat culture vessel 25 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 43 side (or the bottom 44 side) of the container 25, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 43 side (or the bottom 44 side) of the culture container 25.
  • the second mesenchymal stem cells 30 are concentrated on the bottom 44 side of the culture vessel 25, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 on the bottom surface 27 of the culture vessel 25. Can be propagated (differentiated) easily and rapidly.
  • the electron microscope 13 takes an enlarged image of the planar shape of the second mesenchymal stem cell 30 in the culture vessel 25 at intervals of about 1 to 2 hours, and takes an enlarged image of the planar shape of the photographed stem cell 30 for about 1 to 2 hours. It transmits to the computer 11 at intervals.
  • the computer 11 stores (stores) the enlarged image of the planar shape of the second mesenchymal stem cell 30 and the imaging time transmitted from the electron microscope 13 in a storage area in a state associated with the donor identifier (stem cell image fourth memory). Process).
  • the computer 11 displays the enlarged image of the planar shape of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time on the display 16.
  • the person in charge confirms (views) the enlarged image of the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours. While observing the total planar area of the stem cells 30 settled on the bottom surface area of the culture vessel 25, the total planar area of the stem cells 30 reaches the second target ratio (82 to 92% confluent) with respect to the bottom surface area of the culture vessel 25. It is determined whether or not (stem cell fourth observation means). The person in charge directly observes the total planar area of the second mesenchymal stem cell 30 with respect to the bottom surface area of the culture vessel 25 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total plane area of 30 has reached the second target ratio (88-92% confluent) with respect to the bottom area of the culture vessel 25.
  • the person in charge is, as shown in FIG. 13, the total plane area of the second mesenchymal stem cell 30 displayed on the display 16 with respect to the bottom area of the culture vessel 25 is the second target ratio. If it has not reached (88 to 92% confluence), the total planar area of the stem cells 30 relative to the bottom area of the culture vessel 25 is continuously observed at intervals of about 1 to 2 hours. In addition, when the total plane area of the second mesenchymal stem cell 30 reaches the second target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 25 of the stem cell 30 It is assumed that the area has reached the second target ratio.
  • the second mesenchymal stem cell 30 grows on the bottom surface 27 (bottom wall inner surface) of the second flat culture vessel 25 (second culture vessel), and the stem cell 30 forms a colony, As the planar shape of the stem cell 30 expands, as shown in FIG. 14, the total planar area of the stem cell 30 displayed on the display 16 with respect to the bottom surface area of the culture vessel 25 becomes the second target ratio (88 to 92% confluent). When it reaches, a single kind of second mesenchymal stem cell 30 is proliferated in the culture vessel 25, and a culture product solution 31 containing a predetermined metabolite secreted from the active single kind of stem cell 30 is generated. Has been.
  • the stem cell 30 When the total planar area of the second mesenchymal stem cell 30 exceeds 92% with respect to the bottom surface area of the second flat culture vessel 25 (second culture vessel), the stem cell 30 is proliferated. Although the activity is gradually lost, the stem cell 30 is extracted from the culture vessel 25 when the total planar area of the stem cell 30 grows to 88 to 92% of the bottom surface area of the culture vessel 25, so that the activity of the stem cell 30 is retained. The stem cell 30 can be proliferated while maintaining the activity.
  • the culture product solution first extraction step for extracting the culture product solution 31 from the culture vessel 25 is performed.
  • a culture product solution 31 containing a predetermined metabolite secreted from the active second mesenchymal stem cell 30 is extracted from the culture vessel 25.
  • the method for producing a culture product solution can accurately confirm the total planar area with respect to the bottom area of the culture vessel 25 of the second mesenchymal stem cell 30 by observing the total planar area at intervals of about 1 to 2 hours. It can be ascertained that the total planar area of the stem cells 30 has reached the second target ratio with respect to the bottom surface area of the culture vessel 25.
  • a person in charge such as a doctor, nurse, or researcher confirms that the total planar area of the second mesenchymal stem cell 30 with respect to the bottom area of the culture vessel 25 has reached the second target ratio, and then is displayed on the display 16.
  • Click the stem cell fourth observation end button When the stem cell fourth observation end button is clicked, the computer 11 displays a process ninth display screen (not shown) on the display 16. On the process 9th display screen, number 1 and donor data are displayed, stem cell separation end message, stem cell second collection end message, stem cell third observation end message, stem cell fourth observation end message, culture product first Extract button is displayed.
  • the person in charge clicks the culture solution first extraction button on the process ninth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 25.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation An end message and a culture product first extraction end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge aspirates the culture product solution 31 changed from the culture solution 23 injected into the culture vessel 25 in the fourth stem cell observation step from the culture vessel 25 using a syringe or pipette (culture product solution first extraction step). Then, the culture product solution 31 is injected (stored) in the storage container 32.
  • the culture product solution 31 injected into the storage container 32 contains a predetermined metabolite secreted from a specific type of single-type mesenchymal stem cells (single-type stem cells) having an activity from which unnecessary mesenchymal stem cells have been removed. It is the culture product solution 31 containing.
  • the person in charge injects the culture product solution 31 into the storage container 32, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 32.
  • the person in charge clicks the culture solution first extraction end button on the ninth display screen displayed on the display 16, causes the barcode reader 12 to read the QR code of the storage container 32, and then injects the culture product 31.
  • the stored storage container 32 is stored in the refrigerator 34.
  • the culture product solution 31 is stored at about 3 to 4 ° C. in the refrigerator 34.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation
  • An end message, a culture product extraction end message, a culture product manufacture end button, and a culture product manufacture continue button are displayed on the display 16.
  • the culture product production end button is clicked.
  • the culture product production end button is clicked, the system 10 stops in the computer 11.
  • a stem cell collection step of collecting the stem cells 30 from the culture vessel 25 is performed.
  • the second mesenchymal stem cells 30 that have proliferated (differentiated) in the culture vessel 25 are collected from the culture vessel 25.
  • a trypsin solution is injected into the culture vessel 25.
  • the trypsin solution is injected into the culture vessel 25
  • the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 25 are detached from the bottom surface 27 by the trypsin solution and float on the water surface of the trypsin solution.
  • the person in charge sucks the second mesenchymal stem cell 30 using a syringe or pipette, and injects (accommodates) the stem cell 30 into the storage container 33 from the syringe or pipette.
  • the second mesenchymal stem cell 30 injected into the storage container 33 is a specific kind of single mesenchymal stem cell (single seed stem cell) having an activity from which unnecessary mesenchymal stem cells are removed.
  • the person in charge injects the second mesenchymal stem cell 30 (single mesenchymal stem cell) into the storage container 33, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 33.
  • the storage container 33 into which the second mesenchymal stem cells 30 are injected is stored in the refrigerator 34.
  • the second mesenchymal stem cell 30 (single mesenchymal stem cell) is stored in the refrigerator 34 at about 3 to 4 ° C.
  • the intermediate layer bone marrow fluid located in the intermediate layer of the bone marrow fluid separated into layers is extracted, and the intermediate layer bone marrow fluid is cultured together with the culture solution 23 to obtain the first mesenchymal stem cells 26 (first 1 stem cell) is fixed to the bottom surface 27 of the first culture vessel 24, and the stem cell 26 is cultured while the total planar area of the stem cell 26 reaches the first target ratio with respect to the bottom surface area of the first culture vessel 24.
  • Stem cells 26 are collected from the container 24, and the second mesenchymal stem cells 30 (second stem cells) located in the lower layer (lowermost layer) of the stem cells 26 separated in layers are collected, and the stem cells 30 are added to the culture solution 23.
  • the stem cells 30 are fixed to the bottom surface 27 of the second culture vessel 25, a new culture solution 23 is injected into the culture vessel 25, and the stem cells 30 are cultured while the total planar area of the stem cells 30 is that of the culture vessel 25.
  • the culture product solution 31 containing a predetermined metabolite secreted from a single kind of stem cell 30 grown in the course of culturing the stem cell 30 is extracted from the culture vessel 25 and thus has a cultured activity.
  • the second stem cell 30 of a single species a wide variety of metabolites secreted from a variety of stem cells are not included, and only a predetermined metabolite secreted from a single species of stem cell 30 having activity is included.
  • a culture product solution 31 is produced using pure second pure mesenchymal stem cells 30 (second stem cells) from which unnecessary stem cells have been removed. Since only a predetermined metabolite secreted from a kind of second stem cell can be contained, a culture product solution 31 having a high therapeutic effect for a predetermined disease and having a high probability of completely curing the disease is produced.
  • the culture product solution 31 having a high effect on a predetermined beauty can be made.
  • the culture product solution 31 produced by the culture product production method can be used for the treatment of skin diseases such as burns and eczema, for example, by applying it to the skin.
  • eye drops In addition to being used as eye drops, it can be used for the treatment of hay fever by injecting it into the nose, and it can be used for the treatment of scalp disease by applying it to the scalp. In addition, it can be used as a measure against rough skin, breakouts and sunburn, and can be used for beauty such as whitening and removal of wrinkles.
  • FIG. 18 is an explanatory view showing an example of the fifth stem cell observation step
  • FIG. 19 is a side view of the third flat culture vessel.
  • the person in charge clicks the culture product production continuation button displayed on the display 16.
  • the computer 11 displays a process tenth display screen (not shown) on the display 16.
  • process 10th display screen number 1 and donor data are displayed, and a stem cell second collection button, a stem cell fifth observation button, a stem cell sixth observation button, and a culture product second extraction button are displayed.
  • the person in charge clicks the stem cell second collection button on the process tenth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 25.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the donor data match with each other, the number 1 and the donor data are displayed on the display 16 and the second stem cell collection in progress message, the stem cell second collection end button, the stem cell fifth observation button, the stem cell number 1 A 6 observation button and a culture product solution second extraction button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • cleans the inside of the culture container 25 with PBS, inject
  • the person in charge collects the stem cells 30 from the culture vessel 25 and then clicks the stem cell second collection end button.
  • the computer 11 displays a process eleventh display screen (not shown) on the display 16. On the process eleventh display screen, number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation button, a stem cell sixth observation button, and a culture product second extraction button are displayed.
  • the fifth stem cell observation step and the third stem cell fixing step are performed.
  • the second mesenchymal stem cell 30 and the culture solution 23 are injected (contained) into the third flat culture vessel 35 (third culture vessel), and the culture vessel 35 is heated to the body temperature. It is left to stand statically (without moving) for 36 to 48 hours at substantially the same temperature (about 36 to 37 ° C.).
  • Deformation from the initial planar shape of the second mesenchymal stem cells 30 (second stem cells) in the culture vessel 35 is observed with an electron microscope 13 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours. It is determined whether or not the bottom surface 27 of the culture vessel 35 is fixed.
  • a first code sheet 17 on which a QR code specifying a donor is printed is attached to the bottom surface 27 (outer surface of the bottom wall) of the culture vessel 35 into which the second mesenchymal stem cells 30 and the culture solution 23 are injected.
  • a person in charge such as a doctor, nurse, researcher, etc. collects the second mesenchymal stem cell 30 from the culture container 25 and then uses the first code sheet 17 on which the QR code is printed as the bottom surface 27 of the third flat culture container 35. Affix to (outer surface of bottom wall).
  • the fifth button for observing stem cells on the process eleventh display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 25.
  • the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge injects (accommodates) the second mesenchymal stem cell 30 sucked into the syringe or pipette into the culture vessel 35 and injects (accommodates) the culture solution 23 into the culture vessel 35.
  • the third flat culture vessel 35 (third culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 having a predetermined capacity and a predetermined area and having a substantially square shape. The area is larger than the second flat culture vessel 25 (second culture vessel).
  • the third flat culture vessel 35 has a top 47 and a bottom 48 and an injection port 49 formed in the top 47. The injection port 49 is watertightly closed by the lid 50.
  • a flat container having a circular shape or an elliptical shape having a bottom surface 27 having a predetermined capacity and a predetermined area may be used.
  • the third flat culture vessel 35 (third culture vessel) used in the fifth stem cell observation step has a capacity of about 70 to 80 cc (preferably 75 cc) and a bottom area of about 75 to 108 mm 2 . .
  • the third flat culture vessel has a side length of about 8.7 to 10.4 mm.
  • the culture solution 23 is the same as that injected in the first observation of stem cells.
  • the second mesenchymal stem cells 30 injected into the culture vessel 35 are cultured on the bottom surface 27 of the culture vessel 35 with the passage of time, are cultured with the culture solution 23, and gradually grow (differentiate) on the bottom surface 27 of the culture vessel 35. To form colonies.
  • the person in charge injects the second mesenchymal stem cell 30 and the culture solution 23 into the culture container 35, and then installs (sets) the culture container 35 in the sample holder of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom 48 of the third flat culture vessel 35, and the bottom 48 of the culture vessel 35 is held up by the spacer 39.
  • the culture vessel 35 is held in a state inclined at a predetermined angle such that the bottom portion 48 of the culture vessel 25 is on the top and the top portion 47 (injection port 49) of the culture vessel 25 is on the bottom.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 48 of the third flat culture vessel 35, and the top 47 of the culture vessel 35 is held in a state where it is lifted by the spacer 39.
  • the inclination angle ⁇ 2 of the third flat culture vessel 35 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 35 by inclining the third flat culture vessel 35 at the inclination angle with respect to the upper surface 37 of the sample holder 36.
  • the pressure is biased toward the top 47 (or the bottom 48) of the container 35, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 47 (or the bottom 48) of the culture container 35.
  • the second mesenchymal stem cells 30 concentrate on the bottom 48 side of the culture vessel 35, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 is formed on the bottom surface 27 of the culture vessel 35. Can be fixed easily and quickly.
  • the electron microscope 13 takes a magnified image of the planar shape of the second mesenchymal stem cell 30 injected into the culture vessel 35 at intervals of about 1 to 2 hours, and the magnified image of the planar shape of the photographed stem cell 30 is approximately 1 to 2 hours. It transmits to the computer 11 at intervals of 2 hours.
  • the computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image fifth memory). Process).
  • the computer 11 displays the enlarged image of the planar shape of the stem cell 30 and the imaging time transmitted from the electron microscope 13 on the display 16.
  • the person in charge checks (views) the enlarged image of the planar shape of the stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours, and observes the change in the planar shape of the stem cell 30 ( Stem cell fifth observation step).
  • the person in charge may directly observe the change in the planar shape of the stem cell 30 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours.
  • the initial planar shape of the second mesenchymal stem cell 30 is substantially circular.
  • the stem cell 30 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 35, and the stem cell. 30 has not started to proliferate (differentiate).
  • the planar shape after the deformation of the second mesenchymal stem cell 30 is a flat shape in which the stem cell 30 extends in an indefinite shape in one direction with the substantially circular shape before fixing as a nucleus, and the stem cell 30 is a bottom surface 27 (bottom wall) of the culture vessel 35. The stem cell 30 has started to proliferate (differentiate).
  • the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 is observed as a substantially circular shape as a result of the observation in the fifth observation step of the stem cells (see FIG. 12 for assistance), 35 is determined not to have settled on the bottom surface 27 (inner surface of the bottom wall), and changes in the planar shape of the stem cells 30 are continuously observed at intervals of about 1 to 2 hours.
  • the person in charge changes the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 from an approximately circular shape to an indeterminate flat shape with the approximately circular shape as a nucleus (see FIG. 13), it is determined that the stem cells 30 have settled on the bottom surface 27 of the culture vessel 35 (stem cell third fixing step).
  • the stem cell 30 becomes difficult to settle on the bottom surface of the container and the proliferation of the stem cell 30 is slow.
  • the stem cell 30 can be easily fixed on the bottom surface 27 of the culture container 35 by using the third flat culture container 35 having the above-described capacity and the bottom surface area. The stem cell 30 can be rapidly proliferated.
  • the method for producing a culture product solution is to leave the culture vessel 35 statically at a temperature substantially the same as the body temperature for 36 to 48 hours, and at intervals of about 1 to 2 hours between 36 and 48 hours. Since the deformation of the leaf stem cells 30 from the initial planar shape is observed, the deformation of the stem cells 30 is not overlooked, and the establishment of the stem cells 30 on the bottom surface 27 of the culture vessel 35 can be confirmed accurately.
  • the second mesenchymal stem cell 30 (second stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with the substantially circular shape as a nucleus, and the third stem cell 30
  • the stem cell third culturing step and the stem cell sixth observing step are performed after the stem cell third fixing step in which the fixation to the bottom surface 27 of the flat culture vessel 35 (third culture vessel) is confirmed.
  • the culture solution 23 injected into the culture vessel 35 is discharged (discarded) from the culture vessel 35, and a new culture solution 23 is injected (accommodated) into the culture vessel 35. Is done.
  • the culture vessel 35 is left to stand statically (without being moved) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the second mesenchymal stem cell 30 is cultured in the culture vessel 35. (Stem cell third culture step).
  • the total planar area of the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 35 at intervals of about 1 to 2 hours in the standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 35. It is determined whether or not the total planar area of the stem cells 30 has reached the third target ratio with respect to the bottom area of the culture vessel 35.
  • the third target ratio of the total planar area of the second mesenchymal stem cell 30 to the bottom surface area of the culture vessel 35 is 88 to 92% (88 to 92% confluent).
  • a person in charge such as a doctor, nurse, or researcher, confirms that the second mesenchymal stem cell 30 has settled on the bottom surface 27 of the culture vessel 35, and then clicks the stem cell fifth observation end button displayed on the display 16.
  • the computer 11 displays a process twelfth display screen (not shown) on the display 16.
  • process twelfth display screen number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation end message, a stem cell sixth observation button, and a culture product second extraction button are displayed. .
  • the person in charge clicks the sixth stem cell observation button on the process twelfth display screen, removes the culture vessel 35 from the sample holder of the electron microscope 13, and causes the barcode reader 12 to read the QR code of the culture vessel 35.
  • the computer 11 displays the donor data displayed on the display 16 (donor data read into the memory) and the donor data indicated by the QR code read by the barcode reader.
  • the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell second collection end message, the stem cell fifth observation end message, the stem cell sixth observation in progress message, the stem cell number 6
  • An observation end button and a culture product second extraction button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
  • the person in charge discharges (discards) the culture solution 23 injected into the culture vessel 35 in the fifth stem cell observation step, and injects (accommodates) the new culture solution 23 into the culture vessel 35.
  • the new culture solution 23 is the same as that injected in the stem cell first observation means.
  • the person in charge injects a new culture solution 23 into the culture vessel 35 and then installs (sets) the culture vessel 35 in the sample holder 36 of the electron microscope 13.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom 48 of the third flat culture vessel 35, and the bottom 48 of the culture vessel 35 is held up by the spacer 39.
  • the culture vessel 35 is held in a state inclined at a predetermined angle such that the bottom portion 48 of the culture vessel 25 is on the top and the top portion 47 (injection port 49) of the culture vessel 25 is on the bottom.
  • a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 48 of the third flat culture vessel 35, and the top 47 of the culture vessel 35 is held in a state where it is lifted by the spacer 39.
  • the inclination angle ⁇ 2 of the third flat culture vessel 35 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
  • the culture product production method is configured to inject a new culture solution 23 into the culture vessel 35 while discharging the culture solution 23 in the culture vessel 35.
  • the proliferation of the mesenchymal stem cell 30 can be surely promoted.
  • the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 35 by inclining the third flat culture vessel 35 at the inclination angle with respect to the upper surface 37 of the sample holder 36.
  • the pressure is biased toward the top 47 (or the bottom 48) of the container 35, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 47 (or the bottom 48) of the culture container 35.
  • the second mesenchymal stem cells 30 concentrate on the bottom 48 side of the culture vessel 35, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 is formed on the bottom surface 27 of the culture vessel 35. Can be propagated (differentiated) easily and rapidly.
  • the electron microscope 13 takes an enlarged image of the planar shape of the second mesenchymal stem cell 30 in the culture vessel 35 at intervals of about 1 to 2 hours, and takes an enlarged image of the taken planar shape of the stem cell 30 for about 1 to 2 hours. It transmits to the computer 11 at intervals.
  • the computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image sixth memory). Process).
  • the computer 11 displays the enlarged image of the planar shape of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time on the display 16.
  • the person in charge confirms (views) the enlarged image of the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours.
  • the total planar area of the stem cells 30 reaches the third target ratio (82 to 92% confluent) with respect to the bottom area of the culture container 35 while observing the total planar area of the stem cells 30 settled on the culture container 35 with respect to the bottom area. It is determined whether or not (stem cell sixth observation step).
  • the person in charge directly observes the total planar area of the second mesenchymal stem cell 30 with respect to the bottom surface area of the culture vessel 35 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total plane area of 30 has reached the third target ratio (88-92% confluent) with respect to the bottom area of the culture vessel 35.
  • the person in charge has the third target ratio (88 to 92% confluent) as the total planar area of the second mesenchymal stem cell 30 displayed on the display 16 with respect to the bottom area of the culture vessel 35. If it has not reached (supported in FIG. 13), the total planar area of the stem cell 30 with respect to the bottom area of the culture vessel 35 is continuously observed at intervals of about 1 to 2 hours.
  • the total plane area of the second mesenchymal stem cell 30 reaches the third target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 35 of the stem cell 30 It is assumed that the area has reached the third target ratio.
  • the second mesenchymal stem cell 30 grows on the bottom surface 27 (bottom wall inner surface) of the third flat culture vessel 35 (third culture vessel), and the stem cell 30 forms a colony,
  • the planar shape of the stem cell 30 is expanded, the total planar area of the stem cell 30 displayed on the display 16 with respect to the bottom surface area of the culture vessel 35 reaches the third target ratio (88 to 92% confluent) (see FIG. 14).
  • the culture vessel 35 a single type of second mesenchymal stem cell 30 is proliferating, and a culture product solution 31 containing a predetermined metabolite secreted from the active single type of stem cell 30 is generated. Yes.
  • the stem cell 30 When the total planar area of the second mesenchymal stem cell 30 exceeds 92% with respect to the bottom surface area of the third flat culture container 35 (third culture container) and the stem cell 30 proliferates, Although the activity is gradually lost, the stem cell 30 is extracted from the culture vessel 35 when the total planar area of the stem cell 30 grows to 88 to 92% with respect to the bottom surface area of the culture vessel 35, so that the activity of the stem cell 30 is retained. The stem cell 30 can be proliferated while maintaining the activity.
  • a culture product second extraction step for extracting the culture product 31 from the culture vessel 35 is performed.
  • the culture product solution second extraction step the culture product solution 31 containing a predetermined metabolite secreted from the active second mesenchymal stem cell 30 is extracted from the culture vessel 35.
  • the method for producing a culture product solution can accurately confirm the total planar area of the second mesenchymal stem cell 30 relative to the bottom area of the culture vessel 35 by observing the total planar area at intervals of about 1 to 2 hours. It can be ascertained that the total planar area of the stem cells 30 has reached the third target ratio with respect to the bottom surface area of the culture vessel 35.
  • a person in charge such as a doctor, a nurse, or a researcher confirms that the total planar area of the second mesenchymal stem cell 30 with respect to the bottom area of the culture vessel 35 has reached the third target ratio, and then is displayed on the display 16. Click the button for ending stem cell sixth observation.
  • the computer 11 displays a process thirteenth display screen (not shown) on the display 16. On the process 13th display screen, number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation end message, a stem cell sixth observation end message, and a culture product second extraction button are displayed.
  • the person in charge aspirates the culture product solution 31 changed from the culture solution 23 injected into the culture vessel 35 in the stem cell sixth observation step from the culture vessel 35 using a syringe or pipette (culture product solution second extraction step). Then, the culture product solution 31 is injected (stored) in the storage container 32.
  • the culture product solution 31 injected into the storage container 32 contains a predetermined metabolite secreted from a specific type of single-type mesenchymal stem cells (single-type stem cells) having an activity from which unnecessary mesenchymal stem cells have been removed. It is the culture product solution 31 containing.
  • the person in charge injects the culture product solution 31 into the storage container 32, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 32.
  • the person in charge clicks the culture solution second extraction end button on the thirteenth display screen displayed on the display 16, causes the barcode reader 12 to read the QR code of the storage container 32, and then injects the culture product 31.
  • the stored storage container 32 is stored in the refrigerator 34.
  • the culture product solution 31 is stored at about 3 to 4 ° C. in the refrigerator 34.
  • the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12.
  • the number 1 and the donor data are displayed on the display 16, and the culture product extraction end message and the culture product preparation end button are displayed on the display 16.
  • the person in charge clicks the culture production solution production end button.
  • the culture product production end button is clicked, the system 10 stops in the computer 11.
  • a stem cell collection step of collecting the stem cells 30 from the culture vessel 25 is performed.
  • the second mesenchymal stem cells 30 that have proliferated (differentiated) in the culture vessel 35 are collected from the culture vessel 35.
  • the person in charge cleans the inside of the culture container 35 with PBS, injects a trypsin solution into the culture container 35, and aspirates the second mesenchymal stem cells 30 floating on the water surface of the trypsin solution using a syringe or pipette.
  • the stem cell 30 is injected (accommodated) into the storage container 33 from a syringe or pipette.
  • the second mesenchymal stem cell 30 injected into the storage container 33 is a specific kind of single mesenchymal stem cell (single seed stem cell) having an activity from which unnecessary mesenchymal stem cells are removed.
  • the person in charge injects the second mesenchymal stem cell 30 (single mesenchymal stem cell) into the storage container 33, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 33.
  • the storage container 33 into which the second mesenchymal stem cells 30 are injected is stored in the refrigerator 34.
  • the second mesenchymal stem cell 30 (single mesenchymal stem cell) is stored in the refrigerator 34 at about 3 to 4 ° C.
  • the culture product solution 31 is extracted from the second culture vessel 25, the second stem cells 30 are collected from the second culture vessel 25, the stem cells 30 are cultured together with the culture solution 23, and the stem cells 30 are extracted. 2. Fix to the bottom surface 27 of the third culture container 35 having a larger capacity than the culture container 25, inject a new culture solution 23 into the culture container 35, and culture the stem cells 30, while the total planar area of the stem cells 30 is the culture container. When the third target ratio is reached with respect to the bottom surface area of 35, the culture product solution 31 containing a predetermined metabolite secreted from a single type of second stem cell 30 having an activity proliferated in the course of culturing the stem cell 30 is cultured.
  • a variety of stem cells are not cultured in the culture process of the stem cell 30, and a variety of metabolites secreted from the variety of stem cells are included. And producing a culture product solution 31 that contains only a predetermined metabolite secreted from a single type of active second stem cell 30 and exhibits a specific effect on a predetermined disease or a predetermined beauty.
  • the culture product solution 31 that can be effectively used for the treatment of a predetermined disease can be manufactured, and the culture product solution 31 that can be used effectively for a predetermined beauty can be manufactured. .

Landscapes

  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

[Problem] To provide a method for manufacturing a culture product liquid, whereby a culture product liquid is manufactured which includes a predetermined metabolite secreted from a single type of stem cell. [Solution] The method for manufacturing a culture product liquid according to the present invention comprises: extracting an intermediate-layer bone marrow liquid positioned in an intermediate layer from bone marrow liquid separated in layered fashion and culturing the intermediate-layer bone marrow liquid together with a culture liquid; fixing first stem cells to a bottom surface of a first culture container and collecting the first stem cells from the first culture container when the total area of the first stem cells reaches a first target ratio of the bottom-surface area of the first culture container; culturing second stem cells together with the culture liquid, the second stem cells being positioned in a bottom layer from among the first stem cells separated in layered fashion, while collecting the second stem cells; and fixing the second stem cells to the bottom surface of a second culture container, and extracting a culture product liquid including a predetermined metabolite secreted from a single type of second stem cells grown from the second culture container when the total area of the second stem cells reaches a second target ratio of the bottom-surface area of the second culture container.

Description

培養生成液製造方法Production method of culture product
 本発明は、ドナーから採取した骨髄液から作られる幹細胞を利用して培養生成液を製造する培養生成液製造方法に関する。 The present invention relates to a culture product production method for producing a culture product solution using stem cells made from bone marrow fluid collected from a donor.
 培養漕と、培養漕内を満たす培養液と、その表面に高低部を有して幹細胞付着性物質をコートさせた担体とを備え、担体表面に高低を形成させる低部が複数存在する幹細胞培養装置が開示されている(特許文献1参照)。この幹細胞培養装置では、担体を培養液中に浮遊させ、担体表面に幹細胞付着性物質を介して分散状態で付着させた幹細胞を担体表面から剥離させずに増殖させる。 A stem cell culture comprising a culture tub, a culture solution filling the culture tub, and a carrier having a height portion on its surface and coated with a stem cell adhesion substance, wherein there are a plurality of low portions that form a height on the carrier surface. An apparatus is disclosed (see Patent Document 1). In this stem cell culture apparatus, the carrier is suspended in the culture solution, and the stem cells attached in a dispersed state to the carrier surface via the stem cell adhesion substance are proliferated without being detached from the carrier surface.
特開2014-183770号公報JP 2014-183770 A
 前記特許文献1に開示の幹細胞培養装置では、幹細胞を培養した後の培養液は廃棄処分される。幹細胞を培養した後の培養液には幹細胞から分泌された代謝物質が含まれ、その培養液を各種疾患の治療や美容のために使用することができる。しかし、ドナーから採取した組織またはその細胞には多種雑多な幹細胞が存在するから、ドナーから採取した組織またはその細胞に存在する幹細胞を培養したとしても多種雑多な幹細胞が増殖し、それら各種の幹細胞から分泌された多種多様な代謝物質が培養液に含まれることになり、各種の疾患や各種の美容に対する唯一特定の効果を有する培養生成液を作ることが困難であった。 In the stem cell culture apparatus disclosed in Patent Document 1, the culture solution after culturing the stem cells is discarded. The culture solution after culturing the stem cells contains a metabolite secreted from the stem cells, and the culture solution can be used for treatment of various diseases and beauty. However, since various stem cells are present in the tissue or cells collected from the donor, the various stem cells proliferate even if the stem cells present in the tissue or cells collected from the donor are cultured. Since various kinds of metabolites secreted from the culture medium are contained in the culture solution, it is difficult to produce a culture product solution having only a specific effect on various diseases and various cosmetics.
 本発明の目的は、単一種の幹細胞から分泌された所定の代謝物質を含み、各種の疾患や各種の美容に対する唯一特定の効果を有する培養生成液を製造することができる培養生成液製造方法を提供することにある。 An object of the present invention is to provide a culture product production method capable of producing a culture product solution containing a predetermined metabolite secreted from a single type of stem cell and having a single specific effect on various diseases and various cosmetics. It is to provide.
 前記課題を解決するための本発明の前提は、ドナーから採取した骨髄液から作られる幹細胞を利用して培養生成液を製造する培養生成液製造方法である。 The premise of the present invention for solving the above problems is a culture product production method for producing a culture product using stem cells made from bone marrow fluid collected from a donor.
 前記前提における本発明の特徴は、培養生成液製造方法が、ドナーから採取した骨髄液を層状に分離する骨髄液分離工程と、骨髄液分離工程によって層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出する骨髄液抽出工程と、骨髄液抽出工程によって抽出した中間層骨髄液と所定の培養液とを所定容量かつ所定面積の底面を有する第1培養容器に注入し、第1培養容器を所定時間静的に放置して中間層骨髄液に含まれる第1幹細胞を第1培養容器の底面に定着させる幹細胞第1定着工程と、幹細胞第1定着工程によって第1幹細胞を第1培養容器の底面に定着させた後、第1培養容器内の培養液を排出しつつあらたな培養液を第1培養容器に注入し、第1培養容器を所定時間静的に放置して第1培養容器の底面面積に対する第1幹細胞の総平面面積が第1目標割合に達するまで第1幹細胞を培養する幹細胞第1培養工程と、幹細胞第1培養工程における第1幹細胞の培養過程において、第1幹細胞の総平面面積が第1目標割合に達した場合、第1培養容器から第1幹細胞を採取する幹細胞第1採取工程と、幹細胞第1採取工程によって採取した第1幹細胞を層状に遠心分離する幹細胞分離工程と、幹細胞分離工程によって層状に分離した第1幹細胞のうちの最下層に位置する第2幹細胞を採取する幹細胞第2採取工程と、幹細胞第2採取工程によって採取した第2幹細胞と所定の培養液とを第1培養容器よりも大きい容量かつ大きい底面面積の底面を有する第2培養容器に注入し、第2培養容器を所定時間静的に放置して第2幹細胞を第2培養容器の底面に定着させる幹細胞第2定着工程と、幹細胞第2定着工程によって第2幹細胞を第2培養容器の底面に定着させた後、第2培養容器内の培養液を排出しつつあらたな培養液を第2培養容器に注入し、第2培養容器を所定時間静的に放置して第2培養容器の底面面積に対する第2幹細胞の総平面面積が第2目標割合に達するまで第2幹細胞を培養する幹細胞第2培養工程と、幹細胞第2培養工程における培養過程において、第2幹細胞の総平面面積が第2目標割合に達した場合、増殖した単一種の第2幹細胞から分泌された所定の代謝物質を含む培養生成液を第2培養容器から抽出する培養生成液第1抽出工程とを有することにある。 The feature of the present invention based on the above premise is that the method for producing a culture solution includes a bone marrow fluid separation step in which bone marrow fluid collected from a donor is separated into layers, and an intermediate layer of the bone marrow fluid separated in layers by the bone marrow fluid separation step. A bone marrow fluid extraction step for extracting the located intermediate layer bone marrow fluid, and the intermediate layer bone marrow fluid extracted by the bone marrow fluid extraction step and a predetermined culture solution are injected into a first culture vessel having a predetermined volume and a predetermined area bottom surface, The first culture cell is left statically for a predetermined time, and the first stem cell is fixed by the stem cell first fixing step for fixing the first stem cell contained in the intermediate layer bone marrow fluid to the bottom surface of the first culture container, and the stem cell first fixing step. After fixing on the bottom surface of the first culture vessel, a new culture solution is poured into the first culture vessel while discharging the culture solution in the first culture vessel, and the first culture vessel is left statically for a predetermined time. Against the bottom area of the first culture vessel In the first stem cell culturing step of culturing the first stem cells until the total planar area of the first stem cells reaches the first target ratio, and the culturing process of the first stem cells in the first stem cell culturing step, the total planar area of the first stem cells is A first stem cell collection step for collecting the first stem cells from the first culture container when the first target ratio is reached, a stem cell separation step for centrifuging the first stem cells collected in the first stem cell collection step, and a stem cell The second stem cell collecting step for collecting the second stem cell located in the lowermost layer of the first stem cells separated in a layered manner by the separating step, the second stem cell collected by the second stem cell collecting step, and a predetermined culture solution Pour into a second culture container having a larger volume and a larger bottom area than the one culture container, and leave the second culture container statically for a predetermined time to fix the second stem cells to the bottom surface of the second culture container. The stem cell second fixing step and the stem cell second fixing step fix the second stem cell on the bottom surface of the second culture vessel, and then discharge the culture solution in the second culture vessel to the second culture. A second stem cell that is poured into the container and statically left in the second culture container for a predetermined time, and the second stem cell is cultured until the total planar area of the second stem cell with respect to the bottom surface area of the second culture container reaches a second target ratio. In the culturing process and the culturing process in the stem cell second culturing process, when the total planar area of the second stem cells reaches the second target ratio, culturing includes a predetermined metabolite secreted from the single stem cell that has proliferated. And having a culture product solution first extraction step of extracting the product solution from the second culture vessel.
 本発明の培養生成液製造方法の一例として、幹細胞第1定着工程および幹細胞第1培養工程では、第1培養容器を所定角度に傾斜させた状態で所定時間静的に放置し、幹細胞第2定着工程および幹細胞第2培養工程では、第2培養容器を所定角度に傾斜させた状態で所定時間静的に放置する。 As an example of the method for producing a culture product of the present invention, in the stem cell first fixing step and the stem cell first culturing step, the first culture vessel is allowed to stand statically for a predetermined time in a state where the first culture vessel is inclined at a predetermined angle, thereby stem cell second fixing. In the step and the stem cell second culture step, the second culture vessel is statically left for a predetermined time in a state where the second culture vessel is inclined at a predetermined angle.
 本発明の培養生成液製造方法の他の一例としては、培養生成液製造方法が、培養生成液第1抽出工程によって第2培養容器内から培養生成液を抽出した後、第2培養容器から第2幹細胞を採取する幹細胞第2採取工程と、所定容量かつ所定面積の底面を有して第2培養容器よりも大きい容量かつ大きい底面面積の底面を有する第3培養容器に幹細胞第2採取工程によって採取した第2幹細胞とあらたな培養液とを注入し、第3培養容器を所定時間静的に放置して第2幹細胞を第3培養容器の底面に定着させる幹細胞第3定着工程と、幹細胞第3定着工程によって第2幹細胞を第3培養容器の底面に定着させた後、第3培養容器内の培養液を排出しつつあらたな培養液を第3培養容器に注入し、第3培養容器を所定時間静的に放置して第3培養容器の底面面積に対する第2幹細胞の総平面面積が第3目標割合に達するまで第2幹細胞を培養する幹細胞第3培養工程と、幹細胞第3培養工程における培養過程において、第2幹細胞の総平面面積が第3目標割合に達した場合、増殖した単一種の第2幹細胞から分泌された所定の代謝物質を含む培養生成液を第3培養容器から抽出する培養生成液第2抽出工程とを含む。 As another example of the culture product production method of the present invention, the culture product production method extracts the culture product solution from the second culture vessel in the culture product solution first extraction step, and then extracts the culture product solution from the second culture vessel. A stem cell second collecting step for collecting two stem cells, and a stem cell second collecting step in a third culture vessel having a bottom surface with a predetermined volume and a predetermined area and a larger volume and a larger bottom area than the second culture vessel. Injecting the collected second stem cells and a new culture solution, and statically leaving the third culture vessel for a predetermined time to establish the second stem cells on the bottom surface of the third culture vessel; After fixing the second stem cells on the bottom surface of the third culture vessel by the 3 fixing step, a new culture solution is poured into the third culture vessel while discharging the culture solution in the third culture vessel. Leave it statically for a certain period of time In the third stem cell culturing step for culturing the second stem cells until the total planar area of the second stem cells with respect to the bottom surface area of the container reaches the third target ratio, and in the culturing process in the third stem cell culturing step, the total planar area of the second stem cells When the third target ratio is reached, a culture product solution second extraction step of extracting a culture product solution containing a predetermined metabolite secreted from the proliferated single species of second stem cells from the third culture vessel is included.
 本発明の培養生成液製造方法の他の一例として、幹細胞第3定着工程および幹細胞第3培養工程では、第3培養容器を所定角度に傾斜させた状態で所定時間静的に放置する。 As another example of the method for producing a culture product solution of the present invention, in the third stem cell fixing step and the third stem cell culture step, the third culture vessel is statically left for a predetermined time in a state where the third culture vessel is inclined at a predetermined angle.
 本発明の培養生成液製造方法の他の一例としては、骨髄液分離工程が、ドナーから2~3ccの骨髄液を採取し、2~3ccの骨髄液を上下方向へ延びる分離容器に注入し、分離容器を体温と略同一の温度で所定時間静的に放置して骨髄液を分離容器内において上下方向へ層状に分離させ、骨髄液抽出工程が、分離容器内において層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出する。 As another example of the culture product production method of the present invention, the bone marrow fluid separation step collects 2 to 3 cc of bone marrow from a donor, and injects 2 to 3 cc of bone marrow into a separation container extending vertically. The separation container is statically left at a temperature substantially the same as the body temperature for a predetermined time to separate the bone marrow fluid into layers in the vertical direction in the separation container, and the bone marrow fluid extraction step is performed to remove the bone marrow fluid separated into layers in the separation container. The middle layer bone marrow fluid located in the middle layer is extracted.
 本発明の培養生成液製造方法の他の一例としては、第1培養容器の容量が、約20~30ccであり、第1幹細胞の初期平面形状が、略円形であり、第1幹細胞の変形後の平面形状が、略円形を核として第1幹細胞が一方向へ不定形に伸張した扁平形状であり、幹細胞第1定着工程では、第1培養容器を体温と略同一の温度で12~24時間静的に放置しつつ、12~24時間の間において約1~2時間間隔で第1培養容器内の第1幹細胞の初期平面形状からの変形を観察し、第1幹細胞が初期平面形状から不定形の扁平形状に変形した場合、第1幹細胞が第1培養容器の底面に定着したと判断する。 As another example of the culture product production method of the present invention, the capacity of the first culture vessel is about 20 to 30 cc, the initial planar shape of the first stem cells is substantially circular, and the first stem cells are deformed. The planar shape is a flat shape in which the first stem cells are indefinitely elongated in one direction with a substantially circular nucleus, and in the first stem cell fixing step, the first culture vessel is kept at a temperature substantially the same as the body temperature for 12 to 24 hours. While standing statically, the deformation of the first stem cells in the first culture vessel from the initial planar shape is observed at intervals of about 1 to 2 hours during 12 to 24 hours. When deformed into a regular flat shape, it is determined that the first stem cells have settled on the bottom surface of the first culture vessel.
 本発明の培養生成液製造方法の他の一例として、幹細胞第1採取工程では、第1培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第1培養容器の底面に定着した第1幹細胞の第1培養容器の底面面積に対する総平面面積を観察する。 As another example of the method for producing a culture product of the present invention, in the first stem cell collection step, the first culture container is statically allowed to stand for 36 to 48 hours at a temperature substantially the same as the body temperature for 36 to 48 hours. The total planar area of the first stem cells that have settled on the bottom surface of the first culture vessel at about 1 to 2 hours is observed with respect to the bottom surface area of the first culture vessel.
 本発明の培養生成液製造方法の他の一例としては、第1培養容器の底面面積に対する第1幹細胞の総平面面積の第1目標割合が70~80%である。 As another example of the method for producing a culture product solution of the present invention, the first target ratio of the total planar area of the first stem cells to the bottom area of the first culture vessel is 70 to 80%.
 本発明の培養生成液製造方法の他の一例としては、幹細胞分離工程が、第1幹細胞を分離容器に注入し、分離容器を遠心分離器に設置して第1幹細胞を遠心分離させ、幹細胞第1採取工程が、分離容器内において層状に遠心分離した第1幹細胞のうちの最下層に位置する第2幹細胞を採取する。 As another example of the method for producing a culture product solution of the present invention, the stem cell separation step injects the first stem cells into a separation container, sets the separation container in a centrifuge, and centrifuges the first stem cells. 1 collection process collect | recovers the 2nd stem cell located in the lowest layer among the 1st stem cells centrifuged in the layer form in the isolation | separation container.
 本発明の培養生成液製造方法の他の一例としては、第2培養容器の容量が約40~60ccであり、第3培養容器の容量が約70~80ccであり、第2幹細胞の初期平面形状が略円形であり、第2幹細胞の変形後の平面形状が略円形を核として第2幹細胞が一方向へ不定形に伸張した扁平形状であり、幹細胞第2定着工程および幹細胞第3定着工程では、第2培養容器および第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第2および第3培養容器内の第2幹細胞の初期平面形状からの変形を観察し、第2幹細胞が初期平面形状から不定形の扁平形状に変形した場合、第2幹細胞が第2および第3培養容器の底面に定着したと判断する。 As another example of the method for producing a culture product of the present invention, the capacity of the second culture container is about 40-60 cc, the capacity of the third culture container is about 70-80 cc, and the initial planar shape of the second stem cell Is substantially flat, and the planar shape of the second stem cell after deformation is a flat shape in which the second stem cell is indefinitely elongated in one direction with the substantially circular shape as a nucleus. In the stem cell second fixing step and the stem cell third fixing step, The second and third culture containers are allowed to stand for 36 to 48 hours statically at the same temperature as the body temperature for 36 to 48 hours while the second and third culture containers are spaced at about 1 to 2 hours between 36 and 48 hours. When the deformation of the second stem cell from the initial planar shape was observed and the second stem cell was deformed from the initial planar shape to an indeterminate flat shape, the second stem cell was fixed on the bottom surfaces of the second and third culture vessels. Judge.
 本発明の培養生成液製造方法の他の一例として、幹細胞第2採取工程および幹細胞第3採取工程では、第2培養容器および第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第2および第3培養容器の底面に定着した第2幹細胞の第2および第3培養容器の底面面積に対する総平面面積を観察する。 As another example of the method for producing a culture product of the present invention, in the second stem cell collection step and the third stem cell collection step, the second culture vessel and the third culture vessel are statically kept at a temperature substantially the same as the body temperature for 36 to 48 hours. The total planar area of the second stem cells established on the bottom surfaces of the second and third culture vessels at intervals of about 1 to 2 hours during 36 to 48 hours with respect to the bottom surface areas of the second and third culture vessels Observe.
 本発明の培養生成液製造方法の他の一例としては、第2培養容器の底面面積に対する第2幹細胞の総平面面積の第2目標割合が88~92%であり、第3培養容器の底面面積に対する第2幹細胞の総平面面積の第3目標割合が88~92%である。 As another example of the culture product production method of the present invention, the second target ratio of the total planar area of the second stem cells to the bottom area of the second culture container is 88 to 92%, and the bottom area of the third culture container The third target ratio of the total planar area of the second stem cells is 88-92%.
 本発明の培養生成液製造方法の他の一例としては、第1および第2幹細胞が間葉系幹細胞である。 As another example of the method for producing a culture product solution of the present invention, the first and second stem cells are mesenchymal stem cells.
 本発明にかかる培養生成液製造方法によれば、層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出し、中間層骨髄液を培養液とともに培養して第1幹細胞を第1培養容器の底面に定着させ、第1幹細胞を培養しつつ第1幹細胞の総平面面積が第1培養容器の底面面積に対して第1目標割合に達した場合、第1培養容器から第1幹細胞を採取し、層状に分離させた第1幹細胞のうちの最下層に位置する第2幹細胞を採取するとともに、第2幹細胞を培養液とともに培養して第2幹細胞を第2培養容器の底面に定着させ、第2培養容器内にあらたな培養液を注入し、第2幹細胞を培養しつつ第2幹細胞の総平面面積が第2培養容器の底面面積に対して第2目標割合に達した場合、第2幹細胞の培養過程において増殖した単一種の第2幹細胞から分泌された所定の代謝物質を含む培養生成液を第2培養容器から抽出するから、培養された単一種の第2幹細胞を利用することで、多種雑多な幹細胞から分泌された多種多様な代謝物質が含まれることはなく、単一種の第2幹細胞から分泌された所定の代謝物質のみを含み、所定の疾患やスキンケア、ヘアケア、ボディケア等の所定の美容に対して唯一特定の効果を発揮する培養生成液を作ることができ、所定の疾患の治療に有効に使用することが可能な培養生成液を作ることができるとともに、所定の美容に有効に使用することが可能な培養生成液を作ることができる。培養生成液製造方法は、不要な幹細胞が除去されたピュア(純粋)な第2幹細胞を利用して培養生成液が作られ、その培養生成液に単一種の第2幹細胞から分泌された所定の代謝物質のみを含ませることができるから、所定の疾患に対して高い治療効果を有し、その疾患を完治させる確立が高い培養生成液を作ることができ、所定の美容に対して高い効果を有する培養生成液を作ることができる。 According to the culture product production method of the present invention, the intermediate layer bone marrow fluid located in the intermediate layer of the bone marrow fluid separated into layers is extracted, and the intermediate layer bone marrow fluid is cultured with the culture solution to obtain the first stem cells. When the total planar area of the first stem cells reaches the first target ratio with respect to the bottom area of the first culture container while culturing the first stem cells while being fixed on the bottom surface of the first culture container, Collecting one stem cell and collecting the second stem cell located in the lowermost layer of the first stem cells separated into layers, culturing the second stem cell together with a culture solution, and cultivating the second stem cell to the bottom surface of the second culture vessel The total planar area of the second stem cells reached the second target ratio with respect to the bottom area of the second culture vessel while injecting a new culture solution into the second culture vessel and culturing the second stem cells. A single species grown in the course of culturing second stem cells Since the culture product solution containing the predetermined metabolite secreted from the second stem cell is extracted from the second culture vessel, various kinds secreted from various stem cells can be obtained by using the cultured single type of second stem cell. It does not contain a variety of metabolites, contains only certain metabolites secreted from a single type of second stem cell, and is only specific for a given disease, skin care, hair care, body care, etc. A culture product that can produce a culture product solution that can be used effectively for the treatment of a given disease, and that can be used effectively for a given beauty. The product liquid can be made. In the culture product production method, a culture product solution is produced using pure second stem cells from which unnecessary stem cells have been removed, and a predetermined kind of secreted from a single kind of second stem cells is produced in the culture product solution. Since it can contain only metabolites, it has a high therapeutic effect on a given disease, can make a culture product that has a high probability of completely curing the disease, and has a high effect on a given beauty. A culture product solution can be made.
 幹細胞第1定着工程および幹細胞第1培養工程において、第1培養容器を所定角度に傾斜させた状態で所定時間静的に放置し、幹細胞第2定着工程および幹細胞第2培養工程において、第2培養容器を所定角度に傾斜させた状態で所定時間静的に放置する培養生成液製造方法は、幹細胞第1定着工程および幹細胞第1培養工程において、第1培養容器を所定角度に傾斜させた状態で所定時間静的に放置することで、第1培養容器の底面に第1幹細胞を確実に定着させることができ、第1幹細胞の増殖を確実に促進することができる。培養生成液製造方法は、幹細胞第2定着工程および幹細胞第2培養工程において、第2培養容器を所定角度に傾斜させた状態で所定時間静的に放置することで、第2培養容器の底面に第2幹細胞を確実に定着させることができ、第2幹細胞の増殖を確実に促進することができる。 In the stem cell first fixing step and the stem cell first culturing step, the first culture vessel is statically left for a predetermined time in a state inclined at a predetermined angle, and in the stem cell second fixing step and the stem cell second culturing step, the second culture is performed. The method of producing a culture product solution in which the container is statically left for a predetermined time in a state where the container is inclined at a predetermined angle is obtained in a state where the first culture container is inclined at a predetermined angle in the stem cell first fixing step and the stem cell first culture step. By standing statically for a predetermined time, the first stem cells can be reliably fixed on the bottom surface of the first culture vessel, and the proliferation of the first stem cells can be surely promoted. The method for producing a culture product includes the step of statically leaving the second culture vessel tilted at a predetermined angle for a predetermined time in the second stem cell fixing step and the second stem cell culture step, so that the bottom of the second culture vessel The second stem cell can be firmly established, and the proliferation of the second stem cell can be surely promoted.
 第2培養容器内から培養生成液を抽出した後に第2培養容器から第2幹細胞を採取し、第2幹細胞を培養液とともに培養して第2幹細胞を第2培養容器よりも大きい容量かつ大きい底面面積の底面を有する第3培養容器の底面に定着させ、第3培養容器内にあらたな培養液を注入し、第2幹細胞を培養しつつ第2幹細胞の総平面面積が第3培養容器の底面面積に対して第3目標割合に達した場合、第2幹細胞の培養過程において増殖した単一種の第2幹細胞から分泌された所定の代謝物質を含む培養生成液を第3培養容器から抽出する培養生成液製造方法は、第2幹細胞をさらに第3培養容器で培養し、第2幹細胞の総平面面積が第3培養容器の底面面積に対して第3目標割合に達した場合、第2幹細胞の培養過程において増殖した単一種の第2幹細胞から分泌された所定の代謝物質を含む培養生成液を第3培養容器から抽出するから、幹細胞の培養過程において多種雑多な幹細胞が培養されることはなく、多種雑多な幹細胞から分泌された多種多様な代謝物質が含まれることはなく、単一種の第2幹細胞から分泌された所定の代謝物質のみを含み、所定の疾患や所定の美容に対して唯一特定の効果を発揮する培養生成液を作ることができ、所定の疾患の治療に有効に使用することが可能な培養生成液を作ることができるとともに、所定の美容に有効に使用することが可能な培養生成液を作ることができる。培養生成液製造方法は、第2培養容器よりも大きい容量の第3培養容器を利用することで、一度に多量の培養生成液を作ることができる。 After extracting the culture product solution from the second culture vessel, the second stem cells are collected from the second culture vessel, the second stem cells are cultured with the culture solution, and the second stem cells have a larger capacity and a larger bottom surface than the second culture vessel. The bottom surface of the third culture vessel is fixed to the bottom surface of the third culture vessel having a bottom surface area, a new culture solution is injected into the third culture vessel, and the second stem cells are cultured while the total planar area of the second stem cells is the bottom surface of the third culture vessel. When the third target ratio is reached with respect to the area, a culture product solution containing a predetermined metabolite secreted from a single type of second stem cell grown in the culture process of the second stem cell is extracted from the third culture vessel. In the production method, the second stem cells are further cultured in the third culture container, and when the total planar area of the second stem cells reaches the third target ratio with respect to the bottom area of the third culture container, Single species grown during the culture process Since the culture product solution containing a predetermined metabolite secreted from the second stem cell is extracted from the third culture vessel, the various stem cells are not cultured in the stem cell culturing process and are secreted from the various stem cells. A variety of metabolites that contain only a specific metabolite secreted from a single type of second stem cell, and that produce a specific effect on a specific disease or a specific beauty A culture product that can be used for the treatment of a given disease and can be used effectively for a given beauty. it can. The culture product production method can produce a large amount of culture product at a time by using a third culture vessel having a larger capacity than the second culture vessel.
 幹細胞第3定着工程および幹細胞第3培養工程において、第3培養容器を所定角度に傾斜させた状態で所定時間静的に放置する培養生成液製造方法は、幹細胞第3定着工程および幹細胞第3培養工程において、第3培養容器を所定角度に傾斜させた状態で所定時間静的に放置することで、第2培養容器の底面に第2幹細胞を確実に定着させることができ、第2幹細胞の増殖を確実に促進することができる。 In the stem cell third fixing step and the stem cell third culturing step, the method for producing a culture product solution in which the third culture vessel is statically left for a predetermined time in a state where the third culture vessel is inclined at a predetermined angle includes the stem cell third fixing step and the stem cell third culture. In the process, the second stem cells can be reliably fixed on the bottom surface of the second culture container by allowing the third culture container to stand statically for a predetermined time in a state where the third culture container is inclined at a predetermined angle. Can be surely promoted.
 骨髄液分離工程において、ドナーから2~3ccの骨髄液を採取し、2~3ccの骨髄液を上下方向へ延びる分離容器に注入し、分離容器を体温と略同一の温度で所定時間静的に放置して骨髄液を分離容器内において上下方向へ層状に分離させ、骨髄液抽出工程において、分離容器内において層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出する培養生成液製造方法は、多種雑多な幹細胞を含む骨髄液を体温と略同一の温度で所定時間静的に放置して上下方向へ層状に分離させることで、骨髄液から特定の中間層骨髄液が確実に抽出され、その中間層骨髄液から単一種の第2幹細胞が培養されるから、不要な幹細胞が除去された単一種の幹細胞から分泌された所定の代謝物質のみを含み、所定の疾患や所定の美容に対して唯一特定の効果を発揮する培養生成液を作ることができ、所定の疾患の治療に有効に使用することが可能な培養生成液を作ることができるとともに、所定の美容に有効に使用することが可能な培養生成液を作ることができる。 In the bone marrow fluid separation step, 2 to 3 cc of bone marrow fluid is collected from the donor, and 2 to 3 cc of bone marrow fluid is injected into a separation container extending in the vertical direction, and the separation container is statically fixed at a temperature substantially equal to the body temperature for a predetermined time. Culturing the bone marrow fluid by separating it into layers in the vertical direction in the separation container and extracting the intermediate layer bone marrow fluid located in the middle layer of the bone marrow fluid separated into layers in the separation container in the bone marrow fluid extraction step In the production method, bone marrow fluid containing various stem cells is statically left for a predetermined time at approximately the same temperature as the body temperature and separated into layers in the vertical direction. Since it is reliably extracted and a single type of second stem cell is cultured from the intermediate layer bone marrow fluid, it contains only a predetermined metabolite secreted from the single type of stem cell from which unnecessary stem cells have been removed, For a given beauty It is possible to make a culture product solution that exhibits only a specific effect, to make a culture product solution that can be used effectively for treatment of a given disease, and to be used effectively for a given beauty. Possible culture products can be made.
 第1培養容器の容量が約20~30ccであり、第1幹細胞の初期平面形状が略円形であり、第1幹細胞の変形後の平面形状が略円形を核として第1幹細胞が一方向へ不定形に伸張した扁平形状であり、幹細胞第1定着工程において、第1培養容器を体温と略同一の温度で12~24時間静的に放置しつつ、12~24時間の間において約1~2時間間隔で第1培養容器内の第1幹細胞の初期平面形状からの変形を観察し、第1幹細胞が初期平面形状から不定形の扁平形状に変形した場合、第1幹細胞が第1培養容器の底面に定着したと判断する培養生成液製造方法は、第1培養容器の容量が30ccを超過すると、第1幹細胞が第1培養容器の底面に定着し難くなるとともに第1幹細胞の増殖が遅くなるが、前記容量の第1培養容器を使用することで、第1幹細胞が第1培養容器の底面に早期かつ容易に定着し、第1培養容器において第1幹細胞が素早く増殖することで、単一種の幹細胞が短い期間で作られるとともに、不要な幹細胞が除去された単一種の幹細胞から分泌された所定の代謝物質のみを含む多量の培養生成液を短い期間で作ることができる。培養生成液製造方法は、第1培養容器を体温と略同一の温度で12~24時間静的放置しつつ、12~24時間の間において約1~2時間間隔で第1培養容器内の第1幹細胞の初期平面形状からの変形を観察し、第1幹細胞が略円形を核として一方向へ不定形に伸張した扁平形状に変形した場合に第1幹細胞が第1培養容器の底面に定着したと判断することで、第1幹細胞の第1培養容器の底面への定着を見逃すことはなく、第1幹細胞の平面形状の変化によって第1幹細胞の第1培養容器の底面に対する定着を正確に把握することができるとともに、第1培養容器の底面に対する第1幹細胞の定着を確認した後、第1培養容器内の培養液を排出しつつあらたな培養液を第1培養容器に注入することで、第1幹細胞の増殖を確実に促進することができ、その第1幹細胞を利用して単一種の幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 The capacity of the first culture vessel is about 20-30 cc, the initial planar shape of the first stem cells is substantially circular, and the first stem cells are deformed in one direction with the deformed planar shape of the first stem cells as a nucleus. In the stem cell first colonization step, the first culture vessel is statically left at a temperature substantially the same as the body temperature for 12 to 24 hours, and is about 1-2 for 12 to 24 hours. When the deformation from the initial planar shape of the first stem cells in the first culture container is observed at time intervals, and the first stem cells are deformed from the initial planar shape to an indeterminate flat shape, the first stem cells are in the first culture container. In the method for producing a culture product solution that is determined to have settled on the bottom surface, when the capacity of the first culture container exceeds 30 cc, the first stem cells are difficult to settle on the bottom surface of the first culture container and the growth of the first stem cells is slowed. Use the first culture vessel of the above capacity. As a result, the first stem cells quickly and easily settle on the bottom surface of the first culture container, and the first stem cells proliferate quickly in the first culture container, so that a single type of stem cells can be made in a short period of time and unnecessary. A large amount of a culture product solution containing only a predetermined metabolite secreted from a single kind of stem cell from which various stem cells have been removed can be produced in a short period of time. The method for producing a culture product solution comprises the first culture container being left to stand for 12 to 24 hours at a temperature substantially the same as the body temperature, and the first culture container in the first culture container at intervals of about 1 to 2 hours during 12 to 24 hours. When the deformation of the stem cell from the initial planar shape was observed and the first stem cell was deformed into a flat shape extending in an irregular shape in one direction with a substantially circular nucleus, the first stem cell was fixed on the bottom surface of the first culture vessel. Therefore, it is possible to accurately grasp the fixation of the first stem cell to the bottom surface of the first culture container by the change in the planar shape of the first stem cell without missing the fixation of the first stem cell to the bottom surface of the first culture container. And after confirming the establishment of the first stem cells on the bottom surface of the first culture container, by injecting a new culture medium into the first culture container while discharging the culture medium in the first culture container, Encourage the proliferation of primary stem cells It can be, it is possible to make the culture product liquor containing only a predetermined metabolites secreted by utilizing the first stem cells from a single type of stem cell to ensure.
 幹細胞第1採取工程において、第1培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第1培養容器の底面に定着した第1幹細胞の第1培養容器の底面面積に対する総平面面積を観察する培養生成液製造方法は、約1~2時間間隔で総平面面積を観察することで、第1幹細胞の第1培養容器の底面面積に対する総平面面積を正確に確認することができ、第1培養容器の底面面積に対して第1幹細胞の総平面面積が第1目標割合に達したことを確実に把握することができるとともに、第1培養容器からの第1幹細胞の採取のタイミングを誤ることなく、第1幹細胞の活性を保持しつつ第1培養容器から第1幹細胞を採取することができ、その第1幹細胞を利用して単一種の幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 In the first stem cell collection step, the bottom surface of the first culture container is left at about 1 to 2 hours between 36 and 48 hours while the first culture container is statically left at a temperature substantially the same as the body temperature for 36 to 48 hours. The culture product producing method for observing the total planar area of the first stem cells settled on the first culture vessel with respect to the bottom area of the first culture vessel observes the total planar area at intervals of about 1 to 2 hours. The total plane area relative to the bottom area of the culture vessel can be accurately confirmed, and the total plane area of the first stem cells has reached the first target ratio with respect to the bottom area of the first culture container. The first stem cell can be collected from the first culture container while maintaining the activity of the first stem cell without mistaking the timing of collecting the first stem cell from the first culture container. Using a single species of trunk It can be made to ensure the culture product liquor containing only a predetermined metabolites secreted from cells.
 第1培養容器の底面面積に対する第1幹細胞の総平面面積の第1目標割合が70~80%である培養生成液製造方法は、第1培養容器の底面面積に対する第1幹細胞の総平面面積が80%を超過して第1幹細胞が増殖すると、第1幹細胞の活性が次第に失われるが、第1培養容器の底面面積に対して第1幹細胞の総平面面積が70~80%に増殖したときに、第1幹細胞を第1培養容器から採取するから、第1幹細胞の活性を保持することができ、活性を保持した状態で第1幹細胞を増殖させることができるとともに、その第1幹細胞を利用して単一種の幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 In the culture product production method in which the first target ratio of the total planar area of the first stem cells to the bottom area of the first culture container is 70 to 80%, the total planar area of the first stem cells relative to the bottom area of the first culture container is When the first stem cells proliferate in excess of 80%, the activity of the first stem cells is gradually lost, but when the total planar area of the first stem cells grows to 70-80% with respect to the bottom area of the first culture vessel In addition, since the first stem cells are collected from the first culture vessel, the activity of the first stem cells can be maintained, the first stem cells can be propagated while maintaining the activity, and the first stem cells are used. Thus, a culture product solution containing only a predetermined metabolite secreted from a single kind of stem cell can be reliably produced.
 幹細胞分離工程において、第1幹細胞を分離容器に注入し、分離容器を遠心分離器に設置して第1幹細胞を遠心分離させ、幹細胞第1採取工程において、分離容器内において層状に遠心分離した第1幹細胞のうちの最下層に位置する第2幹細胞を採取する培養生成液製造方法は、不要な幹細胞を含む第1幹細胞を遠心分離によって層状に分離させ、層状に遠心分離した第1幹細胞のうちの最下層に位置する第2幹細胞を採取することで、第1幹細胞から特定の第2幹細胞を確実に抽出することができ、第1幹細胞から不要な幹細胞を除去することができる。培養生成液製造方法は、培養対象の特定種類の第2幹細胞のみを培養することができ、その第1幹細胞を利用して単一種の幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 In the stem cell separation step, the first stem cells are injected into a separation container, the separation container is placed in a centrifuge and the first stem cells are centrifuged. In the first stem cell collection step, the first stem cells are centrifuged in layers in the separation container. A method for producing a culture product solution for collecting second stem cells located in the lowermost layer of one stem cell includes separating first stem cells containing unnecessary stem cells into layers by centrifugation, and centrifuging the first stem cells into layers. By collecting the second stem cells located in the lowermost layer, specific second stem cells can be reliably extracted from the first stem cells, and unnecessary stem cells can be removed from the first stem cells. The culture product production method can culture only a specific type of second stem cells to be cultured, and includes only a predetermined metabolite secreted from a single type of stem cell using the first stem cells. Can be made reliably.
 第2培養容器の容量が約40~60ccであり、第3培養容器の容量が約70~80ccであり、第2幹細胞の初期平面形状が略円形であり、第2幹細胞の変形後の平面形状が略円形を核として第2幹細胞が一方向へ不定形に伸張した扁平形状であり、幹細胞第2定着工程および幹細胞第3定着工程において、第2培養容器および第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第2および第3培養容器内の第2幹細胞の初期平面形状からの変形を観察し、第2幹細胞が初期平面形状から不定形の扁平形状に変形した場合、第2幹細胞が第2および第3培養容器の底面に定着したと判断する培養生成液製造方法は、第2培養容器の容量が60ccを超過し、第3培養容器の容量が80ccを超過すると、第2幹細胞が第2および第3培養容器の底面に定着し難くなるとともに第2幹細胞の増殖が遅くなるが、前記容量の第2および第3培養容器を使用することで、第2幹細胞が第2および第3培養容器の底面に早期かつ容易に定着し、第2および第3培養容器において第2幹細胞が素早く増殖することで、単一種の第2幹細胞が短い期間で作られるとともに、不要な幹細胞が除去された単一種の第2幹細胞から分泌された所定の代謝物質のみを含む多量の培養生成液を短い期間で作ることができる。培養生成液製造方法は、第2および第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第2および第3培養容器内の第2幹細胞の初期平面形状からの変形を観察し、第2幹細胞が略円形を核として一方向へ不定形に伸張した扁平形状に変形した場合に第2幹細胞が第2および第3培養容器の底面に定着したと判断することで、第2幹細胞の第2および第3培養容器の底面への定着を見逃すことはなく、第2幹細胞の平面形状の変化によって第2幹細胞の第2および第3培養容器の底面に対する定着を正確に把握することができるとともに、第2および第3培養容器の底面に対する第2幹細胞の定着を確認した後、第2および第3培養容器内の培養液を排出しつつあらたな培養液を第2および第3培養容器に注入することで、第2幹細胞の増殖を確実に促進することができ、その第2幹細胞を利用して単一種の第2幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 The capacity of the second culture vessel is about 40 to 60 cc, the capacity of the third culture vessel is about 70 to 80 cc, the initial planar shape of the second stem cell is substantially circular, and the planar shape after deformation of the second stem cell Is a flat shape in which the second stem cell is indefinitely elongated in one direction with a substantially circular nucleus, and the second culture vessel and the third culture vessel are substantially the same as the body temperature in the second stem cell fixing step and the third stem cell fixing step. While standing statically for 36 to 48 hours at a temperature of 36 to 48 hours, the deformation from the initial planar shape of the second stem cells in the second and third culture vessels was observed at intervals of about 1 to 2 hours during 36 to 48 hours. When the second stem cell is deformed from the initial planar shape to an indeterminate flat shape, the culture product producing method for determining that the second stem cell has settled on the bottom surfaces of the second and third culture vessels Volume exceeds 60cc, 3rd culture When the capacity of the vessel exceeds 80 cc, the second stem cells are difficult to settle on the bottom surfaces of the second and third culture vessels and the growth of the second stem cells is slow, but the second and third culture vessels having the above-mentioned capacities are used. As a result, the second stem cells are quickly and easily fixed on the bottom surfaces of the second and third culture vessels, and the second stem cells proliferate quickly in the second and third culture vessels. A large amount of a culture product containing only a predetermined metabolite secreted from a single type of second stem cell from which unnecessary stem cells have been removed can be produced in a short period of time. The production method of the culture product comprises the second and third culture vessels statically left at a temperature substantially the same as the body temperature for 36 to 48 hours, while the second and third culture containers are spaced at intervals of about 1 to 2 hours between 36 and 48 hours. When the deformation of the second stem cell in the third culture vessel from the initial planar shape is observed and the second stem cell is deformed into a flat shape extending in an irregular shape in one direction with a substantially circular shape as the nucleus, the second stem cell is second By determining that the second stem cells have settled on the bottom surface of the third culture container, the second stem cells are not missed by the second stem cells due to the change in the planar shape of the second stem cells. The second and third culture vessels can be accurately fixed on the bottom surfaces of the second and third culture vessels, and the second stem cells are confirmed to be fixed on the bottom surfaces of the second and third culture vessels. New medium while draining By injecting the nutrient solution into the second and third culture vessels, the proliferation of the second stem cell can be surely promoted, and a predetermined secreted from a single type of second stem cell using the second stem cell. A culture product containing only metabolites can be produced reliably.
 幹細胞第2および第3採取工程において、第2培養容器および第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、36~48時間の間において約1~2時間間隔で第2および第3培養容器の底面に定着した第2幹細胞の第2および第3培養容器の底面面積に対する総平面面積を観察する培養生成液製造方法は、約1~2時間間隔で総平面面積を観察することで、第2幹細胞の第2および第3培養容器の底面面積に対する総平面面積を正確に確認することができ、第2および第3培養容器の底面面積に対して第2幹細胞の総平面面積が第2および第3目標割合に達したことを確実に把握することができるとともに、第2および第3培養容器からの第2幹細胞の採取のタイミングを誤ることなく、第2幹細胞の活性を保持しつつ第2および第3培養容器から第2幹細胞を採取することができ、その第2幹細胞を利用して単一種の幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 In the second and third stem cell collection steps, the second and third culture vessels are statically left at the same temperature as the body temperature for 36 to 48 hours, and between about 36 and 48 hours, about 1-2 hours. The method for producing a culture solution for observing the total planar area of the second stem cells fixed on the bottom surfaces of the second and third culture vessels with respect to the bottom surface area of the second and third culture vessels at intervals of about 1 to 2 hours By observing the planar area, the total planar area with respect to the bottom area of the second and third culture vessels of the second stem cells can be confirmed accurately, and the second stem cell is compared with the bottom areas of the second and third culture vessels. While it is possible to reliably grasp that the total planar area of the stem cells has reached the second and third target ratios, the second stem cells can be collected from the second and third culture vessels without mistaking the timing. Retains stem cell activity The second stem cells can be collected from the second and third culture vessels while the second stem cells are used to reliably produce a culture solution containing only a predetermined metabolite secreted from a single kind of stem cells. Can do.
 第2培養容器の底面面積に対する第2幹細胞の総平面面積の第2目標割合が88~92%であり、第3培養容器の底面面積に対する第2幹細胞の総平面面積の第3目標割合が88~92%である培養生成液製造方法は、第2および第3培養容器の底面面積に対する第2幹細胞の総平面面積が92%を超過して第2幹細胞が増殖すると、第2幹細胞の活性が次第に失われるが、第2および第3培養容器の底面面積に対して第2幹細胞の総平面面積が88~92%に増殖したときに、第2幹細胞を第2および第3培養容器から採取するから、第2幹細胞の活性を保持することができ、活性を保持した状態で第2幹細胞を増殖させることができるとともに、その第2幹細胞を利用して単一種の第2幹細胞から分泌された所定の代謝物質のみを含む培養生成液を確実に作ることができる。 The second target ratio of the total planar area of the second stem cells to the bottom area of the second culture container is 88 to 92%, and the third target ratio of the total planar area of the second stem cells to the bottom area of the third culture container is 88. In the method for producing a culture product solution of ˜92%, the activity of the second stem cells is increased when the total planar area of the second stem cells with respect to the bottom area of the second and third culture vessels exceeds 92% and the second stem cells proliferate. Although gradually lost, the second stem cells are collected from the second and third culture vessels when the total planar area of the second stem cells grows to 88-92% with respect to the bottom area of the second and third culture vessels. The second stem cell can retain the activity, and the second stem cell can be proliferated while retaining the activity, and the second stem cell is used to secrete the second stem cell from a single type of second stem cell. Contains only the metabolites of Nutrient product solution can be made to ensure.
 第1および第2幹細胞が間葉系幹細胞である培養生成液製造方法は、培養された単一種の第2間葉系幹細胞を利用することで、多種雑多な間葉系幹細胞から分泌された多種多様な代謝物質が含まれることはなく、単一種の第2間葉系幹細胞から分泌された所定の代謝物質のみを含み、所定の疾患やスキンケア、ヘアケア、ボディケア等の所定の美容に対して唯一特定の効果を発揮する培養生成液を作ることができ、所定の疾患の治療に有効に使用することが可能な培養生成液を作ることができるとともに、所定の美容に有効に使用することが可能な培養生成液を作ることができる。培養生成液製造方法は、不要な幹細胞が除去されたピュア(純粋)な第2間葉系幹細胞を利用して培養生成液が作られ、その培養生成液に単一種の第2間葉系幹細胞から分泌された所定の代謝物質のみを含ませることができるから、所定の疾患に対して高い治療効果を有し、その疾患を完治させる確立が高い培養生成液を作ることができ、所定の美容に対して高い効果を有する培養生成液を作ることができる。 The method for producing a culture product in which the first and second stem cells are mesenchymal stem cells uses a variety of mesenchymal stem cells that are secreted from a variety of mesenchymal stem cells by using a single type of cultured second mesenchymal stem cells. It does not contain a variety of metabolites, contains only certain metabolites secreted from a single type of second mesenchymal stem cell, and is used for certain diseases such as skin care, hair care, and body care. It is possible to make a culture product solution that exhibits only a specific effect, to make a culture product solution that can be used effectively for treatment of a given disease, and to be used effectively for a given beauty. Possible culture products can be made. In the culture product production method, a culture product solution is made using pure second mesenchymal stem cells from which unnecessary stem cells have been removed, and a single type of second mesenchymal stem cells is used as the culture product solution. Because it can contain only certain metabolites secreted from, it can produce a culture product that has a high therapeutic effect on a given disease and is highly established to completely cure the disease. It is possible to produce a culture product solution having a high effect on the above.
一例として示す培養生成液製造システムの概略構成図。The schematic block diagram of the culture solution manufacturing system shown as an example. 骨髄液分離工程の一例を示す説明図。Explanatory drawing which shows an example of a bone marrow fluid separation process. 図2から続く骨髄液分離工程の説明図。Explanatory drawing of the bone marrow fluid separation process continued from FIG. 図3から続く骨髄液分離工程の説明図。Explanatory drawing of the bone marrow fluid separation process following FIG. 幹細胞第1観察工程の一例を示す説明図。Explanatory drawing which shows an example of a stem cell 1st observation process. 第1扁平培養容器の側面図。The side view of a 1st flat culture container. 第1間葉系幹細胞の平面形状の一例を示す部分拡大図。The partial enlarged view which shows an example of the planar shape of a 1st mesenchymal stem cell. 第1間葉系幹細胞の平面形状の他の一例を示す部分拡大図。The elements on larger scale which show another example of the planar shape of a 1st mesenchymal stem cell. 第1間葉系幹細胞の平面形状の他の一例を示す部分拡大図。The elements on larger scale which show another example of the planar shape of a 1st mesenchymal stem cell. 幹細胞分離工程の一例を示す説明図。Explanatory drawing which shows an example of a stem cell isolation | separation process. 幹細胞第2抽出工程の一例を示す説明図。Explanatory drawing which shows an example of a stem cell 2nd extraction process. 幹細胞第3観察工程の一例を示す説明図。Explanatory drawing which shows an example of a stem cell 3rd observation process. 第2扁平培養容器の側面図。The side view of a 2nd flat culture container. 第2間葉系幹細胞の平面形状の一例を示す部分拡大図。The elements on larger scale which show an example of the planar shape of a 2nd mesenchymal stem cell. 第2間葉系幹細胞の平面形状の他の一例を示す部分拡大図。The elements on larger scale which show another example of the planar shape of a 2nd mesenchymal stem cell. 第2間葉系幹細胞の平面形状の他の一例を示す部分拡大図。The elements on larger scale which show another example of the planar shape of a 2nd mesenchymal stem cell. 抽出された培養生成液および第2間葉系幹細胞の保存の一例を示す図。The figure which shows an example of preservation | save of the extracted culture product liquid and a 2nd mesenchymal stem cell. 幹細胞第5観察工程の一例を示す説明図。Explanatory drawing which shows an example of a stem cell 5th observation process. 第3扁平培養容器の側面図。The side view of a 3rd flat culture container.
 一例として示す培養生成液製造システム10の概略構成図である図1等の添付の図面を参照し、本発明にかかる培養生成液製造方法の詳細を説明すると、以下のとおりである。なお、図2は、骨髄液分離工程の一例を示す説明図であり、図3は、図2から続く骨髄液分離工程の説明図である。図4は、図3から続く骨髄液分離工程の説明図である。 The details of the culture product production method according to the present invention will be described below with reference to the accompanying drawings such as FIG. 1 which is a schematic configuration diagram of the culture product production system 10 shown as an example. 2 is an explanatory view showing an example of the bone marrow fluid separation step, and FIG. 3 is an explanatory view of the bone marrow fluid separation step continued from FIG. FIG. 4 is an explanatory diagram of a bone marrow fluid separation process continued from FIG.
 培養生成液製造方法は、骨髄液に含まれる複数種類の間葉系幹細胞の中から特定種類の単一種の間葉系幹細胞(単一種幹細胞)を培養しつつ、単一種の間葉系幹細胞から分泌された所定の代謝物質を含む培養生成液を製造する。培養生成液製造方法は、複数のドナー(人)から採取した骨髄液(原料骨髄液)を原料とし、培養生成液製造システム10を利用して骨髄液分離工程、骨髄液抽出工程、幹細胞第1定着工程、幹細胞第1培養工程、幹細胞第1採取工程、幹細胞分離工程、幹細胞第2採取工程、幹細胞第2定着工程、幹細胞第2培養工程、培養生成液第1抽出工程を経ることによって製造される。さらに、培養生成液製造システム10を利用して幹細胞第2採取工程、幹細胞第3定着工程、幹細胞第3培養工程、培養生成液第2抽出工程を経ることによって製造される。 The culture product production method is a method of culturing a specific type of single mesenchymal stem cell (single seed stem cell) from a plurality of types of mesenchymal stem cells contained in bone marrow fluid, A culture product containing a secreted predetermined metabolite is produced. In the culture product production method, bone marrow fluid (raw material bone marrow fluid) collected from a plurality of donors (people) is used as a raw material, and the bone marrow fluid separation step, bone marrow fluid extraction step, stem cell first using the culture product production system 10. Manufactured through a fixing process, a stem cell first culturing process, a stem cell first collecting process, a stem cell separating process, a stem cell second collecting process, a stem cell second fixing process, a stem cell second culturing process, and a culture product solution first extracting process. The Furthermore, it is manufactured by using the culture product production system 10 through a stem cell second collection step, a stem cell third fixing step, a stem cell third culture step, and a culture product second extraction step.
 幹細胞第1定着工程には、幹細胞第1観察工程が含まれ、幹細胞第2採取工程には、幹細胞第2観察工程が含まれる。幹細胞第2定着工程には、幹細胞第3観察工程が含まれ、培養生成液第1抽出工程には、幹細胞第4観察工程が含まれる。幹細胞第3定着工程には、幹細胞第5観察工程が含まれ、培養生成液第2抽出工程には、幹細胞第6観察工程が含まれる。 The stem cell first fixing step includes a stem cell first observation step, and the stem cell second collection step includes a stem cell second observation step. The stem cell second fixing step includes a stem cell third observation step, and the culture product solution first extraction step includes a stem cell fourth observation step. The stem cell third fixing step includes a stem cell fifth observation step, and the culture product solution second extraction step includes a stem cell sixth observation step.
 培養生成液製造システム10は、コンピュータ11とバーコードリーダ12と電子顕微鏡13とから形成されている。コンピュータ11は、中央処理装置(CPUや仮想CPU)と記憶装置(メモリや仮想メモリ)と大容量記憶領域(ハードディスクや仮想ハードディスク等)とを備え、物理的なOS(オペレーティングシステム)や仮想OS(仮想オペレーティングシステム)によって動作する。コンピュータ11には、キーボード14やマウス15等の入力装置、ディスプレイ16やプリンタ(図示せず)等の出力装置がインターフェイス(無線または有線)を介して接続されている。 The culture product production system 10 includes a computer 11, a barcode reader 12, and an electron microscope 13. The computer 11 includes a central processing unit (CPU or virtual CPU), a storage device (memory or virtual memory), and a large-capacity storage area (hard disk, virtual hard disk, etc.), and a physical OS (operating system) or virtual OS ( Virtual operating system). An input device such as a keyboard 14 and a mouse 15 and an output device such as a display 16 and a printer (not shown) are connected to the computer 11 via an interface (wireless or wired).
 培養生成液製造システム10では、ドナーデータ(ドナー特定情報)がQRコード(登録商標)を利用して管理される。ドナーデータには、ドナーの氏名、住所、電話番号、生年月日、性別、血液型、身長、体重、メールアドレス等がある。システム10では、二次元コードとしてQRコードを使用しているが、QRコードの他に、マトリックス式のSPコード、ベリコード(VeriCode)、マキシコード(MaxiCode)、CPコード、DataMatrix、Code1、AztecCode、インタクタコード、カードeを使用することができる。なお、システム10で使用する二次元コードには、今後開発されるすべてのそれが含まれる。 In the culture product production system 10, donor data (donor identification information) is managed using a QR code (registered trademark). Donor data includes the donor's name, address, telephone number, date of birth, sex, blood type, height, weight, email address, and the like. In the system 10, a QR code is used as a two-dimensional code, but in addition to the QR code, a matrix type SP code, VeriCode (MaxiCode), CP code, DataMatrix, Code1, AztecCode, Intercode Kuta code and card e can be used. The two-dimensional code used in the system 10 includes all that will be developed in the future.
 骨髄液分離工程では、ドナーから採取した骨髄液18を層状に分離させる。骨髄液採取では、それらドナーの胸骨または腸骨(骨盤)から2~3cc(2~3ml)の骨髄液18が採取される。骨髄液18は、ドナーに局所麻酔をかけた後、骨髄を穿刺して骨髄液(骨髄血)を吸引する「骨髄穿刺」(マルク)によって採取される。医師や看護師、研究者等の担当者は、骨髄液18の採取と同時に、コンピュータ11においてシステム10を起動し、キーボード14やマウス15等の入力装置を利用してドナーデータをコンピュータ11に入力する。 In the bone marrow fluid separation step, the bone marrow fluid 18 collected from the donor is separated into layers. In the bone marrow fluid collection, 2 to 3 cc (2 to 3 ml) of bone marrow fluid 18 is collected from the sternum or iliac bone (pelvis) of these donors. The bone marrow fluid 18 is collected by “bone marrow puncture” (Marc), in which the donor is locally anesthetized and then the bone marrow is punctured to suck the bone marrow fluid (bone marrow blood). A doctor, nurse, researcher, or other person in charge starts up the system 10 in the computer 11 simultaneously with the collection of the bone marrow fluid 18 and inputs donor data into the computer 11 using an input device such as a keyboard 14 or a mouse 15. To do.
 コンピュータ11は、ドナーデータが入力される度毎(ドナーから骨髄液18を採取する度毎)に各ドナーを特定するユニークなドナー識別子を生成し、ドナーデータをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(ドナーデータ記憶工程)。コンピュータ11は、入力されたドナーデータを二次元コードライター機能によってQRコード(二次元コード)に変換し(二次元コード(QRコード)変換手段)、QRコードが印字された第1コード用紙17を出力するとともに(二次元コード(QRコード)出力工程)、そのQRコードを各ドナーを特定するドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(二次元コード(QRコード)記憶工程)。なお、2番目のドナーデータが入力された場合、QRコードが印字された第2コード用紙を出力し、3番目のドナーデータが入力された場合、QRコードが印字された第3コード用紙を出力するように、異なるドナーに応じて第1~第nコード用紙が出力される。 The computer 11 generates a unique donor identifier that identifies each donor each time donor data is input (every time the bone marrow fluid 18 is collected from the donor), and stores the storage area in a state in which the donor data is associated with the donor identifier. (Donor data storage step). The computer 11 converts the inputted donor data into a QR code (two-dimensional code) by a two-dimensional code writer function (two-dimensional code (QR code) conversion means), and the first code sheet 17 on which the QR code is printed In addition to outputting (two-dimensional code (QR code) output step), the QR code is stored (stored) in a storage area in association with a donor identifier that identifies each donor (two-dimensional code (QR code) storage step). . When the second donor data is input, the second code sheet on which the QR code is printed is output. When the third donor data is input, the third code sheet on which the QR code is printed is output. Thus, the first to nth code sheets are output according to different donors.
 なお、NO1が印字された第1コード用紙17に印字されたQRコードには、骨髄液分離工程、骨髄液抽出工程、幹細胞第1観察工程、幹細胞第1定着工程、幹細胞第1培養工程、幹細胞第2観察工程、幹細胞第1採取工程、幹細胞分離工程、幹細胞第2採取工程、幹細胞第3観察工程、幹細胞第2定着工程、幹細胞第2培養工程、幹細胞第4観察工程、培養生成液第1抽出工程、幹細胞第2採取工程、幹細胞第3定着工程、幹細胞第3培養工程、培養生成液第2抽出工程、幹細胞第2採取工程、幹細胞第5観察工程、幹細胞第3定着工程、幹細胞第3培養工程、幹細胞第6観察工程、培養生成液第2抽出工程を示す番号1が格納されている。コンピュータ11は、骨髄液分離工程から培養生成液第1抽出工程の各工程を実施する度毎に、記憶領域に格納したドナーデータとバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較する。 The QR code printed on the first code sheet 17 printed with NO1 includes a bone marrow fluid separation step, a bone marrow fluid extraction step, a stem cell first observation step, a stem cell first colonization step, a stem cell first culture step, a stem cell. Second observation step, stem cell first collection step, stem cell separation step, stem cell second collection step, stem cell third observation step, stem cell second colonization step, stem cell second culture step, stem cell fourth observation step, culture product solution first Extraction step, stem cell second collection step, stem cell third colonization step, stem cell third culture step, culture product solution second extraction step, stem cell second collection step, stem cell fifth observation step, stem cell third colonization step, stem cell third The number 1 indicating the culture step, the sixth stem cell observation step, and the culture product second extraction step is stored. Each time the computer 11 performs the steps from the bone marrow fluid separation step to the culture product first extraction step, the computer 11 stores the donor data stored in the storage area and the donor data indicated by the QR code read by the barcode reader 12. Compare.
 ドナーから採取された2~3ccの骨髄液18は、図2に示すように、上下方向へ延びるガラス試験管19(分離容器)内に注入(収容)される。なお、2~3ccの骨髄液18には、0.5~1ml(約5×10(cells/ml))の複数種類の間葉系幹細胞が含まれる。骨髄液18を注入するガラス試験管19の外周面には、第1コード用紙17が貼付されている。骨髄液18を注入したガラス試験管19は、図3に示すように、試験管立て20にセットされ、試験管立て20とともに恒温槽21内に収容される。 As shown in FIG. 2, 2 to 3 cc of bone marrow fluid 18 collected from the donor is injected (accommodated) into a glass test tube 19 (separation container) extending vertically. The 2-3 cc bone marrow fluid 18 contains 0.5 to 1 ml (about 5 × 10 7 (cells / ml)) of a plurality of types of mesenchymal stem cells. A first code sheet 17 is attached to the outer peripheral surface of the glass test tube 19 into which the bone marrow fluid 18 is injected. As shown in FIG. 3, the glass test tube 19 into which the bone marrow fluid 18 has been injected is set in a test tube stand 20 and accommodated in a thermostatic chamber 21 together with the test tube stand 20.
 医師や看護師、研究者等の担当者は、ガラス試験管19の外周面にQRコードが印字された第1コード用紙17を貼付した後、ガラス試験管19のQRコードをバーコードリーダ12に読み取らせる。バーコードリーダ12は、インターフェイス(有線または無線)を介してコンピュータ11に接続されている。バーコードリーダ12は、読み取ったQRコードをコンピュータ11に送信する。 A person in charge such as a doctor, nurse, researcher or the like attaches the first code sheet 17 on which the QR code is printed on the outer peripheral surface of the glass test tube 19, and then attaches the QR code of the glass test tube 19 to the barcode reader 12. Let me read. The barcode reader 12 is connected to the computer 11 via an interface (wired or wireless). The bar code reader 12 transmits the read QR code to the computer 11.
 コンピュータ11は、バーコードリーダ12から送信されたQRコードが示す番号1およびドナーデータを記憶領域から抽出してキャッシュメモリに読み出すとともに、工程第1表示画面(図示せず)をディスプレイ16に表示する。工程第1表示画面には、番号1およびドナーデータが表示されるとともに、骨髄液分離ボタン、骨髄液抽出ボタン、幹細胞第1観察ボタン、幹細胞第2観察ボタン、幹細胞第1採取ボタン、ログアウトボタンが表示される。ログアウトボタンをクリックすると、コンピュータ11においてシステム10が停止する。 The computer 11 extracts the number 1 and the donor data indicated by the QR code transmitted from the barcode reader 12 from the storage area and reads them into the cache memory, and displays a process first display screen (not shown) on the display 16. . On the process first display screen, number 1 and donor data are displayed, and a bone marrow fluid separation button, a bone marrow fluid extraction button, a stem cell first observation button, a stem cell second observation button, a stem cell first collection button, and a logout button Is displayed. When the logout button is clicked, the system 10 stops in the computer 11.
 担当者は、ディスプレイ16に表示された骨髄液分離ボタンをクリックした後、注射器からガラス試験管19に骨髄液18を注入し、骨髄液18を注入したガラス試験管19を試験管立て20に挿入(セット)する。担当者は、図3に示すように、試験管立て20を恒温槽21内に収容し、骨髄液18を注入したガラス試験管19を恒温槽21において所定時間(約2時間)静的に放置(動かすことなく静かに放置)する。恒温槽21内の温度は、体温と略同一の約36~37℃に保持されている。コンピュータ11は、第1コード用紙17に印字されたQRコードが示す番号1およびドナーデータをディスプレイ16に表示するとともに、骨髄液分離実施中メッセージ、骨髄液分離終了ボタンをディスプレイ16に表示する。 The person in charge clicks the bone marrow fluid separation button displayed on the display 16, injects the bone marrow fluid 18 into the glass test tube 19 from the syringe, and inserts the glass test tube 19 into which the bone marrow fluid 18 is injected into the test tube stand 20. (set. As shown in FIG. 3, the person in charge accommodates the test tube stand 20 in a thermostatic chamber 21 and statically leaves the glass test tube 19 into which the bone marrow fluid 18 has been injected in the thermostatic chamber 21 for a predetermined time (about 2 hours). (Leave quietly without moving). The temperature in the thermostatic chamber 21 is maintained at about 36 to 37 ° C., which is substantially the same as the body temperature. The computer 11 displays the number 1 and the donor data indicated by the QR code printed on the first code sheet 17 on the display 16, and displays a bone marrow fluid separation in progress message and a bone marrow fluid separation end button on the display 16.
 ガラス試験管19を恒温槽21に所定時間(約2時間)静的に放置することで、図4に示すように、試験管20に注入された骨髄液18が試験管20内において上下方向へ何層かの層状に分離される(骨髄液分離工程)。幹細胞の培養には通常150~200cc(150~200ml)の骨髄液が必要とされているが、培養生成液製造方法は、ドナーから採取された2~3ccの少量の骨髄液18から単一種幹細胞が作られるから、ドナーから2~3ccの少量の骨髄液18を採取すればよく、骨髄液18の採取時にドナーにかかる負担を最小限にすることができる。 By leaving the glass test tube 19 statically in the thermostatic chamber 21 for a predetermined time (about 2 hours), the bone marrow fluid 18 injected into the test tube 20 is vertically moved in the test tube 20 as shown in FIG. Separated into several layers (bone marrow fluid separation step). Stem cell culture usually requires 150 to 200 cc (150 to 200 ml) of bone marrow fluid, but the production method of the culture product is based on a single type of stem cell from a small amount of 2 to 3 cc of bone marrow fluid 18 collected from a donor. Therefore, a small amount of 2 to 3 cc of bone marrow fluid 18 may be collected from the donor, and the burden on the donor when collecting bone marrow fluid 18 can be minimized.
 骨髄液18を層状に分離させた骨髄液分離工程の後、骨髄液抽出工程が行われる。骨髄液抽出工程では、層状に分離した骨髄液18から中間層骨髄液22が抽出される。担当者は、骨髄液18が層状に分離したことを確認した後、ディスプレイ16に表示された骨髄液分離終了ボタンをクリックする。骨髄液分離終了ボタンをクリックすると、コンピュータ11は、工程第2表示画面(図示せず)をディスプレイ16に表示する。工程第2表示画面には、番号1およびドナーデータが表示されるとともに、骨髄液分離終了メッセージ、骨髄液抽出ボタン、幹細胞第1観察ボタン、幹細胞第2観察ボタン、幹細胞第1採取ボタンが表示される。 The bone marrow fluid extraction step is performed after the bone marrow fluid separation step in which the bone marrow fluid 18 is separated into layers. In the bone marrow fluid extraction step, the intermediate layer bone marrow fluid 22 is extracted from the bone marrow fluid 18 separated into layers. The person in charge confirms that the bone marrow fluid 18 has been separated into layers, and then clicks the bone marrow fluid separation end button displayed on the display 16. When the bone marrow fluid separation end button is clicked, the computer 11 displays a process second display screen (not shown) on the display 16. On the process second display screen, number 1 and donor data are displayed, and a bone marrow fluid separation end message, a bone marrow fluid extraction button, a stem cell first observation button, a stem cell second observation button, and a stem cell first collection button are displayed. The
 担当者は、工程第2表示画面の骨髄液抽出ボタンをクリックし、ガラス試験管19のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、骨髄液分離終了メッセージ、骨髄液抽出実施中メッセージ、骨髄液抽出終了ボタンをディスプレイに表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the bone marrow fluid extraction button on the process second display screen, and causes the barcode reader 12 to read the QR code of the glass test tube 19. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16 and a bone marrow fluid separation end message, a bone marrow fluid extraction in progress message, and a bone marrow fluid extraction end button are displayed on the display. . If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、恒温槽21内から試験管立て20を取り出し、試験管立て20からガラス試験管19を引き抜き、層状に分離した骨髄液18の特定の層に存在する中間層骨髄液22を抽出する(骨髄液抽出工程)。担当者は、注射器(図示せず)を利用して層状に分離した骨髄液18のうちの中間層に位置する2~4mmの層厚みの中間層骨髄液22を抽出(吸引)する。または、ピペット(図示せず)を利用して層状に分離した骨髄液18のうちの中間層に位置する2~4mmの層厚みの中間層骨髄液22を抽出(吸引)する。 The person in charge takes out the test tube stand 20 from the thermostatic chamber 21, pulls out the glass test tube 19 from the test tube stand 20, and extracts the intermediate layer bone marrow fluid 22 existing in a specific layer of the bone marrow fluid 18 separated into layers. (Bone marrow fluid extraction process). The person in charge extracts (suctions) the intermediate layer bone marrow fluid 22 having a layer thickness of 2 to 4 mm located in the intermediate layer of the bone marrow fluid 18 separated into layers using a syringe (not shown). Alternatively, the intermediate layer bone marrow fluid 22 having a layer thickness of 2 to 4 mm located in the intermediate layer of the bone marrow fluid 18 separated into layers using a pipette (not shown) is extracted (suctioned).
 培養生成液製造方法では、多種雑多な間葉系幹細胞を含む骨髄液18を上下方向へ層状に分離させた後、注射器またはピペットを利用することで、骨髄液18から特定の中間層骨髄液22を確実に抽出することができ、骨髄液18に含まれる不要な間葉系幹細胞を除去することができる。 In the culture product production method, bone marrow fluid 18 containing various mesenchymal stem cells is separated into layers in the vertical direction, and then a specific intermediate layer bone marrow fluid 22 is obtained from bone marrow fluid 18 by using a syringe or pipette. Can be reliably extracted, and unnecessary mesenchymal stem cells contained in the bone marrow fluid 18 can be removed.
 図5は、幹細胞第1観察工程の一例を示す説明図であり、図6は、第1扁平培養容器の側面図である。図7は、第1間葉系幹細胞26の平面形状の一例を示す部分拡大図であり、図8は、第1間葉系幹細胞26の平面形状の他の一例を示す部分拡大図である。図7,8は、電子顕微鏡13によって撮影された第1間葉系幹細胞26の平面形状の拡大画像を示す。 FIG. 5 is an explanatory view showing an example of the first stem cell observation step, and FIG. 6 is a side view of the first flat culture vessel. FIG. 7 is a partially enlarged view showing an example of the planar shape of the first mesenchymal stem cell 26, and FIG. 8 is a partially enlarged view showing another example of the planar shape of the first mesenchymal stem cell 26. 7 and 8 show enlarged images of the planar shape of the first mesenchymal stem cell 26 taken by the electron microscope 13.
 骨髄液18から中間層に位置する特定の中間層骨髄液22を抽出した骨髄液抽出工程の後、幹細胞第1観察工程が行われる。幹細胞第1観察工程では、中間層骨髄液22および培養液23を第1扁平培養容器24(第1培養容器)に注入(収容)し、培養容器24内を体温と略同一の温度(約36~37℃)に保持しつつ、培養容器24が12~24時間静的に放置(動かすことなく静かに放置)される。 The stem cell first observation step is performed after the bone marrow fluid extraction step of extracting a specific middle layer bone marrow fluid 22 located in the middle layer from the bone marrow fluid 18. In the first stem cell observation step, the intermediate layer bone marrow fluid 22 and the culture solution 23 are injected (contained) into the first flat culture vessel 24 (first culture vessel), and the temperature inside the culture vessel 24 is substantially the same as the body temperature (about 36). The culture vessel 24 is statically left for 12 to 24 hours (slowly left unmoved) while being held at 37 ° C).
 医師や看護師、研究者等の担当者は、骨髄液18から特定の中間層骨髄液22を抽出した後、ディスプレイ16に表示された骨髄液抽出終了ボタンをクリックする。骨髄液抽出終了ボタンをクリックすると、コンピュータ11は、工程第3表示画面(図示せず)をディスプレイ16に表示する。工程第3表示画面には、番号1およびドナーデータが表示されるとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察ボタン、幹細胞第2観察ボタン、幹細胞第1採取ボタンが表示される。 A person in charge such as a doctor, nurse, or researcher extracts a specific intermediate layer bone marrow fluid 22 from the bone marrow fluid 18 and then clicks a bone marrow fluid extraction end button displayed on the display 16. When the bone marrow fluid extraction end button is clicked, the computer 11 displays a process third display screen (not shown) on the display 16. On the process third display screen, number 1 and donor data are displayed, and a bone marrow separation end message, a bone marrow extraction end message, a stem cell first observation button, a stem cell second observation button, and a stem cell first collection button are displayed. Is done.
 担当者は、QRコードが印字された第1コード用紙17を第1扁平培養容器24の底面27(底壁外面)に貼付する。次に、工程第3表示画面の幹細胞第1観察ボタンをクリックし、培養容器24のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察実施中メッセージ、幹細胞第1観察終了ボタンをディスプレイに表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge attaches the first code sheet 17 on which the QR code is printed to the bottom surface 27 (the outer surface of the bottom wall) of the first flat culture vessel 24. Next, the stem cell first observation button on the process third display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 24. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. If the donor data match, the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation in progress message, stem cell first Display the observation end button on the display. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、注射器またはピペットに吸引された中間層骨髄液22を培養容器24に注入(収容)するとともに、注射器またはピペットを利用して培養液23を培養容器24に注入(収容)する。第1扁平培養容器24(第1培養容器)は、透明なガラスまたは透明なプラスチックから作られ、小容量かつ所定面積の底面27を有する平面形状が略正四角形の扁平な容器である。第1扁平培養容器24は、頂部40および底部38と、頂部40に形成された注入口41とを有する。注入口41は、蓋42によって水密に閉塞されている。第1扁平培養容器24として小容量かつ所定面積の底面27を有する平面形状が円形や楕円形の扁平な容器を使用することもできる。幹細胞第1観察手段で使用される第1扁平培養容器24は、その容量が約20~30cc(好ましくは、25cc)であり、その底面面積が約25~36mmである。培養容器24は、その一辺の長さが5~6mmである。 The person in charge injects (accommodates) the intermediate layer bone marrow fluid 22 sucked into the syringe or pipette into the culture container 24 and injects (accommodates) the culture medium 23 into the culture container 24 using the syringe or pipette. The first flat culture vessel 24 (first culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 with a small capacity and a predetermined area and having a substantially square shape. The first flat culture vessel 24 has a top 40 and a bottom 38 and an inlet 41 formed in the top 40. The injection port 41 is watertightly closed by a lid 42. As the first flat culture container 24, a flat container having a small volume and a bottom surface 27 having a predetermined area and having a circular or elliptical planar shape may be used. The first flat culture vessel 24 used in the first stem cell observation means has a capacity of about 20-30 cc (preferably 25 cc) and a bottom area of about 25-36 mm 2 . The culture container 24 has a side length of 5 to 6 mm.
 培養液23には、ペニシリン(約100U/ml)、アムホテリシン(約100ng/ml)、ストレプトマイシン(約100mkg/ml)、L-グルタミン(約2~4ml)、20%ウシ胎児血清を添加したミネラル塩溶液およびアミノ酸が含まれる。培養容器24に注入された中間層骨髄液22に含まれる第1間葉系幹細胞26は、時間の経過とともに培養容器24の底面27に定着しつつ、培養液23によって培養され、培養容器24の底面27において次第に増殖(分化)してコロニーを形成する。 The culture solution 23 is a mineral salt to which penicillin (about 100 U / ml), amphotericin (about 100 ng / ml), streptomycin (about 100 mg / ml), L-glutamine (about 2 to 4 ml) and 20% fetal bovine serum are added. Solutions and amino acids are included. The first mesenchymal stem cells 26 contained in the intermediate layer bone marrow fluid 22 injected into the culture vessel 24 are cultured in the culture solution 23 while being fixed on the bottom surface 27 of the culture vessel 24 over time. It gradually grows (differentiates) on the bottom surface 27 to form a colony.
 なお、培養液には、Dulbecco’s  Modified  Eagle’s  Medium(DMEM)、Grasgow  Minimum  Essential  Medium(GMEM)、RPMI640等を使用することもできる。培養液には、インスリン、トランスフェリン、エタノールアミン、セレニウム、2-メルカプトエタノール、L―アラニル-L-グルタミン、ピルビン酸ナトリウム、L-アラニン、L-アスパラギン、L-アスパラチン酸、グリシン、L-プロリン、L-セリン等を添加することもできる。 In addition, Dulbecco's Modified a Eagle's Medium (DMEM), Grasgo Minimum Essential Medium (GMEM), RPMI 640, and the like can be used as the culture solution. In the culture medium, insulin, transferrin, ethanolamine, selenium, 2-mercaptoethanol, L-alanyl-L-glutamine, sodium pyruvate, L-alanine, L-asparagine, L-aspartic acid, glycine, L-proline L-serine or the like can also be added.
 担当者は、中間層骨髄液22および培養液23を第1扁平培養容器24に注入した後、培養容器24を電子顕微鏡13の試料ホルダに設置(セット)する。なお、電子顕微鏡13の試料ホルダ36の上面37と第1扁平培養容器24の底部38との間にスペーサー39を介在させ、培養容器24の底部38をスペーサー39によって持ち上げた状態に保持し、培養容器24の底部38が上となり培養容器24の頂部40(注入口41)が下となるように、培養容器24を所定角度に傾斜させた状態に保持する。また、電子顕微鏡13の試料ホルダ36の上面37と第1扁平培養容器24の頂部40との間にスペーサー39を介在させ、培養容器24の頂部40をスペーサー39によって持ち上げた状態に保持し、培養容器24の頂部40が上となり培養容器24の底部38が下となるように、培養容器24を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第1扁平培養容器24の傾斜角度α1は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 The person in charge injects the intermediate layer bone marrow fluid 22 and the culture solution 23 into the first flat culture vessel 24 and then installs (sets) the culture vessel 24 in the sample holder of the electron microscope 13. A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 38 of the first flat culture vessel 24, and the bottom portion 38 of the culture vessel 24 is held in a state of being lifted by the spacer 39. The culture vessel 24 is held at a predetermined angle so that the bottom 38 of the vessel 24 is on top and the top 40 (inlet 41) of the culture vessel 24 is on the bottom. In addition, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 40 of the first flat culture vessel 24, and the top 40 of the culture vessel 24 is held in a state of being lifted by the spacer 39. You may hold | maintain the culture container 24 in the state inclined by the predetermined angle so that the top part 40 of the container 24 may become the upper side and the bottom part 38 of the culture container 24 may become the lower side. The inclination angle α1 of the first flat culture vessel 24 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、試料ホルダ36の上面37に対して第1扁平培養容器24を前記傾斜角度で傾斜させることで、培養容器24内において中間骨髄液22および培養液23が培養容器24の頂部40の側(または底部38の側)に偏り、培養容器24の頂部49の側(または底部38の側)において中間骨髄液22と培養液23との水圧が大きくなって第1間葉系幹細胞26が培養容器24の底部38の側に集中し、それによって第1間葉系幹細胞26どうしの活性が高まり、培養容器24の底面27において第1間葉系幹細胞26を容易かつ迅速に定着させることができる。 In the culture product production method, the first flat culture vessel 24 is inclined at the inclination angle with respect to the upper surface 37 of the sample holder 36 so that the intermediate bone marrow fluid 22 and the culture solution 23 are contained in the culture vessel 24 in the culture vessel 24. The first mesenchymal system is biased toward the top 40 (or the bottom 38), and the water pressure between the intermediate bone marrow fluid 22 and the culture fluid 23 increases on the top 49 side (or the bottom 38 side) of the culture vessel 24. The stem cells 26 are concentrated on the bottom 38 side of the culture vessel 24, thereby increasing the activity of the first mesenchymal stem cells 26, and the first mesenchymal stem cells 26 are easily and quickly fixed on the bottom surface 27 of the culture vessel 24. Can be made.
 電子顕微鏡13は、インターフェイス(有線または無線)を介してコンピュータ11に接続されている。電子顕微鏡13は、撮像素子によって被写体の拡大画像を撮影する画像撮影機能を有するとともに、その拡大画像をコンピュータ11に送信する画像送信機能を有する。電子顕微鏡13は、培養容器24に注入された中間層骨髄液22に含まれる第1間葉系幹細胞26の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞26の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。電子顕微鏡13における画像撮影間隔や画像送信間隔は、キーボード14やマウス15等の入力装置によって1~2時間の間で自由に設定することができる。 The electron microscope 13 is connected to the computer 11 via an interface (wired or wireless). The electron microscope 13 has an image capturing function for capturing an enlarged image of a subject using an image sensor, and also has an image transmission function for transmitting the enlarged image to the computer 11. The electron microscope 13 takes magnified images of the planar shape of the first mesenchymal stem cells 26 contained in the intermediate layer bone marrow fluid 22 injected into the culture vessel 24 at intervals of about 1 to 2 hours, and the planar surface of the photographed stem cells 26 is taken. The enlarged image of the shape is transmitted to the computer 11 at intervals of about 1 to 2 hours. The image capturing interval and the image transmission interval in the electron microscope 13 can be freely set within 1 to 2 hours by an input device such as a keyboard 14 or a mouse 15.
 コンピュータ11は、電子顕微鏡13から送信された第1間葉系幹細胞26の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第1記憶工程)。コンピュータ11は、電子顕微鏡13から送信された幹細胞28の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。担当者は、ディスプレイ16に表示された幹細胞26の平面形状の拡大画像を12~24時間の間において約1~2時間間隔で確認(視認)し、中間層骨髄液22に含まれる幹細胞26の平面形状の変化を観察する(幹細胞第1観察工程)。なお、担当者が電子顕微鏡13の観察窓から第1間葉系幹細胞26の平面形状の変化を12~24時間の間において約1~2時間間隔で直接観察してもよい。 The computer 11 stores (stores) the enlarged image of the planar shape of the first mesenchymal stem cell 26 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (first storage of the stem cell image) Process). The computer 11 displays on the display 16 an enlarged image of the planar shape of the stem cell 28 transmitted from the electron microscope 13 and the imaging time. The person in charge confirms (views) the enlarged image of the planar shape of the stem cell 26 displayed on the display 16 at intervals of about 1 to 2 hours during 12 to 24 hours, and determines the stem cells 26 contained in the intermediate layer bone marrow fluid 22. A change in planar shape is observed (stem cell first observation step). The person in charge may directly observe the change in the planar shape of the first mesenchymal stem cell 26 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 12 to 24 hours.
 培養生成液製造方法では、中間層骨髄液に含まれる第1間葉系幹細胞26培養しつつ第1間葉系幹細胞26を第1扁平培養容器24(第1培養容器)の底面27に定着させる(幹細胞第1定着工程)。第1間葉系幹細胞26の初期平面形状は略円形であり、幹細胞26の平面形状が略円形の場合、幹細胞26が培養容器24の底面27(底壁内面)に定着しておらず、幹細胞26が増殖(分化)を開始していない。第1間葉系幹細胞26の変形後の平面形状は定着前の略円形を核として幹細胞26が一方向(所定方向)へ不定形に伸張(拡張)した扁平形状であり、幹細胞26が培養容器24の底面27(底壁内面)に定着し、幹細胞26が増殖(分化)を開始している。 In the culture product production method, the first mesenchymal stem cell 26 is fixed to the bottom surface 27 of the first flat culture vessel 24 (first culture vessel) while culturing the first mesenchymal stem cell 26 contained in the intermediate layer bone marrow fluid. (Stem cell first fixing step). The initial planar shape of the first mesenchymal stem cell 26 is substantially circular. When the planar shape of the stem cell 26 is substantially circular, the stem cell 26 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24, and the stem cell. 26 has not started to proliferate (differentiate). The planar shape after the deformation of the first mesenchymal stem cell 26 is a flat shape in which the stem cell 26 is stretched (expanded) in one direction (predetermined direction) with a substantially circular shape before fixing as a nucleus, and the stem cell 26 is a culture vessel. 24 has settled on the bottom surface 27 (inner surface of the bottom wall), and the stem cells 26 have started to grow (differentiate).
 担当者は、幹細胞第1観察工程における観察の結果、図6に示すように、ディスプレイ16に表示された第1間葉系幹細胞26の平面形状の拡大画像が略円形のまま観察される場合、幹細胞26が培養容器24の底面27(底壁内面)に定着していないと判断し、幹細胞26の平面形状の変化を約1~2時間間隔で継続して観察する。担当者は、幹細胞第1観察工程における観察の結果、図7に示すように、ディスプレイ16に表示された第1間葉系幹細胞26の平面形状が略円形から略円形を核として不定形の扁平形状に変形した場合、幹細胞26が培養容器24の底面27に定着したと判断する。 As a result of the observation in the first stem cell observation step, the person in charge, as shown in FIG. 6, when the enlarged image of the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 is observed in a substantially circular shape, It is determined that the stem cells 26 are not settled on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24, and the change in the planar shape of the stem cells 26 is continuously observed at intervals of about 1 to 2 hours. As a result of the observation in the first stem cell observation step, the person in charge, as shown in FIG. 7, has a flat shape in which the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 is from an approximately circular shape to an approximately circular shape. When the shape is deformed, it is determined that the stem cell 26 has settled on the bottom surface 27 of the culture vessel 24.
 第1間葉系幹細胞26の定着時に容量が30ccを超過するとともに底面面積が36mmを超過する大きな培養容器を使用すると、幹細胞26が容器の底面に定着し難くなるとともに幹細胞26の増殖が遅くなるが、培養生成液製造方法は、前記容量かつ前記底面面積の第1扁平培養容器24を使用することで、幹細胞26を培養容器24の底面27に容易に定着させることができ、培養容器24において幹細胞26を素早く増殖させることができる。 If a large culture container with a capacity exceeding 30 cc and a bottom area exceeding 36 mm 2 is used when the first mesenchymal stem cell 26 is established, the stem cell 26 becomes difficult to settle on the bottom face of the container and the proliferation of the stem cell 26 is slow. However, in the culture product production method, the stem cell 26 can be easily fixed on the bottom surface 27 of the culture container 24 by using the first flat culture container 24 having the above-described capacity and the bottom surface area. The stem cell 26 can be rapidly proliferated.
 培養生成液製造方法は、培養容器24を体温と略同一の温度で12~24時間静的放置しつつ、12~24時間の間において約1~2時間間隔で培養容器24内の第1間葉系幹細胞26の初期平面形状からの変形を観察するから、幹細胞26の変形を見逃すことはなく、幹細胞26の培養容器24の底面27に対する定着を正確に確認することができる。 The culture product producing method is such that the culture container 24 is left to stand at a temperature substantially the same as the body temperature for 12 to 24 hours, and the first interval in the culture container 24 is about 1 to 2 hours between 12 and 24 hours. Since the deformation of the leaf stem cells 26 from the initial planar shape is observed, the deformation of the stem cells 26 is not missed, and the establishment of the stem cells 26 on the bottom surface 27 of the culture vessel 24 can be confirmed accurately.
 図9は、第1間葉系幹細胞26の平面形状の他の一例を示す部分拡大図である。図9は、電子顕微鏡13によって撮影された第1間葉系幹細胞26の平面形状の拡大画像を示す。幹細胞第1観察工程における観察の結果、第1間葉系幹細胞26(第1幹細胞)が略円形(初期平面形状)から略円形を核として不定形の扁平形状に変形し、幹細胞26の第1扁平培養容器24(第1培養容器)の底面27への定着を確認した幹細胞第1定着工程の後、幹細胞第1培養工程および幹細胞第2観察工程が行われる。 FIG. 9 is a partially enlarged view showing another example of the planar shape of the first mesenchymal stem cell 26. FIG. 9 shows an enlarged image of the planar shape of the first mesenchymal stem cell 26 photographed by the electron microscope 13. As a result of the observation in the first stem cell observation step, the first mesenchymal stem cell 26 (first stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with a substantially circular shape as a nucleus, and the first stem cell 26 has a first shape. After the stem cell first fixing step in which the fixation on the bottom surface 27 of the flat culture vessel 24 (first culture vessel) is confirmed, the stem cell first culturing step and the stem cell second observation step are performed.
 幹細胞第1培養工程および幹細胞第2観察工程では、培養容器24内に注入されている培養液23が培養容器24から排出(廃棄)され、培養容器24内にあらたな培養液23が注入(収容)される。次に、培養容器24が体温と略同一の温度(約36~37℃)で36~48時間静的に放置(動かすことなく静かに放置)され、培養容器24の底面面積に対する第1間葉系幹細胞26の総平面面積が第1目標割合に達するまで幹細胞26が培養される(幹細胞第1培養工程)。 In the stem cell first culture step and the stem cell second observation step, the culture solution 23 injected into the culture vessel 24 is discharged (discarded) from the culture vessel 24, and a new culture solution 23 is injected (accommodated) into the culture vessel 24. ) Next, the culture vessel 24 is statically left (i.e., silently left unmoved) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the first mesenchyme relative to the bottom surface area of the culture vessel 24 is left. The stem cells 26 are cultured until the total planar area of the stem cells 26 reaches the first target ratio (stem cell first culture step).
 36~48時間の放置時間において約1~2時間間隔で培養容器24の底面27に定着した第1間葉系幹細胞26の培養容器24の底面面積に対する総平面面積を電子顕微鏡13で観察し、幹細胞26の総平面面積が培養容器24の底面面積に対して第1目標割合に達したか否かが判断される。培養容器24の底面面積に対する第1間葉系幹細胞26の総平面面積の第1目標割合は、70~80%(70~80%コンフルエント)である。 The total planar area of the first mesenchymal stem cells 26 fixed to the bottom surface 27 of the culture vessel 24 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 24. It is determined whether or not the total planar area of the stem cells 26 has reached the first target ratio with respect to the bottom area of the culture vessel 24. The first target ratio of the total planar area of the first mesenchymal stem cell 26 to the bottom surface area of the culture vessel 24 is 70 to 80% (70 to 80% confluent).
 医師や看護師、研究者等の担当者は、中間層骨髄液22に含まれる第1間葉系幹細胞26の培養容器24の底面27に対する定着を確認した後、ディスプレイ16に表示された幹細胞第1観察終了ボタンをクリックする。幹細胞第1観察終了ボタンをクリックすると、コンピュータ11は、工程第4表示画面(図示せず)をディスプレイ16に表示する。工程第4表示画面には、番号1およびドナーデータが表示されるとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察終了メッセージ、幹細胞第2観察ボタン、幹細胞第1採取ボタンが表示される。 A person in charge such as a doctor, nurse, or researcher confirms that the first mesenchymal stem cell 26 contained in the intermediate layer bone marrow fluid 22 has settled on the bottom surface 27 of the culture vessel 24 and then displays the stem cell number displayed on the display 16. 1 Click the observation end button. When the stem cell first observation end button is clicked, the computer 11 displays a process fourth display screen (not shown) on the display 16. On the process fourth display screen, number 1 and donor data are displayed, and a bone marrow fluid separation end message, a bone marrow fluid extraction end message, a stem cell first observation end message, a stem cell second observation button, and a stem cell first collection button are displayed. Is displayed.
 担当者は、工程第4表示画面の幹細胞第2観察ボタンをクリックし、培養容器24を電子顕微鏡16の試料ホルダから取り外すとともに、培養容器24のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察終了メッセージ、幹細胞第2観察実施中メッセージ、幹細胞第2観察終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the stem cell second observation button on the process fourth display screen, removes the culture container 24 from the sample holder of the electron microscope 16, and causes the barcode reader 12 to read the QR code of the culture container 24. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation An ongoing message and a stem cell second observation end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、幹細胞第1観察工程において培養容器24に注入した培養液23を培養容器24から排出(廃棄)し、あらたな培養液23を培養容器24に注入(収容)する。あらたな培養液23は、幹細胞第1観察工程において注入されたそれと同一である。担当者は、あらたな培養液23を培養容器24に注入した後、培養容器24を電子顕微鏡13の試料ホルダに設置(セット)する。 The person in charge discharges (discards) the culture solution 23 injected into the culture vessel 24 in the stem cell first observation step from the culture vessel 24 and injects (accommodates) the new culture solution 23 into the culture vessel 24. The new culture solution 23 is the same as that injected in the stem cell first observation step. The person in charge injects a new culture solution 23 into the culture vessel 24 and then installs (sets) the culture vessel 24 in the sample holder of the electron microscope 13.
 なお、電子顕微鏡13の試料ホルダ36の上面37と第1扁平培養容器24の底部38との間にスペーサー39を介在させ、培養容器24の底部38をスペーサー39によって持ち上げた状態に保持し、培養容器24の底部38が上となり培養容器24の頂部40(注入口41)が下となるように、培養容器24を所定角度に傾斜させた状態に保持する(図6参照)。また、電子顕微鏡13の試料ホルダ36の上面37と第1扁平培養容器24の頂部40との間にスペーサー39を介在させ、培養容器24の頂部40をスペーサー39によって持ち上げた状態に保持し、培養容器24の頂部40が上となり培養容器24の底部38が下となるように、培養容器24を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第1扁平培養容器24の傾斜角度α1は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 38 of the first flat culture vessel 24, and the bottom portion 38 of the culture vessel 24 is held in a state of being lifted by the spacer 39. The culture vessel 24 is held at a predetermined angle so that the bottom 38 of the vessel 24 is on top and the top 40 (inlet 41) of the culture vessel 24 is on the bottom (see FIG. 6). In addition, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 40 of the first flat culture vessel 24, and the top 40 of the culture vessel 24 is held in a state of being lifted by the spacer 39. You may hold | maintain the culture container 24 in the state inclined by the predetermined angle so that the top part 40 of the container 24 may become the upper side and the bottom part 38 of the culture container 24 may become the lower side. The inclination angle α1 of the first flat culture vessel 24 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、第1間葉系幹細胞26の定着を確認した後、培養容器24の培養液23を排出しつつあらたな培養液23を培養容器24に注入することで、幹細胞26の増殖を確実に促進することができる。培養生成液製造方法は、試料ホルダ36の上面37に対して第1扁平培養容器24を前記傾斜角度で傾斜させることで、培養容器24内において第1間葉系幹細胞26および培養液23が培養容器24の頂部40の側(または底部38の側)に偏り、培養容器24の頂部40の側(または底部38の側)において第1間葉系幹細胞26と培養液23との水圧が大きくなって第1間葉系幹細胞26が培養容器24の底部38の側に集中し、それによって第1間葉系幹細胞26どうしの活性が高まり、培養容器24の底面27において第1間葉系幹細胞26を容易かつ迅速に増殖(分化)させることができる。 After confirming the establishment of the first mesenchymal stem cell 26, the culture product production method injects a new culture solution 23 into the culture vessel 24 while discharging the culture solution 23 in the culture vessel 24. Proliferation can be reliably promoted. In the culture product production method, the first mesenchymal stem cell 26 and the culture solution 23 are cultured in the culture vessel 24 by inclining the first flat culture vessel 24 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 40 side (or the bottom 38 side) of the container 24, and the water pressure between the first mesenchymal stem cell 26 and the culture solution 23 increases on the top 40 side (or the bottom 38 side) of the culture container 24. Thus, the first mesenchymal stem cells 26 concentrate on the bottom 38 side of the culture vessel 24, thereby increasing the activity of the first mesenchymal stem cells 26, and the first mesenchymal stem cells 26 are formed on the bottom surface 27 of the culture vessel 24. Can be propagated (differentiated) easily and rapidly.
 電子顕微鏡13は、培養容器24内の第1間葉系幹細胞26の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞26の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。コンピュータ11は、電子顕微鏡13から送信された幹細胞26の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第2記憶工程)。コンピュータ11は、電子顕微鏡13から送信された幹細胞26の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。 The electron microscope 13 takes an enlarged image of the planar shape of the first mesenchymal stem cell 26 in the culture vessel 24 at intervals of about 1 to 2 hours, and takes an enlarged image of the planar shape of the photographed stem cell 26 for about 1 to 2 hours. It transmits to the computer 11 at intervals. The computer 11 stores (stores) the enlarged image of the planar shape of the stem cell 26 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image second storage step). The computer 11 displays the enlarged image of the planar shape of the stem cell 26 transmitted from the electron microscope 13 and the imaging time on the display 16.
 担当者は、ディスプレイ16に表示された第1間葉系幹細胞26の平面形状の拡大画像を36~48時間の間において約1~2時間間隔で確認(視認)し、培養容器24の底面27に定着した幹細胞26の培養容器24の底面面積に対する総平面面積を観察しつつ、幹細胞26の総平面面積が培養容器24の底面面積に対して第1目標割合(70~80%コンフルエント)に達したか否かを判断する(幹細胞第2観察工程)。なお、担当者が電子顕微鏡13の観察窓から第1間葉系幹細胞26の培養容器24の底面面積に対する総平面面積を36~48時間の間において約1~2時間間隔で直接観察し、幹細胞26の総平面面積が培養容器24の底面面積に対して第1目標割合(70~80%コンフルエント)に達したか否かを判断してもよい。 The person in charge confirms (views) the enlarged image of the planar shape of the first mesenchymal stem cell 26 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours. While observing the total planar area of the stem cells 26 settled on the bottom surface area of the culture container 24, the total planar area of the stem cells 26 reaches the first target ratio (70 to 80% confluent) with respect to the bottom surface area of the culture container 24. It is determined whether or not (stem cell second observation step). The person in charge directly observes the total planar area of the first mesenchymal stem cell 26 with respect to the bottom surface area of the culture vessel 24 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total planar area of 26 has reached the first target ratio (70 to 80% confluent) with respect to the bottom area of the culture vessel 24.
 担当者は、幹細胞第2観察工程における観察の結果、図7に示すように、ディスプレイ16に表示された第1間葉系幹細胞26の培養容器24の底面面積に対する総平面面積が第1目標割合(70~80%コンフルエント)に達していない場合、幹細胞26の培養容器24の底面面積に対する総平面面積を約1~2時間間隔で継続して観察する。なお、ディスプレイ16に表示された拡大画像の全面積に対して第1間葉系幹細胞26の総平面面積が第1目標割合に達した場合に、幹細胞26の培養容器24の底面面積に対する総平面面積が第1目標割合に達したものとする。 As a result of the observation in the second stem cell observation step, the person in charge shows that the total planar area with respect to the bottom area of the culture vessel 24 of the first mesenchymal stem cell 26 displayed on the display 16 is the first target ratio as shown in FIG. If it has not reached (70 to 80% confluence), the total planar area of the stem cells 26 relative to the bottom area of the culture vessel 24 is continuously observed at intervals of about 1 to 2 hours. In addition, when the total plane area of the first mesenchymal stem cell 26 reaches the first target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 24 of the stem cell 26 It is assumed that the area has reached the first target ratio.
 幹細胞第2観察工程における観察の結果、第1間葉系幹細胞26が培養容器24の底面27(底壁内面)において増殖して幹細胞26がコロニーを形成し、幹細胞26の平面形状が拡張することで、図8に示すように、ディスプレイ16に表示された幹細胞26の培養容器24の底面面積に対する総平面面積が第1目標割合(70~80%コンフルエント)に達した場合、培養容器24から幹細胞26を抽出する幹細胞第1採取工程が行われる。幹細胞第1採取工程では、第1間葉系幹細胞26の総平面面積が第1目標割合に達した時点で、培養容器24内において増殖(分化)した第1間葉系幹細胞26が培養容器24から採取される。 As a result of the observation in the second stem cell observation step, the first mesenchymal stem cell 26 grows on the bottom surface 27 (bottom wall inner surface) of the culture vessel 24 to form a colony, and the planar shape of the stem cell 26 expands. As shown in FIG. 8, when the total planar area of the stem cells 26 displayed on the display 16 with respect to the bottom surface area of the culture vessel 24 reaches the first target ratio (70 to 80% confluent), the stem cells are removed from the culture vessel 24. A first stem cell collection step for extracting 26 is performed. In the first stem cell collection step, when the total planar area of the first mesenchymal stem cells 26 reaches the first target ratio, the first mesenchymal stem cells 26 grown (differentiated) in the culture vessel 24 are cultured in the culture vessel 24. Taken from.
 医師や看護師、研究者等の担当者は、第1間葉系幹細胞26の培養容器24の底面面積に対する総平面面積が第1目標割合に達したことを確認した後、ディスプレイ16に表示された幹細胞第2観察終了ボタンをクリックする。幹細胞第2観察終了ボタンをクリックすると、コンピュータ11は、工程第5表示画面(図示せず)をディスプレイ16に表示する。工程第5表示画面には、番号1およびドナーデータが表示されるとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察終了メッセージ、幹細胞第2観察終了メッセージ、幹細胞第1採取ボタンが表示される。 A person in charge, such as a doctor, nurse, or researcher, confirms that the total planar area of the first mesenchymal stem cell 26 relative to the bottom area of the culture vessel 24 has reached the first target ratio, and then is displayed on the display 16. Click the button for ending stem cell second observation. When the stem cell second observation end button is clicked, the computer 11 displays a process fifth display screen (not shown) on the display 16. On the process fifth display screen, number 1 and donor data are displayed, bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation end message, stem cell first collection button Is displayed.
 担当者は、工程第5表示画面の幹細胞第1採取ボタンをクリックし、培養容器24のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、骨髄液分離終了メッセージ、骨髄液抽出終了メッセージ、幹細胞第1観察終了メッセージ、幹細胞第2観察終了メッセージ、幹細胞第1採取実施中メッセージ、幹細胞第1採取終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the stem cell first collection button on the process fifth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 24. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the bone marrow fluid separation end message, bone marrow fluid extraction end message, stem cell first observation end message, stem cell second observation An end message, a stem cell first collection execution message, and a stem cell first collection end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、培養容器24に注入されている幹細胞第2観察時の培養液23を注射器またはピペットを利用して培養容器24から排出(廃棄)し、培養容器24内をPBSで洗浄した後、注射器またはピペットに吸引されたトリプシン液を培養容器24内に注入する。培養容器24にトリプシン液を注入すると、培養容器24の底面27に定着した第1間葉系幹細胞26がトリプシン液によって底面27から剥離し、トリプシン液の水面に浮上する。担当者は、ピペットを利用して幹細胞26を採取(吸引)し、幹細胞26をピペット内に収容する(幹細胞第1採取工程)。 The person in charge discharges (discards) the culture solution 23 in the second observation of the stem cells injected into the culture vessel 24 from the culture vessel 24 using a syringe or pipette, and after washing the inside of the culture vessel 24 with PBS, The trypsin solution sucked into the syringe or pipette is injected into the culture container 24. When the trypsin solution is injected into the culture vessel 24, the first mesenchymal stem cells 26 fixed on the bottom surface 27 of the culture vessel 24 are detached from the bottom surface 27 by the trypsin solution and float on the water surface of the trypsin solution. The person in charge collects (suctions) the stem cells 26 using a pipette, and stores the stem cells 26 in the pipette (stem cell first collection step).
 培養生成液製造方法は、約1~2時間間隔で総平面面積を観察することで、第1間葉系幹細胞26の培養容器24の底面面積に対する総平面面積を正確に確認することができ、培養容器24の底面面積に対して幹細胞26の総平面面積が第1目標割合に達したことを確実に把握することができる。 By observing the total planar area at intervals of about 1 to 2 hours, the culture product production method can accurately confirm the total planar area with respect to the bottom area of the culture vessel 24 of the first mesenchymal stem cell 26, It can be ascertained that the total planar area of the stem cells 26 has reached the first target ratio with respect to the bottom surface area of the culture vessel 24.
 図10は、幹細胞分離工程の一例を示す説明図である。培養容器24から第1間葉系幹細胞26を採取した幹細胞第1採取工程の後、幹細胞分離工程が行われる。幹細胞分離工程では、第1採取手段によって採取された第1間葉系幹細胞26が遠心分離器28によって層状に遠心分離される。医師や看護師、研究者等の担当者は、第1間葉系幹細胞26を培養容器24からピペットに吸引した後、ディスプレイ16に表示された幹細胞第1採取終了ボタンをクリックする。 FIG. 10 is an explanatory diagram showing an example of the stem cell separation step. After the first stem cell collection step in which the first mesenchymal stem cells 26 are collected from the culture vessel 24, a stem cell separation step is performed. In the stem cell separation step, the first mesenchymal stem cells 26 collected by the first collection means are centrifuged in layers by the centrifuge 28. A person in charge, such as a doctor, nurse, or researcher, aspirates the first mesenchymal stem cell 26 from the culture vessel 24 into the pipette, and then clicks the stem cell first collection end button displayed on the display 16.
 幹細胞第1採取終了ボタンをクリックすると、コンピュータ11は、工程第6表示画面(図示せず)をディスプレイ16に表示する。工程第6表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞分離ボタン、幹細胞第2抽出ボタン、幹細胞第3観察ボタン、幹細胞第4観察ボタン、第1抽出ボタンが表示される。担当者は、QRコードが印字された第1コード用紙17を第1間葉系幹細胞26を注入するガラス試験管29の外周面に貼付する。 When the stem cell first collection end button is clicked, the computer 11 displays a process sixth display screen (not shown) on the display 16. On the process sixth display screen, number 1 and donor data are displayed, and a stem cell separation button, a stem cell second extraction button, a stem cell third observation button, a stem cell fourth observation button, and a first extraction button are displayed. The person in charge affixes the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the glass test tube 29 into which the first mesenchymal stem cells 26 are injected.
 次に、工程第6表示画面の幹細胞分離ボタンをクリックし、ガラス試験管29のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離実施中メッセージ、幹細胞分離終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 Next, the stem cell separation button on the process sixth display screen is clicked, and the QR code of the glass test tube 29 is read by the barcode reader 12. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the data are compared with each other and the donor data match, the number 1 and the donor data are displayed on the display 16, and a stem cell separation in progress message and a stem cell separation end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、ピペット内の第1間葉系幹細胞26をそのガラス試験管29に注入(収容)し、ガラス試験管29を遠心分離器28に設置(セット)する。担当者は、幹細胞26を遠心分離器28によって所定時間遠心分離した後、ガラス試験管29を遠心分離器28から取り出す。ガラス試験管29内の第1間葉系幹細胞26は、遠心分離器28によって上下方向へ何層かの層状に分離する(幹細胞分離工程)。 The person in charge injects (accommodates) the first mesenchymal stem cell 26 in the pipette into the glass test tube 29 and installs (sets) the glass test tube 29 in the centrifuge 28. The person in charge centrifuges the stem cells 26 with the centrifuge 28 for a predetermined time, and then removes the glass test tube 29 from the centrifuge 28. The first mesenchymal stem cells 26 in the glass test tube 29 are separated into several layers in the vertical direction by the centrifuge 28 (stem cell separation step).
 図11は、幹細胞第2採取工程の一例を示す説明図である。第1間葉系幹細胞26を層状に分離させた幹細胞分離工程の後、幹細胞第2採取工程が行われる。幹細胞第2採取工程では、層状に分離した第1間葉系幹細胞26から下層(最下層)に位置する第2間葉系幹細胞30が採取される。医師や看護師、研究者等の担当者は、遠心分離器28によって第1間葉系幹細胞26を上下方向へ層状に分離させた後、ガラス試験管29を遠心分離器28から取り出し、ディスプレイ16に表示された幹細胞分離終了ボタンをクリックする。 FIG. 11 is an explanatory diagram showing an example of the second stem cell collection step. After the stem cell separation step in which the first mesenchymal stem cells 26 are separated into layers, a stem cell second collection step is performed. In the second stem cell collection step, second mesenchymal stem cells 30 located in the lower layer (lowermost layer) are collected from the first mesenchymal stem cells 26 separated into layers. A doctor, nurse, researcher, or other person in charge uses the centrifuge 28 to separate the first mesenchymal stem cells 26 in layers in the vertical direction, and then removes the glass test tube 29 from the centrifuge 28 and displays the display 16. Click the stem cell separation end button displayed in.
 幹細胞分離終了ボタンをクリックすると、コンピュータ11は、工程第7表示画面(図示せず)をディスプレイ16に表示する。工程第7表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞分離終了メッセージ、幹細胞第2採取ボタン、幹細胞第3観察ボタン、幹細胞第4観察ボタン、培養生成液第1抽出ボタンが表示される。 When the stem cell separation end button is clicked, the computer 11 displays a process seventh display screen (not shown) on the display 16. On the process seventh display screen, number 1 and donor data are displayed, and a stem cell separation end message, a stem cell second collection button, a stem cell third observation button, a stem cell fourth observation button, and a culture product solution first extraction button are displayed. Is displayed.
 担当者は、工程第7表示画面の幹細胞第2採取ボタンをクリックし、ガラス試験管29のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離終了メッセージ、幹細胞第2採取実施中メッセージ、幹細胞第2採取終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the stem cell second collection button on the process seventh display screen, and causes the barcode reader 12 to read the QR code of the glass test tube 29. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match with each other, the number 1 and the donor data are displayed on the display 16, and a stem cell separation end message, a stem cell second collection in progress message, and a stem cell second collection end button are displayed on the display 16. indicate. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、ガラス試験管29において層状に分離した第1間葉系幹細胞26のうちの下層(最下層)に存在する第2間葉系幹細胞30を採取する(幹細胞第2採取工程)。担当者は、注射器を利用して層状に分離した第1間葉系幹細胞26のうちの下層(最下層)に位置する第2間葉系幹細胞30を採取(吸引)する。または、ピペットを利用して層状に分離した第1間葉系幹細胞26のうちの下層(最下層)に位置する第2間葉系幹細胞30を採取(吸引)する。 The person in charge collects the second mesenchymal stem cell 30 present in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers in the glass test tube 29 (second stem cell collecting step). The person in charge collects (sucks) the second mesenchymal stem cells 30 located in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers using a syringe. Alternatively, the second mesenchymal stem cells 30 located in the lower layer (lowermost layer) of the first mesenchymal stem cells 26 separated into layers using a pipette are collected (sucked).
 培養生成液製造方法は、不要な幹細胞を含む第1間葉系幹細胞26を遠心分離器28で遠心分離して上下方向へ層状に分離させ、層状に遠心分離した幹細胞26のうちの下層(最下層)に位置する第2間葉系幹細胞30を採取することで、幹細胞26から特定の第2間葉系幹細胞30を確実に採取することができ、幹細胞26から不要な間葉系幹細胞を除去することができる。 The production method of the culture product is obtained by centrifuging the first mesenchymal stem cells 26 containing unnecessary stem cells with a centrifuge 28 and separating them in layers in the vertical direction. By collecting the second mesenchymal stem cell 30 located in the lower layer, a specific second mesenchymal stem cell 30 can be reliably collected from the stem cell 26, and unnecessary mesenchymal stem cells are removed from the stem cell 26. can do.
 培養生成液製造方法は、第1扁平培養容器24(第1培養容器)の底面面積に対する第1間葉系幹細胞26の総平面面積が80%を超過して幹細胞26が増殖すると、幹細胞26の活性が次第に失われるが、培養容器24の底面面積に対して幹細胞26の総平面面積が70~80%に増殖したときに、幹細胞26を培養容器24から採取するから、幹細胞26の活性を保持することができ、活性を保持した状態で幹細胞26を増殖させることができるとともに、幹細胞26から活性を有する第2間葉系幹細胞30を採取することができる。 When the total planar area of the first mesenchymal stem cell 26 with respect to the bottom surface area of the first flat culture vessel 24 (first culture vessel) exceeds 80% and the stem cell 26 proliferates, Although the activity is gradually lost, the stem cell 26 is collected from the culture vessel 24 when the total planar area of the stem cell 26 grows to 70 to 80% of the bottom surface area of the culture vessel 24, so that the activity of the stem cell 26 is retained. The stem cells 26 can be proliferated while maintaining the activity, and the second mesenchymal stem cells 30 having activity can be collected from the stem cells 26.
 図12は、第2定着手段に含まれる幹細胞第3観察工程の一例を示す説明図であり、図13は、第2扁平培養容器の側面図である。図14は、第2間葉系幹細胞30の平面形状の一例を示す部分拡大図であり、図15は、第2間葉系幹細胞30の平面形状の他の一例を示す部分拡大図である。図14,15は、電子顕微鏡13によって撮影された第2間葉系幹細胞30の平面形状の拡大画像を示す。 FIG. 12 is an explanatory view showing an example of the third observation process of stem cells included in the second fixing means, and FIG. 13 is a side view of the second flat culture vessel. FIG. 14 is a partially enlarged view showing an example of the planar shape of the second mesenchymal stem cell 30, and FIG. 15 is a partially enlarged view showing another example of the planar shape of the second mesenchymal stem cell 30. 14 and 15 show enlarged images of the planar shape of the second mesenchymal stem cell 30 photographed by the electron microscope 13.
 第1間葉系幹細胞26から下層(最下層)に位置する特定の第2間葉系幹細胞30を採取した幹細胞第2採取工程の後、幹細胞第3観察工程および幹細胞第2定着工程が行われる。幹細胞第3観察工程および幹細胞第2定着工程では、第2間葉系幹細胞30および培養液23が第2扁平培養容器25(第2培養容器)に注入(収容)され、培養容器25が体温と略同一の温度(約36~37℃)で36~48時間静的に放置(動かすことなく静かに放置)される。 The stem cell third observation step and the stem cell second colonization step are performed after the stem cell second collection step in which specific second mesenchymal stem cells 30 located in the lower layer (lowermost layer) are collected from the first mesenchymal stem cell 26. . In the stem cell third observation step and the stem cell second fixing step, the second mesenchymal stem cell 30 and the culture solution 23 are injected (contained) into the second flat culture vessel 25 (second culture vessel), and the culture vessel 25 is heated to the body temperature. It is left to stand statically (without moving) for 36 to 48 hours at substantially the same temperature (about 36 to 37 ° C.).
 36~48時間の放置時間において約1~2時間間隔で培養容器25内の第2間葉系幹細胞30(第2幹細胞)の初期平面形状からの変形を電子顕微鏡13で観察し、幹細胞30が培養容器25の底面27に定着したか否かが判断される。第2間葉系幹細胞30および培養液23を注入する培養容器25の底面27(底壁外面)には、ドナーを特定するQRコードを印字した第1コード用紙17が貼付されている。 Deformation from the initial planar shape of the second mesenchymal stem cell 30 (second stem cell) in the culture vessel 25 is observed with the electron microscope 13 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours. It is determined whether or not the bottom surface 27 of the culture vessel 25 is fixed. A first code sheet 17 on which a QR code specifying a donor is printed is attached to the bottom surface 27 (outer surface of the bottom wall) of the culture vessel 25 into which the second mesenchymal stem cells 30 and the culture solution 23 are injected.
 医師や看護師、研究者等の担当者は、第1間葉系幹細胞26から特定の第2間葉系幹細胞30を採取した後、ディスプレイ16に表示された幹細胞第2採取終了ボタンをクリックする。幹細胞第2採取終了ボタンをクリックすると、コンピュータ11は、工程第8表示画面(図示せず)をディスプレイ16に表示する。工程第8表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察ボタン、幹細胞第4観察ボタン、培養生成液第1抽出ボタンが表示される。 A person in charge such as a doctor, a nurse, or a researcher collects a specific second mesenchymal stem cell 30 from the first mesenchymal stem cell 26 and then clicks a stem cell second collection end button displayed on the display 16. . When the stem cell second collection end button is clicked, the computer 11 displays a process eighth display screen (not shown) on the display 16. On the process eighth display screen, number 1 and donor data are displayed, a stem cell separation end message, a stem cell second collection end message, a stem cell third observation button, a stem cell fourth observation button, and a culture solution first extraction button Is displayed.
 担当者は、QRコードが印字された第1コード用紙17を第2扁平培養容器25の底面27(底壁外面)に貼付する。次に、工程第8表示画面の幹細胞第3観察ボタンをクリックし、培養容器25のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察実施中メッセージ、幹細胞第3観察終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge attaches the first code sheet 17 on which the QR code is printed to the bottom surface 27 (outer surface of the bottom wall) of the second flat culture vessel 25. Next, the third stem cell observation button on the process eighth display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 25. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation in progress message, the stem cell third An observation end button is displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、注射器またはピペットに吸引された第2間葉系幹細胞30を培養容器25に注入(収容)するとともに、培養液23を培養容器25に注入(収容)する。第2扁平培養容器25(第2培養容器)は、透明なガラスまたは透明なプラスチックから作られ、所定容量かつ所定面積の底面27を有する平面形状が略四角形の扁平な容器であり、底面27の面積が第1扁平培養容器24(第1培養容器)の約2倍である。第2扁平培養容器25は、頂部43および底部44と、頂部43に形成された注入口45とを有する。注入口45は、蓋46によって水密に閉塞されている。第2扁平培養容器25として所定容量かつ所定面積の底面27を有する平面形状が円形や楕円形の扁平な容器を使用することもできる。 The person in charge injects (accommodates) the second mesenchymal stem cell 30 sucked into the syringe or pipette into the culture container 25 and injects (accommodates) the culture solution 23 into the culture container 25. The second flat culture vessel 25 (second culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 having a predetermined capacity and a predetermined area and having a substantially square shape. The area is about twice that of the first flat culture vessel 24 (first culture vessel). The second flat culture vessel 25 has a top portion 43 and a bottom portion 44 and an injection port 45 formed in the top portion 43. The injection port 45 is watertightly closed by a lid 46. As the second flat culture vessel 25, a flat vessel having a circular shape or an elliptical shape having a bottom surface 27 having a predetermined capacity and a predetermined area may be used.
 幹細胞第3観察工程で使用される第2扁平培養容器25(第2培養容器)は、その容量が約40~60cc(好ましくは、50cc)であり、その底面面積が約50~72mmである。培養容器25は、その一辺の長さが約7~8.5mmである。培養液23は、幹細胞第1観察において注入されたそれと同一である。培養容器25に注入された第2間葉系幹細胞30は、時間の経過とともに培養容器25の底面27に定着しつつ、培養液23によって培養され、培養容器25の底面27において次第に増殖(分化)してコロニーを形成する。 The second flat culture vessel 25 (second culture vessel) used in the third stem cell observation step has a capacity of about 40 to 60 cc (preferably 50 cc) and a bottom area of about 50 to 72 mm 2 . . The culture container 25 has a side length of about 7 to 8.5 mm. The culture solution 23 is the same as that injected in the first observation of stem cells. The second mesenchymal stem cells 30 injected into the culture vessel 25 are cultured with the culture solution 23 while being fixed on the bottom surface 27 of the culture vessel 25 as time passes, and gradually grow (differentiate) on the bottom surface 27 of the culture vessel 25. To form colonies.
 担当者は、第2間葉系幹細胞30および培養液23を第2扁平培培養容器25に注入した後、培養容器25を電子顕微鏡13の試料ホルダ36に設置(セット)する。電子顕微鏡13の試料ホルダ36の上面37と第2扁平培養容器25の底部44との間にスペーサー39を介在させ、培養容器25の底部44をスペーサー39によって持ち上げた状態に保持し、培養容器25の底部44が上となり培養容器25の頂部43(注入口45)が下となるように、培養容器25を所定角度に傾斜させた状態に保持する。また、電子顕微鏡13の試料ホルダ36の上面37と第2扁平培養容器25の頂部43との間にスペーサー39を介在させ、培養容器25の頂部43をスペーサー39によって持ち上げた状態に保持し、培養容器25の頂部43が上となり培養容器25の底部44が下となるように、培養容器25を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第2扁平培養容器25の傾斜角度α2は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 The person in charge injects the second mesenchymal stem cell 30 and the culture solution 23 into the second flat culture vessel 25 and then installs (sets) the culture vessel 25 in the sample holder 36 of the electron microscope 13. A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 44 of the second flat culture vessel 25, and the bottom portion 44 of the culture vessel 25 is held in a state lifted by the spacer 39. The culture vessel 25 is held in a state inclined at a predetermined angle such that the bottom portion 44 of the culture vessel is on the top and the top portion 43 (injection port 45) of the culture vessel 25 is on the bottom. In addition, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 43 of the second flat culture vessel 25, and the top 43 of the culture vessel 25 is held in a state lifted by the spacer 39. You may hold | maintain the culture container 25 in the state inclined to the predetermined angle so that the top part 43 of the container 25 may become the upper side and the bottom part 44 of the culture container 25 may become the lower side. The inclination angle α2 of the second flat culture vessel 25 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、試料ホルダ36の上面37に対して第2扁平培養容器25を前記傾斜角度で傾斜させることで、培養容器25内において第2間葉系幹細胞30および培養液23が培養容器25の頂部43の側(または底部44の側)に偏り、培養容器25の頂部43の側(または底部44の側)において第2間葉系幹細胞30と培養液23との水圧が大きくなって第2間葉系幹細胞30が培養容器25の底部44の側に集中し、それによって第2間葉系幹細胞30どうしの活性が高まり、培養容器25の底面27において第2間葉系幹細胞30を容易かつ迅速に定着させることができる。 In the culture product production method, the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 25 by inclining the second flat culture vessel 25 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 43 side (or the bottom 44 side) of the container 25, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 43 side (or the bottom 44 side) of the culture container 25. Thus, the second mesenchymal stem cells 30 are concentrated on the bottom 44 side of the culture vessel 25, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 on the bottom surface 27 of the culture vessel 25. Can be fixed easily and quickly.
 電子顕微鏡13は、培養容器25に注入された第2間葉系幹細胞30の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞30の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第3記憶工程)。コンピュータ11は、電子顕微鏡13から送信された幹細胞30の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。担当者は、ディスプレイ16に表示された幹細胞30の平面形状の拡大画像を36~48時間の間において約1~2時間間隔で確認(視認)し、幹細胞30の平面形状の変化を観察する(幹細胞第3観察工程)。なお、担当者が電子顕微鏡13の観察窓から幹細胞30の平面形状の変化を36~48時間の間において約1~2時間間隔で直接観察してもよい。 The electron microscope 13 takes a magnified image of the planar shape of the second mesenchymal stem cell 30 injected into the culture vessel 25 at intervals of about 1 to 2 hours, and the magnified image of the planar shape of the photographed stem cell 30 is approximately 1 to 2 times. It transmits to the computer 11 at intervals of 2 hours. The computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in a storage area in a state associated with the donor identifier (stem cell image third memory). Process). The computer 11 displays the enlarged image of the planar shape of the stem cell 30 and the imaging time transmitted from the electron microscope 13 on the display 16. The person in charge checks (views) the enlarged image of the planar shape of the stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours, and observes the change in the planar shape of the stem cell 30 ( Stem cell third observation step). The person in charge may directly observe the change in the planar shape of the stem cell 30 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours.
 第2間葉系幹細胞30の初期平面形状は略円形であり、幹細胞30の平面形状が略円形の場合、幹細胞30が培養容器25の底面27(底壁内面)に定着しておらず、幹細胞30が増殖(分化)を開始していない。第2間葉系幹細胞30の変形後の平面形状は定着前の略円形を核として幹細胞30が一方向へ不定形に伸張した扁平形状であり、幹細胞30が培養容器25の底面27(底壁内面)に定着し、幹細胞30が増殖(分化)を開始している。 The initial planar shape of the second mesenchymal stem cell 30 is substantially circular. When the planar shape of the stem cell 30 is approximately circular, the stem cell 30 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 25, and the stem cell. 30 has not started to proliferate (differentiate). The planar shape after deformation of the second mesenchymal stem cell 30 is a flat shape in which the stem cell 30 extends in an indefinite shape in one direction with a substantially circular shape before fixation as a nucleus, and the stem cell 30 is a bottom surface 27 (bottom wall) of the culture vessel 25. The stem cell 30 has started to proliferate (differentiate).
 担当者は、幹細胞第3観察工程における観察の結果、図12に示すように、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状が略円形のまま観察される場合、幹細胞30が培養容器25の底面27(底壁内面)に定着していないと判断し、幹細胞30の平面形状の変化を約1~2時間間隔で継続して観察する。担当者は、幹細胞第3観察手段における観察の結果、図13に示すように、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状が略円形から略円形を核として不定形の扁平形状に変形した場合、幹細胞30が培養容器25の底面27に定着したと判断する(幹細胞第2定着工程)。 As a result of the observation in the third stem cell observation step, the person in charge looks at the stem cell 30 when the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 remains substantially circular as shown in FIG. It is determined that the bottom surface 27 (inner wall inner surface) of the culture vessel 25 has not settled, and the change in the planar shape of the stem cell 30 is continuously observed at intervals of about 1 to 2 hours. As shown in FIG. 13, as a result of observation by the stem cell third observation means, the person in charge has an irregular flat shape in which the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 is from a substantially circular shape to a substantially circular shape as a nucleus. When the shape is deformed, it is determined that the stem cell 30 has settled on the bottom surface 27 of the culture vessel 25 (stem cell second fixing step).
 第2間葉系幹細胞30の定着時に容量が60ccを超過するとともに底面面積が72mmを超過する大きな培養容器を使用すると、幹細胞30が容器の底面に定着し難くなるとともに幹細胞30の増殖が遅くなるが、培養生成液製造方法は、前記容量かつ前記底面面積の第2扁平培養容器25を使用することで、幹細胞30を培養容器25の底面27に容易に定着させることができ、培養容器25において幹細胞30を素早く増殖させることができる。 When a large culture container having a capacity exceeding 60 cc and a bottom area exceeding 72 mm 2 is used when the second mesenchymal stem cell 30 is fixed, the stem cell 30 becomes difficult to settle on the bottom surface of the container and the proliferation of the stem cell 30 is slow. However, in the method for producing a culture product solution, the stem cell 30 can be easily fixed on the bottom surface 27 of the culture container 25 by using the second flat culture container 25 having the above-mentioned capacity and the bottom surface area. The stem cell 30 can be rapidly proliferated.
 培養生成液製造方法は、培養容器25を体温と略同一の温度で36~48時間静的放置しつつ、36~48時間の間において約1~2時間間隔で培養容器25内の第2間葉系幹細胞30の初期平面形状からの変形を観察するから、幹細胞30の変形を見逃すことはなく、幹細胞30の培養容器25の底面27に対する定着を正確に確認することができる。 The method for producing a culture product solution is to leave the culture vessel 25 statically at a temperature substantially the same as the body temperature for 36 to 48 hours, and at intervals of about 1 to 2 hours between 36 and 48 hours. Since the deformation of the leaf stem cells 30 from the initial planar shape is observed, the deformation of the stem cells 30 is not overlooked, and the establishment of the stem cells 30 on the bottom surface 27 of the culture vessel 25 can be confirmed accurately.
 図16は、第2間葉系幹細胞30の平面形状の他の一例を示す部分拡大図であり、図17は、抽出された培養生成液31および第2間葉系幹細胞30の保存の一例を示す図である。図16は、電子顕微鏡13によって撮影された第2間葉系幹細胞30の平面形状の拡大画像を示す。幹細胞第3観察工程における観察の結果、第2間葉系幹細胞30(第2幹細胞)が略円形(初期平面形状)から略円形を核として不定形の扁平形状に変形し、幹細胞30の第2扁平培養容器25(第2培養容器)の底面27への定着を確認した幹細胞第3観察工程の後、幹細胞第2培養工程および幹細胞第4観察工程が行われる。 FIG. 16 is a partially enlarged view showing another example of the planar shape of the second mesenchymal stem cell 30, and FIG. 17 shows an example of preservation of the extracted culture product solution 31 and the second mesenchymal stem cell 30. FIG. FIG. 16 shows an enlarged image of the planar shape of the second mesenchymal stem cell 30 photographed by the electron microscope 13. As a result of the observation in the third stem cell observation step, the second mesenchymal stem cell 30 (second stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with a substantially circular shape as a nucleus, and the second stem cell 30 The stem cell second culture step and the stem cell fourth observation step are performed after the stem cell third observation step in which the fixation to the bottom surface 27 of the flat culture vessel 25 (second culture vessel) is confirmed.
 幹細胞第2培養工程および幹細胞第4観察工程では、培養容器25内に注入されている培養液23が培養容器25から排出(廃棄)され、培養容器25にあらたな培養液23が注入(収容)される。培養容器25が体温と略同一の温度(約36~37℃)で36~48時間静的に放置(動かすことなく静かに放置)され、培養容器25において第2間葉系幹細胞30が培養される(幹細胞第2培養工程)。36~48時間の放置時間において約1~2時間間隔で培養容器25の底面27に定着した第2間葉系幹細胞30の培養容器25の底面面積に対する総平面面積を電子顕微鏡13で観察し、幹細胞30の総平面面積が培養容器25の底面面積に対して第2目標割合に達したか否かが判断される。培養容器25の底面面積に対する第2間葉系幹細胞30の総平面面積の第2目標割合は、88~92%(88~92%コンフルエント)である。 In the stem cell second culture step and the stem cell fourth observation step, the culture solution 23 injected into the culture vessel 25 is discharged (discarded) from the culture vessel 25, and a new culture solution 23 is injected (accommodated) into the culture vessel 25. Is done. The culture vessel 25 is left to stand statically (without moving) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the second mesenchymal stem cell 30 is cultured in the culture vessel 25. (Stem cell second culture step). The total planar area of the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 25 at intervals of about 1 to 2 hours in the standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 25; It is determined whether or not the total planar area of the stem cells 30 has reached the second target ratio with respect to the bottom area of the culture vessel 25. The second target ratio of the total planar area of the second mesenchymal stem cell 30 to the bottom surface area of the culture vessel 25 is 88 to 92% (88 to 92% confluent).
 医師や看護師、研究者等の担当者は、第2間葉系幹細胞30の培養容器25の底面27に対する定着を確認した後、ディスプレイ16に表示された幹細胞第3観察終了ボタンをクリックする。幹細胞第3観察終了ボタンをクリックすると、コンピュータ11は、工程第8表示画面(図示せず)をディスプレイ16に表示する。工程第8表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察終了メッセージ、幹細胞第4観察ボタン、培養生成液第1抽出ボタンが表示される。 A person in charge, such as a doctor, nurse, or researcher, confirms that the second mesenchymal stem cell 30 has settled on the bottom surface 27 of the culture vessel 25, and then clicks the stem cell third observation end button displayed on the display 16. When the stem cell third observation end button is clicked, the computer 11 displays a process eighth display screen (not shown) on the display 16. On the process eighth display screen, number 1 and donor data are displayed, a stem cell separation end message, a stem cell second collection end message, a stem cell third observation end message, a stem cell fourth observation button, and a culture product solution first extraction A button is displayed.
 担当者は、工程第8表示画面の幹細胞第4観察ボタンをクリックし、培養容器25を電子顕微鏡13の試料ホルダから取り外すとともに、培養容器25のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダによって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察終了メッセージ、幹細胞第4観察実施中メッセージ、幹細胞第4観察終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the stem cell fourth observation button on the process eighth display screen, removes the culture vessel 25 from the sample holder of the electron microscope 13, and causes the barcode reader 12 to read the QR code of the culture vessel 25. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data displayed on the display 16 (donor data read into the memory) and the donor data indicated by the QR code read by the barcode reader. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation are performed. A middle message and a stem cell fourth observation end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、幹細胞第2培養工程および幹細胞第4観察工程において培養容器25内に注入した培養液23を培養容器25から排出(廃棄)し、あらたな培養液23を培養容器25に注入(収容)する。あらたな培養液23は、幹細胞第1観察手段において注入されたそれと同一である。担当者は、あらたな培養液23を培養容器25に注入した後、培養容器25を電子顕微鏡13の試料ホルダに設置(セット)する。電子顕微鏡13の試料ホルダ36の上面37と第2扁平培養容器25の底部44との間にスペーサー39を介在させ、培養容器25の底部44をスペーサー39によって持ち上げた状態に保持し、培養容器25の底部44が上となり培養容器25の頂部43(注入口45)が下となるように、培養容器25を所定角度に傾斜させた状態に保持する。また、電子顕微鏡13の試料ホルダ36の上面37と第2扁平培養容器25の頂部43との間にスペーサー39を介在させ、培養容器25の頂部43をスペーサー39によって持ち上げた状態に保持し、培養容器25の頂部43が上となり培養容器25の底部44が下となるように、培養容器25を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第2扁平培養容器25の傾斜角度α2は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 The person in charge discharges (discards) the culture solution 23 injected into the culture vessel 25 in the stem cell second culture step and the stem cell fourth observation step, and injects (accommodates) the new culture solution 23 into the culture vessel 25. ) The new culture solution 23 is the same as that injected in the stem cell first observation means. The person in charge injects a new culture solution 23 into the culture vessel 25 and then installs (sets) the culture vessel 25 on the sample holder of the electron microscope 13. A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom portion 44 of the second flat culture vessel 25, and the bottom portion 44 of the culture vessel 25 is held in a state lifted by the spacer 39. The culture vessel 25 is held in a state inclined at a predetermined angle such that the bottom portion 44 of the culture vessel is on the top and the top 43 (injection port 45) of the culture vessel 25 is on the bottom. In addition, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 43 of the second flat culture vessel 25, and the top 43 of the culture vessel 25 is held in a state lifted by the spacer 39. You may hold | maintain the culture container 25 in the state inclined to the predetermined angle so that the top part 43 of the container 25 may become the upper side and the bottom part 44 of the culture container 25 may become the lower side. The inclination angle α2 of the second flat culture vessel 25 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、第2間葉系幹細胞30の定着を確認した後、培養容器25内の培養液23を排出しつつあらたな培養液23を培養容器25に注入することで、第2間葉系幹細胞30の増殖を確実に促進することができる。培養生成液製造方法は、試料ホルダ36の上面37に対して第2扁平培養容器25を前記傾斜角度で傾斜させることで、培養容器25内において第2間葉系幹細胞30および培養液23が培養容器25の頂部43の側(または底部44の側)に偏り、培養容器25の頂部43の側(または底部44の側)において第2間葉系幹細胞30と培養液23との水圧が大きくなって第2間葉系幹細胞30が培養容器25の底部44の側に集中し、それによって第2間葉系幹細胞30どうしの活性が高まり、培養容器25の底面27において第2間葉系幹細胞30を容易かつ迅速に増殖(分化)させることができる。 After confirming the establishment of the second mesenchymal stem cell 30, the culture product production method is configured to inject a new culture solution 23 into the culture vessel 25 while discharging the culture solution 23 in the culture vessel 25. The proliferation of the mesenchymal stem cell 30 can be surely promoted. In the culture product production method, the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 25 by inclining the second flat culture vessel 25 at the inclination angle with respect to the upper surface 37 of the sample holder 36. It is biased toward the top 43 side (or the bottom 44 side) of the container 25, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 43 side (or the bottom 44 side) of the culture container 25. Thus, the second mesenchymal stem cells 30 are concentrated on the bottom 44 side of the culture vessel 25, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 on the bottom surface 27 of the culture vessel 25. Can be propagated (differentiated) easily and rapidly.
 電子顕微鏡13は、培養容器25内の第2間葉系幹細胞30の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞30の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第4記憶工程)。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。 The electron microscope 13 takes an enlarged image of the planar shape of the second mesenchymal stem cell 30 in the culture vessel 25 at intervals of about 1 to 2 hours, and takes an enlarged image of the planar shape of the photographed stem cell 30 for about 1 to 2 hours. It transmits to the computer 11 at intervals. The computer 11 stores (stores) the enlarged image of the planar shape of the second mesenchymal stem cell 30 and the imaging time transmitted from the electron microscope 13 in a storage area in a state associated with the donor identifier (stem cell image fourth memory). Process). The computer 11 displays the enlarged image of the planar shape of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time on the display 16.
 担当者は、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状の拡大画像を36~48時間の間において約1~2時間間隔で確認(視認)し、培養容器25の底面27に定着した幹細胞30の培養容器25の底面面積に対する総平面面積を観察しつつ、幹細胞30の総平面面積が培養容器25の底面面積に対して第2目標割合(82~92%コンフルエント)に達したか否かを判断する(幹細胞第4観察手段)。なお、担当者が電子顕微鏡13の観察窓から第2間葉系幹細胞30の培養容器25の底面面積に対する総平面面積を36~48時間の間において約1~2時間間隔で直接観察し、幹細胞30の総平面面積が培養容器25の底面面積に対して第2目標割合(88~92%コンフルエント)に達したか否かを判断してもよい。 The person in charge confirms (views) the enlarged image of the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours. While observing the total planar area of the stem cells 30 settled on the bottom surface area of the culture vessel 25, the total planar area of the stem cells 30 reaches the second target ratio (82 to 92% confluent) with respect to the bottom surface area of the culture vessel 25. It is determined whether or not (stem cell fourth observation means). The person in charge directly observes the total planar area of the second mesenchymal stem cell 30 with respect to the bottom surface area of the culture vessel 25 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total plane area of 30 has reached the second target ratio (88-92% confluent) with respect to the bottom area of the culture vessel 25.
 担当者は、幹細胞第4観察工程における観察の結果、図13に示すように、ディスプレイ16に表示された第2間葉系幹細胞30の培養容器25の底面面積に対する総平面面積が第2目標割合(88~92%コンフルエント)に達していない場合、幹細胞30の培養容器25の底面面積に対する総平面面積を約1~2時間間隔で継続して観察する。なお、ディスプレイ16に表示された拡大画像の全面積に対して第2間葉系幹細胞30の総平面面積が第2目標割合に達した場合に、幹細胞30の培養容器25の底面面積に対する総平面面積が第2目標割合に達したものとする。 As a result of the observation in the fourth stem cell observation step, the person in charge is, as shown in FIG. 13, the total plane area of the second mesenchymal stem cell 30 displayed on the display 16 with respect to the bottom area of the culture vessel 25 is the second target ratio. If it has not reached (88 to 92% confluence), the total planar area of the stem cells 30 relative to the bottom area of the culture vessel 25 is continuously observed at intervals of about 1 to 2 hours. In addition, when the total plane area of the second mesenchymal stem cell 30 reaches the second target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 25 of the stem cell 30 It is assumed that the area has reached the second target ratio.
 幹細胞第4観察工程における観察の結果、第2間葉系幹細胞30が第2扁平培養容器25(第2培養容器)の底面27(底壁内面)において増殖して幹細胞30がコロニーを形成し、幹細胞30の平面形状が拡張することで、図14に示すように、ディスプレイ16に表示された幹細胞30の培養容器25の底面面積に対する総平面面積が第2目標割合(88~92%コンフルエント)に達した場合、培養容器25において、単一種の第2間葉系幹細胞30が増殖しているとともに、活性を有する単一種の幹細胞30から分泌された所定の代謝物質を含む培養生成液31が生成されている。 As a result of the observation in the stem cell fourth observation step, the second mesenchymal stem cell 30 grows on the bottom surface 27 (bottom wall inner surface) of the second flat culture vessel 25 (second culture vessel), and the stem cell 30 forms a colony, As the planar shape of the stem cell 30 expands, as shown in FIG. 14, the total planar area of the stem cell 30 displayed on the display 16 with respect to the bottom surface area of the culture vessel 25 becomes the second target ratio (88 to 92% confluent). When it reaches, a single kind of second mesenchymal stem cell 30 is proliferated in the culture vessel 25, and a culture product solution 31 containing a predetermined metabolite secreted from the active single kind of stem cell 30 is generated. Has been.
 培養生成液製造方法は、第2扁平培養容器25(第2培養容器)の底面面積に対する第2間葉系幹細胞30の総平面面積が92%を超過して幹細胞30が増殖すると、幹細胞30の活性が次第に失われるが、培養容器25の底面面積に対して幹細胞30の総平面面積が88~92%に増殖したときに、幹細胞30を培養容器25から抽出するから、幹細胞30の活性を保持することができ、活性を保持した状態で幹細胞30を増殖させることができる。 When the total planar area of the second mesenchymal stem cell 30 exceeds 92% with respect to the bottom surface area of the second flat culture vessel 25 (second culture vessel), the stem cell 30 is proliferated. Although the activity is gradually lost, the stem cell 30 is extracted from the culture vessel 25 when the total planar area of the stem cell 30 grows to 88 to 92% of the bottom surface area of the culture vessel 25, so that the activity of the stem cell 30 is retained. The stem cell 30 can be proliferated while maintaining the activity.
 幹細胞30の培養容器25の底面面積に対する総平面面積が第2目標割合に達した場合、培養容器25から培養生成液31を抽出する培養生成液第1抽出工程が行われる。培養生成液第1抽出工程では、活性を有する第2間葉系幹細胞30から分泌された所定の代謝物質を含む培養生成液31が培養容器25から抽出される。培養生成液製造方法は、約1~2時間間隔で総平面面積を観察することで、第2間葉系幹細胞30の培養容器25の底面面積に対する総平面面積を正確に確認することができ、培養容器25の底面面積に対して幹細胞30の総平面面積が第2目標割合に達したことを確実に把握することができる。 When the total planar area of the stem cells 30 with respect to the bottom surface area of the culture vessel 25 reaches the second target ratio, the culture product solution first extraction step for extracting the culture product solution 31 from the culture vessel 25 is performed. In the culture product solution first extraction step, a culture product solution 31 containing a predetermined metabolite secreted from the active second mesenchymal stem cell 30 is extracted from the culture vessel 25. The method for producing a culture product solution can accurately confirm the total planar area with respect to the bottom area of the culture vessel 25 of the second mesenchymal stem cell 30 by observing the total planar area at intervals of about 1 to 2 hours. It can be ascertained that the total planar area of the stem cells 30 has reached the second target ratio with respect to the bottom surface area of the culture vessel 25.
 医師や看護師、研究者等の担当者は、第2間葉系幹細胞30の培養容器25の底面面積に対する総平面面積が第2目標割合に達したことを確認した後、ディスプレイ16に表示された幹細胞第4観察終了ボタンをクリックする。幹細胞第4観察終了ボタンをクリックすると、コンピュータ11は、工程第9表示画面(図示せず)をディスプレイ16に表示する。工程第9表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察終了メッセージ、幹細胞第4観察終了メッセージ、培養生成液第1抽出ボタンが表示される。 A person in charge such as a doctor, nurse, or researcher confirms that the total planar area of the second mesenchymal stem cell 30 with respect to the bottom area of the culture vessel 25 has reached the second target ratio, and then is displayed on the display 16. Click the stem cell fourth observation end button. When the stem cell fourth observation end button is clicked, the computer 11 displays a process ninth display screen (not shown) on the display 16. On the process 9th display screen, number 1 and donor data are displayed, stem cell separation end message, stem cell second collection end message, stem cell third observation end message, stem cell fourth observation end message, culture product first Extract button is displayed.
 担当者は、工程第9表示画面の培養生成液第1抽出ボタンをクリックし、培養容器25のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察終了メッセージ、幹細胞第4観察終了メッセージ、培養生成液第1抽出終了ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the culture solution first extraction button on the process ninth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 25. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation An end message and a culture product first extraction end button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、幹細胞第4観察工程において培養容器25内に注入した培養液23から変化した培養生成液31を注射器やピペットを利用して培養容器25から吸引し(培養生成液第1抽出工程)、培養生成液31を保存容器32に注入(収容)する。保存容器32に注入された培養生成液31は、不要な間葉系幹細胞が除去された活性を有する特定種類の単一種の間葉系幹細胞(単一種幹細胞)から分泌された所定の代謝物質を含む培養生成液31である。 The person in charge aspirates the culture product solution 31 changed from the culture solution 23 injected into the culture vessel 25 in the fourth stem cell observation step from the culture vessel 25 using a syringe or pipette (culture product solution first extraction step). Then, the culture product solution 31 is injected (stored) in the storage container 32. The culture product solution 31 injected into the storage container 32 contains a predetermined metabolite secreted from a specific type of single-type mesenchymal stem cells (single-type stem cells) having an activity from which unnecessary mesenchymal stem cells have been removed. It is the culture product solution 31 containing.
 担当者は、培養生成液31を保存容器32に注入した後、QRコードが印字された第1コード用紙17を保存容器32の外周面に貼付する。担当者は、ディスプレイ16に表示された第9表示画面の培養生成液第1抽出終了ボタンをクリックし、保存容器32のQRコードをバーコードリーダ12に読み取らせた後、培養生成液31を注入した保存容器32を冷蔵庫34に収納する。培養生成液31は、冷蔵庫34において約3~4℃で保存される。 The person in charge injects the culture product solution 31 into the storage container 32, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 32. The person in charge clicks the culture solution first extraction end button on the ninth display screen displayed on the display 16, causes the barcode reader 12 to read the QR code of the storage container 32, and then injects the culture product 31. The stored storage container 32 is stored in the refrigerator 34. The culture product solution 31 is stored at about 3 to 4 ° C. in the refrigerator 34.
 QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞分離終了メッセージ、幹細胞第2採取終了メッセージ、幹細胞第3観察終了メッセージ、幹細胞第4観察終了メッセージ、培養生成液抽出終了メッセージ、培養生成液製造終了ボタン、培養生成液製造継続ボタンをディスプレイ16に表示する。培養生成液の製造を終了する場合、培養生成液製造終了ボタンをクリックする。培養生成液製造終了ボタンをクリックすると、コンピュータ11においてシステム10が停止する。 When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell separation end message, the stem cell second collection end message, the stem cell third observation end message, and the stem cell fourth observation An end message, a culture product extraction end message, a culture product manufacture end button, and a culture product manufacture continue button are displayed on the display 16. When the production of the culture product is finished, the culture product production end button is clicked. When the culture product production end button is clicked, the system 10 stops in the computer 11.
 培養生成液製造終了ボタンをクリックした場合、培養容器25から幹細胞30を採取する幹細胞採取工程が行われる。幹細胞採取工程では、培養容器25内において増殖(分化)した第2間葉系幹細胞30が培養容器25から採取される。培養容器25内をPBSで洗浄した後、トリプシン液を培養容器25内に注入する。培養容器25にトリプシン液を注入すると、培養容器25の底面27に定着した第2間葉系幹細胞30がトリプシン液によって底面27から剥離し、トリプシン液の水面に浮上する。担当者は、注射器またはピペットを利用して第2間葉系幹細胞30を吸引し、幹細胞30を注射器またはピペットから保存容器33に注入(収容)する。 When the culture production solution production end button is clicked, a stem cell collection step of collecting the stem cells 30 from the culture vessel 25 is performed. In the stem cell collection step, the second mesenchymal stem cells 30 that have proliferated (differentiated) in the culture vessel 25 are collected from the culture vessel 25. After the culture vessel 25 is washed with PBS, a trypsin solution is injected into the culture vessel 25. When the trypsin solution is injected into the culture vessel 25, the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 25 are detached from the bottom surface 27 by the trypsin solution and float on the water surface of the trypsin solution. The person in charge sucks the second mesenchymal stem cell 30 using a syringe or pipette, and injects (accommodates) the stem cell 30 into the storage container 33 from the syringe or pipette.
 保存容器33に注入された第2間葉系幹細胞30は、不要な間葉系幹細胞が除去された活性を有する特定種類の単一種の間葉系幹細胞(単一種幹細胞)である。担当者は、第2間葉系幹細胞30(単一種の間葉系幹細胞)を保存容器33に注入した後、QRコードが印字された第1コード用紙17を保存容器33の外周面に貼付し、第2間葉系幹細胞30を注入した保存容器33を冷蔵庫34に収納する。第2間葉系幹細胞30(単一種の間葉系幹細胞)は、冷蔵庫34において約3~4℃で保存される。 The second mesenchymal stem cell 30 injected into the storage container 33 is a specific kind of single mesenchymal stem cell (single seed stem cell) having an activity from which unnecessary mesenchymal stem cells are removed. The person in charge injects the second mesenchymal stem cell 30 (single mesenchymal stem cell) into the storage container 33, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 33. The storage container 33 into which the second mesenchymal stem cells 30 are injected is stored in the refrigerator 34. The second mesenchymal stem cell 30 (single mesenchymal stem cell) is stored in the refrigerator 34 at about 3 to 4 ° C.
 培養生成液製造方法は、層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出し、中間層骨髄液を培養液23とともに培養して第1間葉系幹細胞26(第1幹細胞)を第1培養容器24の底面27に定着させ、幹細胞26を培養しつつ幹細胞26の総平面面積が第1培養容器24の底面面積に対して第1目標割合に達した場合、培養容器24から幹細胞26を採取し、層状に分離させた幹細胞26のうちの下層(最下層)に位置する第2間葉系幹細胞30(第2幹細胞)を採取するとともに、幹細胞30を培養液23とともに培養して幹細胞30を第2培養容器25の底面27に定着させ、培養容器25内にあらたな培養液23を注入し、幹細胞30を培養しつつ幹細胞30の総平面面積が培養容器25の底面面積に対して第2目標割合に達した場合、幹細胞30の培養過程において増殖した単一種の幹細胞30から分泌された所定の代謝物質を含む培養生成液31を培養容器25から抽出するから、培養された活性を有する単一種の第2幹細胞30を利用することで、多種雑多な幹細胞から分泌された多種多様な代謝物質が含まれることはなく、活性を有する単一種の幹細胞30から分泌された所定の代謝物質のみを含み、所定の疾患やスキンケア、ヘアケア、ボディケア等の所定の美容に対して唯一特定の効果を発揮する培養生成液31を製造することができ、所定の疾患の治療に有効に使用することが可能な培養生成液31を製造することができるとともに、所定の美容に有効に使用することが可能な培養生成液31を製造することができる。 In the production method of the culture solution, the intermediate layer bone marrow fluid located in the intermediate layer of the bone marrow fluid separated into layers is extracted, and the intermediate layer bone marrow fluid is cultured together with the culture solution 23 to obtain the first mesenchymal stem cells 26 (first 1 stem cell) is fixed to the bottom surface 27 of the first culture vessel 24, and the stem cell 26 is cultured while the total planar area of the stem cell 26 reaches the first target ratio with respect to the bottom surface area of the first culture vessel 24. Stem cells 26 are collected from the container 24, and the second mesenchymal stem cells 30 (second stem cells) located in the lower layer (lowermost layer) of the stem cells 26 separated in layers are collected, and the stem cells 30 are added to the culture solution 23. And the stem cells 30 are fixed to the bottom surface 27 of the second culture vessel 25, a new culture solution 23 is injected into the culture vessel 25, and the stem cells 30 are cultured while the total planar area of the stem cells 30 is that of the culture vessel 25. For the bottom area 2. When the target ratio is reached, the culture product solution 31 containing a predetermined metabolite secreted from a single kind of stem cell 30 grown in the course of culturing the stem cell 30 is extracted from the culture vessel 25 and thus has a cultured activity. By using the second stem cell 30 of a single species, a wide variety of metabolites secreted from a variety of stem cells are not included, and only a predetermined metabolite secreted from a single species of stem cell 30 having activity is included. Can be produced, and can be used effectively for the treatment of a predetermined disease, and can produce a culture solution 31 that exhibits only a specific effect on a predetermined disease, skin care, hair care, body care, etc. Can be produced, and the culture product 31 that can be used effectively for a predetermined beauty can be produced.
 培養生成液製造方法は、不要な幹細胞が除去されたピュア(純粋)な第2間葉系幹細胞30(第2幹細胞)を利用して培養生成液31が作られ、その培養生成液31に単一種の第2幹細胞から分泌された所定の代謝物質のみを含ませることができるから、所定の疾患に対して高い治療効果を有し、その疾患を完治させる確立が高い培養生成液31を作ることができ、所定の美容に対して高い効果を有する培養生成液31を作ることができる。培養生成液製造方法によって製造された培養生成液31は、たとえばそれを肌に塗布することで、やけどや湿疹等の肌の疾患の治療に使用することができ、それを目に点眼することで目薬として使用することができるとともに、鼻に注入することで花粉症の治療に使用することができ、それを頭皮に塗布することで頭皮の疾患の治療に使用することができる。また、それを肌荒れや吹き出物、日焼け対策として使用することができ、美白や皺の除去等の美容に使用することができる。 In the culture product production method, a culture product solution 31 is produced using pure second pure mesenchymal stem cells 30 (second stem cells) from which unnecessary stem cells have been removed. Since only a predetermined metabolite secreted from a kind of second stem cell can be contained, a culture product solution 31 having a high therapeutic effect for a predetermined disease and having a high probability of completely curing the disease is produced. The culture product solution 31 having a high effect on a predetermined beauty can be made. The culture product solution 31 produced by the culture product production method can be used for the treatment of skin diseases such as burns and eczema, for example, by applying it to the skin. In addition to being used as eye drops, it can be used for the treatment of hay fever by injecting it into the nose, and it can be used for the treatment of scalp disease by applying it to the scalp. In addition, it can be used as a measure against rough skin, breakouts and sunburn, and can be used for beauty such as whitening and removal of wrinkles.
 図18は、幹細胞第5観察工程の一例を示す説明図であり、図19は、第3扁平培養容器の側面図である。培養生成液の製造を継続する場合、培養容器25において増殖(分化)した第2間葉系幹細胞30を培養容器25から採取する幹細胞第2採取工程が行われる。幹細胞第2採取工程では、培養容器25内において増殖(分化)した第2間葉系幹細胞30が培養容器25から採取される。 FIG. 18 is an explanatory view showing an example of the fifth stem cell observation step, and FIG. 19 is a side view of the third flat culture vessel. When the production of the culture product solution is continued, a second stem cell collecting step for collecting the second mesenchymal stem cells 30 proliferated (differentiated) in the culture vessel 25 from the culture vessel 25 is performed. In the second stem cell collection step, the second mesenchymal stem cell 30 proliferated (differentiated) in the culture vessel 25 is collected from the culture vessel 25.
 医師や看護師、研究者等の担当者は、ディスプレイ16に表示された培養生成液製造継続ボタンをクリックする。培養生成液製造継続ボタンをクリックすると、コンピュータ11は、工程第10表示画面(図示せず)をディスプレイ16に表示する。工程第10表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞第2採取ボタン、幹細胞第5観察ボタン、幹細胞第6観察ボタン、培養生成液第2抽出ボタンが表示される。 The person in charge, such as a doctor, nurse, or researcher, clicks the culture product production continuation button displayed on the display 16. When the culture product production continuation button is clicked, the computer 11 displays a process tenth display screen (not shown) on the display 16. In the process 10th display screen, number 1 and donor data are displayed, and a stem cell second collection button, a stem cell fifth observation button, a stem cell sixth observation button, and a culture product second extraction button are displayed.
 担当者は、工程第10表示画面の幹細胞第2採取ボタンをクリックし、培養容器25のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞第2採取実施中メッセージ、幹細胞第2採取終了ボタン、幹細胞第5観察ボタン、幹細胞第6観察ボタン、培養生成液第2抽出ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the stem cell second collection button on the process tenth display screen, and causes the barcode reader 12 to read the QR code of the culture vessel 25. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match with each other, the number 1 and the donor data are displayed on the display 16 and the second stem cell collection in progress message, the stem cell second collection end button, the stem cell fifth observation button, the stem cell number 1 A 6 observation button and a culture product solution second extraction button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、培養容器25内をPBSで洗浄した後、トリプシン液を培養容器25内に注入し、トリプシン液の水面に浮上した第2間葉系幹細胞30を注射器またはピペットを利用して採取(吸引)し、幹細胞26を注射器内またはピペット内に収容する(幹細胞第2採取手段)。担当者は、培養容器25から幹細胞30を採取した後、幹細胞第2採取終了ボタンをクリックする。幹細胞第2採取終了ボタンをクリックすると、コンピュータ11は、工程第11表示画面(図示せず)をディスプレイ16に表示する。工程第11表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞第2採取終了メッセージ、幹細胞第5観察ボタン、幹細胞第6観察ボタン、培養生成液第2抽出ボタンが表示される。 The person in charge wash | cleans the inside of the culture container 25 with PBS, inject | pours a trypsin liquid in the culture container 25, and collect | recovers the 2nd mesenchymal stem cell 30 which floated on the water surface of a trypsin liquid using a syringe or a pipette ( The stem cells 26 are accommodated in a syringe or pipette (second stem cell collection means). The person in charge collects the stem cells 30 from the culture vessel 25 and then clicks the stem cell second collection end button. When the stem cell second collection end button is clicked, the computer 11 displays a process eleventh display screen (not shown) on the display 16. On the process eleventh display screen, number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation button, a stem cell sixth observation button, and a culture product second extraction button are displayed.
 培養容器25から第2間葉系幹細胞30を採取した幹細胞第2採取工程の後、幹細胞第5観察工程および幹細胞第3定着工程が行われる。幹細胞第5観察工程および幹細胞第3定着工程では、第2間葉系幹細胞30および培養液23が第3扁平培養容器35(第3培養容器)に注入(収容)され、培養容器35が体温と略同一の温度(約36~37℃)で36~48時間静的に放置(動かすことなく静かに放置)される。 After the second stem cell collecting step in which the second mesenchymal stem cells 30 are collected from the culture vessel 25, the fifth stem cell observation step and the third stem cell fixing step are performed. In the stem cell fifth observation step and the stem cell third fixing step, the second mesenchymal stem cell 30 and the culture solution 23 are injected (contained) into the third flat culture vessel 35 (third culture vessel), and the culture vessel 35 is heated to the body temperature. It is left to stand statically (without moving) for 36 to 48 hours at substantially the same temperature (about 36 to 37 ° C.).
 36~48時間の放置時間において約1~2時間間隔で培養容器35内の第2間葉系幹細胞30(第2幹細胞)の初期平面形状からの変形を電子顕微鏡13で観察し、幹細胞30が培養容器35の底面27に定着したか否かを判断する。第2間葉系幹細胞30および培養液23を注入する培養容器35の底面27(底壁外面)には、ドナーを特定するQRコードを印字した第1コード用紙17が貼付されている。 Deformation from the initial planar shape of the second mesenchymal stem cells 30 (second stem cells) in the culture vessel 35 is observed with an electron microscope 13 at intervals of about 1 to 2 hours in a standing time of 36 to 48 hours. It is determined whether or not the bottom surface 27 of the culture vessel 35 is fixed. A first code sheet 17 on which a QR code specifying a donor is printed is attached to the bottom surface 27 (outer surface of the bottom wall) of the culture vessel 35 into which the second mesenchymal stem cells 30 and the culture solution 23 are injected.
 医師や看護師、研究者等の担当者は、培養容器25から第2間葉系幹細胞30を採取した後、QRコードが印字された第1コード用紙17を第3扁平培養容器35の底面27(底壁外面)に貼付する。次に、工程第11表示画面の幹細胞第5観察ボタンをクリックし、培養容器25のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞第2採取終了メッセージ、幹細胞第5観察実施中メッセージ、幹細胞第5観察終了ボタン、幹細胞第6観察ボタン、培養生成液第2抽出ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 A person in charge such as a doctor, nurse, researcher, etc. collects the second mesenchymal stem cell 30 from the culture container 25 and then uses the first code sheet 17 on which the QR code is printed as the bottom surface 27 of the third flat culture container 35. Affix to (outer surface of bottom wall). Next, the fifth button for observing stem cells on the process eleventh display screen is clicked to cause the barcode reader 12 to read the QR code of the culture vessel 25. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the donor data match with each other, the number 1 and the donor data are displayed on the display 16, and the stem cell second collection end message, the stem cell fifth observation in progress message, the stem cell fifth observation end button, the stem cell A sixth observation button and a culture product second extraction button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、注射器またはピペットに吸引された第2間葉系幹細胞30を培養容器35に注入(収容)するとともに、培養液23を培養容器35に注入(収容)する。第3扁平培養容器35(第3培養容器)は、透明なガラスまたは透明なプラスチックから作られ、所定容量かつ所定面積の底面27を有する平面形状が略四角形の扁平な容器であり、底面27の面積が第2扁平培養容器25(第2培養容器)よりも大きい。第3扁平培養容器35は、頂部47および底部48と、頂部47に形成された注入口49とを有する。注入口49は、蓋50によって水密に閉塞されている。第3扁平培養容器35として所定容量かつ所定面積の底面27を有する平面形状が円形や楕円形の扁平な容器を使用することもできる。 The person in charge injects (accommodates) the second mesenchymal stem cell 30 sucked into the syringe or pipette into the culture vessel 35 and injects (accommodates) the culture solution 23 into the culture vessel 35. The third flat culture vessel 35 (third culture vessel) is a flat vessel made of transparent glass or transparent plastic and having a bottom surface 27 having a predetermined capacity and a predetermined area and having a substantially square shape. The area is larger than the second flat culture vessel 25 (second culture vessel). The third flat culture vessel 35 has a top 47 and a bottom 48 and an injection port 49 formed in the top 47. The injection port 49 is watertightly closed by the lid 50. As the third flat culture container 35, a flat container having a circular shape or an elliptical shape having a bottom surface 27 having a predetermined capacity and a predetermined area may be used.
 幹細胞第5観察工程で使用される第3扁平培養容器35(第3培養容器)は、その容量が約70~80cc(好ましくは、75cc)であり、その底面面積が約75~108mmである。第3扁平培養容器は、その一辺の長さが約8.7~10.4mmである。培養液23は、幹細胞第1観察において注入されたそれと同一である。培養容器35に注入された第2間葉系幹細胞30は、時間の経過とともに培養容器35の底面27に定着しつつ、培養液23によって培養され、培養容器35の底面27において次第に増殖(分化)してコロニーを形成する。 The third flat culture vessel 35 (third culture vessel) used in the fifth stem cell observation step has a capacity of about 70 to 80 cc (preferably 75 cc) and a bottom area of about 75 to 108 mm 2 . . The third flat culture vessel has a side length of about 8.7 to 10.4 mm. The culture solution 23 is the same as that injected in the first observation of stem cells. The second mesenchymal stem cells 30 injected into the culture vessel 35 are cultured on the bottom surface 27 of the culture vessel 35 with the passage of time, are cultured with the culture solution 23, and gradually grow (differentiate) on the bottom surface 27 of the culture vessel 35. To form colonies.
 担当者は、第2間葉系幹細胞30および培養液23を培養容器35に注入した後、培養容器35を電子顕微鏡13の試料ホルダに設置(セット)する。電子顕微鏡13の試料ホルダ36の上面37と第3扁平培養容器35の底部48との間にスペーサー39を介在させ、培養容器35の底部48をスペーサー39によって持ち上げた状態に保持し、培養容器25の底部48が上となり培養容器25の頂部47(注入口49)が下となるように、培養容器35を所定角度に傾斜させた状態に保持する。また、電子顕微鏡13の試料ホルダ36の上面37と第3扁平培養容器35の頂部48との間にスペーサー39を介在させ、培養容器35の頂部47をスペーサー39によって持ち上げた状態に保持し、培養容器35の頂部47が上となり培養容器35の底部49が下となるように、培養容器35を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第3扁平培養容器35の傾斜角度α2は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 The person in charge injects the second mesenchymal stem cell 30 and the culture solution 23 into the culture container 35, and then installs (sets) the culture container 35 in the sample holder of the electron microscope 13. A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom 48 of the third flat culture vessel 35, and the bottom 48 of the culture vessel 35 is held up by the spacer 39. The culture vessel 35 is held in a state inclined at a predetermined angle such that the bottom portion 48 of the culture vessel 25 is on the top and the top portion 47 (injection port 49) of the culture vessel 25 is on the bottom. Further, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 48 of the third flat culture vessel 35, and the top 47 of the culture vessel 35 is held in a state where it is lifted by the spacer 39. You may hold | maintain the culture container 35 in the state inclined to the predetermined angle so that the top part 47 of the container 35 may become the upper side and the bottom part 49 of the culture container 35 may become the lower side. The inclination angle α2 of the third flat culture vessel 35 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、試料ホルダ36の上面37に対して第3扁平培養容器35を前記傾斜角度で傾斜させることで、培養容器35内において第2間葉系幹細胞30および培養液23が培養容器35の頂部47の側(または底部48の側)に偏り、培養容器35の頂部47の側(または底部48の側)において第2間葉系幹細胞30と培養液23との水圧が大きくなって第2間葉系幹細胞30が培養容器35の底部48の側に集中し、それによって第2間葉系幹細胞30どうしの活性が高まり、培養容器35の底面27において第2間葉系幹細胞30を容易かつ迅速に定着させることができる。 In the culture product production method, the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 35 by inclining the third flat culture vessel 35 at the inclination angle with respect to the upper surface 37 of the sample holder 36. The pressure is biased toward the top 47 (or the bottom 48) of the container 35, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 47 (or the bottom 48) of the culture container 35. Thus, the second mesenchymal stem cells 30 concentrate on the bottom 48 side of the culture vessel 35, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 is formed on the bottom surface 27 of the culture vessel 35. Can be fixed easily and quickly.
 電子顕微鏡13は、培養容器35に注入された第2間葉系幹細胞30の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞30の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第5記憶工程)。コンピュータ11は、電子顕微鏡13から送信された幹細胞30の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。担当者は、ディスプレイ16に表示された幹細胞30の平面形状の拡大画像を36~48時間の間において約1~2時間間隔で確認(視認)し、幹細胞30の平面形状の変化を観察する(幹細胞第5観察工程)。なお、担当者が電子顕微鏡13の観察窓から幹細胞30の平面形状の変化を36~48時間の間において約1~2時間間隔で直接観察してもよい。 The electron microscope 13 takes a magnified image of the planar shape of the second mesenchymal stem cell 30 injected into the culture vessel 35 at intervals of about 1 to 2 hours, and the magnified image of the planar shape of the photographed stem cell 30 is approximately 1 to 2 hours. It transmits to the computer 11 at intervals of 2 hours. The computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image fifth memory). Process). The computer 11 displays the enlarged image of the planar shape of the stem cell 30 and the imaging time transmitted from the electron microscope 13 on the display 16. The person in charge checks (views) the enlarged image of the planar shape of the stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours, and observes the change in the planar shape of the stem cell 30 ( Stem cell fifth observation step). The person in charge may directly observe the change in the planar shape of the stem cell 30 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours.
 第2間葉系幹細胞30の初期平面形状は略円形であり、幹細胞30の平面形状が略円形の場合、幹細胞30が培養容器35の底面27(底壁内面)に定着しておらず、幹細胞30が増殖(分化)を開始していない。第2間葉系幹細胞30の変形後の平面形状は定着前の略円形を核として幹細胞30が一方向へ不定形に伸張した扁平形状であり、幹細胞30が培養容器35の底面27(底壁内面)に定着し、幹細胞30が増殖(分化)を開始している。 The initial planar shape of the second mesenchymal stem cell 30 is substantially circular. When the planar shape of the stem cell 30 is substantially circular, the stem cell 30 is not fixed on the bottom surface 27 (bottom wall inner surface) of the culture vessel 35, and the stem cell. 30 has not started to proliferate (differentiate). The planar shape after the deformation of the second mesenchymal stem cell 30 is a flat shape in which the stem cell 30 extends in an indefinite shape in one direction with the substantially circular shape before fixing as a nucleus, and the stem cell 30 is a bottom surface 27 (bottom wall) of the culture vessel 35. The stem cell 30 has started to proliferate (differentiate).
 担当者は、幹細胞第5観察工程における観察の結果、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状が略円形のまま観察される場合(図12援用)、幹細胞30が培養容器35の底面27(底壁内面)に定着していないと判断し、幹細胞30の平面形状の変化を約1~2時間間隔で継続して観察する。担当者は、幹細胞第3観察手段における観察の結果、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状が略円形から略円形を核として不定形の扁平形状に変形した場合(図13援用)、幹細胞30が培養容器35の底面27に定着したと判断する(幹細胞第3定着工程)。 In the case where the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 is observed as a substantially circular shape as a result of the observation in the fifth observation step of the stem cells (see FIG. 12 for assistance), 35 is determined not to have settled on the bottom surface 27 (inner surface of the bottom wall), and changes in the planar shape of the stem cells 30 are continuously observed at intervals of about 1 to 2 hours. As a result of the observation by the third stem cell observation means, the person in charge changes the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 from an approximately circular shape to an indeterminate flat shape with the approximately circular shape as a nucleus (see FIG. 13), it is determined that the stem cells 30 have settled on the bottom surface 27 of the culture vessel 35 (stem cell third fixing step).
 第2間葉系幹細胞30の定着時に容量が80ccを超過するとともに底面面積が108mmを超過する大きな培養容器を使用すると、幹細胞30が容器の底面に定着し難くなるとともに幹細胞30の増殖が遅くなるが、培養生成液製造方法は、前記容量かつ前記底面面積の第3扁平培養容器35を使用することで、幹細胞30を培養容器35の底面27に容易に定着させることができ、培養容器35において幹細胞30を素早く増殖させることができる。 When a large culture container having a capacity exceeding 80 cc and a bottom area exceeding 108 mm 2 is used when the second mesenchymal stem cell 30 is fixed, the stem cell 30 becomes difficult to settle on the bottom surface of the container and the proliferation of the stem cell 30 is slow. However, in the method for producing a culture product solution, the stem cell 30 can be easily fixed on the bottom surface 27 of the culture container 35 by using the third flat culture container 35 having the above-described capacity and the bottom surface area. The stem cell 30 can be rapidly proliferated.
 培養生成液製造方法は、培養容器35を体温と略同一の温度で36~48時間静的放置しつつ、36~48時間の間において約1~2時間間隔で培養容器35内の第2間葉系幹細胞30の初期平面形状からの変形を観察するから、幹細胞30の変形を見逃すことはなく、幹細胞30の培養容器35の底面27に対する定着を正確に確認することができる。 The method for producing a culture product solution is to leave the culture vessel 35 statically at a temperature substantially the same as the body temperature for 36 to 48 hours, and at intervals of about 1 to 2 hours between 36 and 48 hours. Since the deformation of the leaf stem cells 30 from the initial planar shape is observed, the deformation of the stem cells 30 is not overlooked, and the establishment of the stem cells 30 on the bottom surface 27 of the culture vessel 35 can be confirmed accurately.
 幹細胞第5観察工程における観察の結果、第2間葉系幹細胞30(第2幹細胞)が略円形(初期平面形状)から略円形を核として不定形の扁平形状に変形し、幹細胞30の第3扁平培養容器35(第3培養容器)の底面27への定着を確認した幹細胞第3定着工程の後、幹細胞第3培養工程および幹細胞第6観察工程が行われる。 As a result of the observation in the fifth stem cell observation step, the second mesenchymal stem cell 30 (second stem cell) is deformed from a substantially circular shape (initial planar shape) to an indeterminate flat shape with the substantially circular shape as a nucleus, and the third stem cell 30 The stem cell third culturing step and the stem cell sixth observing step are performed after the stem cell third fixing step in which the fixation to the bottom surface 27 of the flat culture vessel 35 (third culture vessel) is confirmed.
 幹細胞第3培養工程および幹細胞第6観察工程では、培養容器35内に注入されている培養液23が培養容器35から排出(廃棄)され、培養容器35にあらたな培養液23が注入(収容)される。培養容器35が体温と略同一の温度(約36~37℃)で36~48時間静的に放置(動かすことなく静かに放置)され、培養容器35において第2間葉系幹細胞30が培養される(幹細胞第3培養工程)。36~48時間の放置時間において約1~2時間間隔で培養容器35の底面27に定着した第2間葉系幹細胞30の培養容器35の底面面積に対する総平面面積を電子顕微鏡13で観察し、幹細胞30の総平面面積が培養容器35の底面面積に対して第3目標割合に達したか否かが判断される。培養容器35の底面面積に対する第2間葉系幹細胞30の総平面面積の第3目標割合は、88~92%(88~92%コンフルエント)である。 In the stem cell third culture step and the stem cell sixth observation step, the culture solution 23 injected into the culture vessel 35 is discharged (discarded) from the culture vessel 35, and a new culture solution 23 is injected (accommodated) into the culture vessel 35. Is done. The culture vessel 35 is left to stand statically (without being moved) for 36 to 48 hours at a temperature substantially the same as the body temperature (about 36 to 37 ° C.), and the second mesenchymal stem cell 30 is cultured in the culture vessel 35. (Stem cell third culture step). The total planar area of the second mesenchymal stem cells 30 fixed on the bottom surface 27 of the culture vessel 35 at intervals of about 1 to 2 hours in the standing time of 36 to 48 hours is observed with the electron microscope 13 with respect to the bottom surface area of the culture vessel 35. It is determined whether or not the total planar area of the stem cells 30 has reached the third target ratio with respect to the bottom area of the culture vessel 35. The third target ratio of the total planar area of the second mesenchymal stem cell 30 to the bottom surface area of the culture vessel 35 is 88 to 92% (88 to 92% confluent).
 医師や看護師、研究者等の担当者は、第2間葉系幹細胞30の培養容器35の底面27に対する定着を確認した後、ディスプレイ16に表示された幹細胞第5観察終了ボタンをクリックする。幹細胞第5観察終了ボタンをクリックすると、コンピュータ11は、工程第12表示画面(図示せず)をディスプレイ16に表示する。工程第12表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞第2採取終了メッセージ、幹細胞第5観察終了メッセージ、幹細胞第6観察ボタン、培養生成液第2抽出ボタンが表示される。 A person in charge, such as a doctor, nurse, or researcher, confirms that the second mesenchymal stem cell 30 has settled on the bottom surface 27 of the culture vessel 35, and then clicks the stem cell fifth observation end button displayed on the display 16. When the stem cell fifth observation end button is clicked, the computer 11 displays a process twelfth display screen (not shown) on the display 16. On the process twelfth display screen, number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation end message, a stem cell sixth observation button, and a culture product second extraction button are displayed. .
 担当者は、工程第12表示画面の幹細胞第6観察ボタンをクリックし、培養容器35を電子顕微鏡13の試料ホルダから取り外すとともに、培養容器35のQRコードをバーコードリーダ12に読み取らせる。QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダによって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、幹細胞第2採取終了メッセージ、幹細胞第5観察終了メッセージ、幹細胞第6観察実施中メッセージ、幹細胞第6観察終了ボタン、培養生成液第2抽出ボタンをディスプレイ16に表示する。それらドナーデータが不一致の場合、コンピュータ11は、エラーメッセージおよび培養中止メッセージをディスプレイ16に表示する。 The person in charge clicks the sixth stem cell observation button on the process twelfth display screen, removes the culture vessel 35 from the sample holder of the electron microscope 13, and causes the barcode reader 12 to read the QR code of the culture vessel 35. When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data displayed on the display 16 (donor data read into the memory) and the donor data indicated by the QR code read by the barcode reader. When the donor data match, the number 1 and the donor data are displayed on the display 16, and the stem cell second collection end message, the stem cell fifth observation end message, the stem cell sixth observation in progress message, the stem cell number 6 An observation end button and a culture product second extraction button are displayed on the display 16. If the donor data do not match, the computer 11 displays an error message and a culture stop message on the display 16.
 担当者は、幹細胞第5観察工程において培養容器35内に注入した培養液23を培養容器35から排出(廃棄)し、あらたな培養液23を培養容器35に注入(収容)する。あらたな培養液23は、幹細胞第1観察手段において注入されたそれと同一である。担当者は、あらたな培養液23を培養容器35に注入した後、培養容器35を電子顕微鏡13の試料ホルダ36に設置(セット)する。 The person in charge discharges (discards) the culture solution 23 injected into the culture vessel 35 in the fifth stem cell observation step, and injects (accommodates) the new culture solution 23 into the culture vessel 35. The new culture solution 23 is the same as that injected in the stem cell first observation means. The person in charge injects a new culture solution 23 into the culture vessel 35 and then installs (sets) the culture vessel 35 in the sample holder 36 of the electron microscope 13.
 電子顕微鏡13の試料ホルダ36の上面37と第3扁平培養容器35の底部48との間にスペーサー39を介在させ、培養容器35の底部48をスペーサー39によって持ち上げた状態に保持し、培養容器25の底部48が上となり培養容器25の頂部47(注入口49)が下となるように、培養容器35を所定角度に傾斜させた状態に保持する。また、電子顕微鏡13の試料ホルダ36の上面37と第3扁平培養容器35の頂部48との間にスペーサー39を介在させ、培養容器35の頂部47をスペーサー39によって持ち上げた状態に保持し、培養容器35の頂部47が上となり培養容器35の底部49が下となるように、培養容器35を所定角度に傾斜させた状態に保持してもよい。試料ホルダ36の上面37に対する第3扁平培養容器35の傾斜角度α2は、2~5°の範囲にあり、好ましくは、2~3°の範囲にある。 A spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the bottom 48 of the third flat culture vessel 35, and the bottom 48 of the culture vessel 35 is held up by the spacer 39. The culture vessel 35 is held in a state inclined at a predetermined angle such that the bottom portion 48 of the culture vessel 25 is on the top and the top portion 47 (injection port 49) of the culture vessel 25 is on the bottom. Further, a spacer 39 is interposed between the upper surface 37 of the sample holder 36 of the electron microscope 13 and the top 48 of the third flat culture vessel 35, and the top 47 of the culture vessel 35 is held in a state where it is lifted by the spacer 39. You may hold | maintain the culture container 35 in the state inclined to the predetermined angle so that the top part 47 of the container 35 may become the upper side and the bottom part 49 of the culture container 35 may become the lower side. The inclination angle α2 of the third flat culture vessel 35 with respect to the upper surface 37 of the sample holder 36 is in the range of 2 to 5 °, and preferably in the range of 2 to 3 °.
 培養生成液製造方法は、第2間葉系幹細胞30の定着を確認した後、培養容器35内の培養液23を排出しつつあらたな培養液23を培養容器35に注入することで、第2間葉系幹細胞30の増殖を確実に促進することができる。培養生成液製造方法は、試料ホルダ36の上面37に対して第3扁平培養容器35を前記傾斜角度で傾斜させることで、培養容器35内において第2間葉系幹細胞30および培養液23が培養容器35の頂部47の側(または底部48の側)に偏り、培養容器35の頂部47の側(または底部48の側)において第2間葉系幹細胞30と培養液23との水圧が大きくなって第2間葉系幹細胞30が培養容器35の底部48の側に集中し、それによって第2間葉系幹細胞30どうしの活性が高まり、培養容器35の底面27において第2間葉系幹細胞30を容易かつ迅速に増殖(分化)させることができる。 After confirming the establishment of the second mesenchymal stem cell 30, the culture product production method is configured to inject a new culture solution 23 into the culture vessel 35 while discharging the culture solution 23 in the culture vessel 35. The proliferation of the mesenchymal stem cell 30 can be surely promoted. In the culture product production method, the second mesenchymal stem cell 30 and the culture solution 23 are cultured in the culture vessel 35 by inclining the third flat culture vessel 35 at the inclination angle with respect to the upper surface 37 of the sample holder 36. The pressure is biased toward the top 47 (or the bottom 48) of the container 35, and the water pressure between the second mesenchymal stem cell 30 and the culture solution 23 increases on the top 47 (or the bottom 48) of the culture container 35. Thus, the second mesenchymal stem cells 30 concentrate on the bottom 48 side of the culture vessel 35, thereby increasing the activity of the second mesenchymal stem cells 30, and the second mesenchymal stem cell 30 is formed on the bottom surface 27 of the culture vessel 35. Can be propagated (differentiated) easily and rapidly.
 電子顕微鏡13は、培養容器35内の第2間葉系幹細胞30の平面形状の拡大画像を約1~2時間間隔で撮影し、撮影した幹細胞30の平面形状の拡大画像を約1~2時間間隔でコンピュータ11に送信する。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをドナー識別子に関連付けた状態で記憶領域に格納(記憶)する(幹細胞画像第6記憶工程)。コンピュータ11は、電子顕微鏡13から送信された第2間葉系幹細胞30の平面形状の拡大画像と撮影時間とをディスプレイ16に表示する。 The electron microscope 13 takes an enlarged image of the planar shape of the second mesenchymal stem cell 30 in the culture vessel 35 at intervals of about 1 to 2 hours, and takes an enlarged image of the taken planar shape of the stem cell 30 for about 1 to 2 hours. It transmits to the computer 11 at intervals. The computer 11 stores (stores) the planar enlarged image of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time in the storage area in a state associated with the donor identifier (stem cell image sixth memory). Process). The computer 11 displays the enlarged image of the planar shape of the second mesenchymal stem cell 30 transmitted from the electron microscope 13 and the imaging time on the display 16.
 担当者は、ディスプレイ16に表示された第2間葉系幹細胞30の平面形状の拡大画像を36~48時間の間において約1~2時間間隔で確認(視認)し、培養容器35の底面27に定着した幹細胞30の培養容器35の底面面積に対する総平面面積を観察しつつ、幹細胞30の総平面面積が培養容器35の底面面積に対して第3目標割合(82~92%コンフルエント)に達したか否かを判断する(幹細胞第6観察工程)。なお、担当者が電子顕微鏡13の観察窓から第2間葉系幹細胞30の培養容器35の底面面積に対する総平面面積を36~48時間の間において約1~2時間間隔で直接観察し、幹細胞30の総平面面積が培養容器35の底面面積に対して第3目標割合(88~92%コンフルエント)に達したか否かを判断してもよい。 The person in charge confirms (views) the enlarged image of the planar shape of the second mesenchymal stem cell 30 displayed on the display 16 at intervals of about 1 to 2 hours during 36 to 48 hours. The total planar area of the stem cells 30 reaches the third target ratio (82 to 92% confluent) with respect to the bottom area of the culture container 35 while observing the total planar area of the stem cells 30 settled on the culture container 35 with respect to the bottom area. It is determined whether or not (stem cell sixth observation step). The person in charge directly observes the total planar area of the second mesenchymal stem cell 30 with respect to the bottom surface area of the culture vessel 35 from the observation window of the electron microscope 13 at intervals of about 1 to 2 hours during 36 to 48 hours. It may be determined whether the total plane area of 30 has reached the third target ratio (88-92% confluent) with respect to the bottom area of the culture vessel 35.
 担当者は、幹細胞第6観察工程における観察の結果、ディスプレイ16に表示された第2間葉系幹細胞30の培養容器35の底面面積に対する総平面面積が第3目標割合(88~92%コンフルエント)に達していない場合(図13援用)、幹細胞30の培養容器35の底面面積に対する総平面面積を約1~2時間間隔で継続して観察する。なお、ディスプレイ16に表示された拡大画像の全面積に対して第2間葉系幹細胞30の総平面面積が第3目標割合に達した場合に、幹細胞30の培養容器35の底面面積に対する総平面面積が第3目標割合に達したものとする。 As a result of the observation in the stem cell sixth observation step, the person in charge has the third target ratio (88 to 92% confluent) as the total planar area of the second mesenchymal stem cell 30 displayed on the display 16 with respect to the bottom area of the culture vessel 35. If it has not reached (supported in FIG. 13), the total planar area of the stem cell 30 with respect to the bottom area of the culture vessel 35 is continuously observed at intervals of about 1 to 2 hours. In addition, when the total plane area of the second mesenchymal stem cell 30 reaches the third target ratio with respect to the entire area of the enlarged image displayed on the display 16, the total plane with respect to the bottom area of the culture vessel 35 of the stem cell 30 It is assumed that the area has reached the third target ratio.
 幹細胞第6観察工程における観察の結果、第2間葉系幹細胞30が第3扁平培養容器35(第3培養容器)の底面27(底壁内面)において増殖して幹細胞30がコロニーを形成し、幹細胞30の平面形状が拡張することで、ディスプレイ16に表示された幹細胞30の培養容器35の底面面積に対する総平面面積が第3目標割合(88~92%コンフルエント)に達した場合(図14援用)、培養容器35において、単一種の第2間葉系幹細胞30が増殖しているとともに、活性を有する単一種の幹細胞30から分泌された所定の代謝物質を含む培養生成液31が生成されている。 As a result of the observation in the stem cell sixth observation step, the second mesenchymal stem cell 30 grows on the bottom surface 27 (bottom wall inner surface) of the third flat culture vessel 35 (third culture vessel), and the stem cell 30 forms a colony, When the planar shape of the stem cell 30 is expanded, the total planar area of the stem cell 30 displayed on the display 16 with respect to the bottom surface area of the culture vessel 35 reaches the third target ratio (88 to 92% confluent) (see FIG. 14). ) In the culture vessel 35, a single type of second mesenchymal stem cell 30 is proliferating, and a culture product solution 31 containing a predetermined metabolite secreted from the active single type of stem cell 30 is generated. Yes.
 培養生成液製造方法は、第3扁平培養容器35(第3培養容器)の底面面積に対する第2間葉系幹細胞30の総平面面積が92%を超過して幹細胞30が増殖すると、幹細胞30の活性が次第に失われるが、培養容器35の底面面積に対して幹細胞30の総平面面積が88~92%に増殖したときに、幹細胞30を培養容器35から抽出するから、幹細胞30の活性を保持することができ、活性を保持した状態で幹細胞30を増殖させることができる。 When the total planar area of the second mesenchymal stem cell 30 exceeds 92% with respect to the bottom surface area of the third flat culture container 35 (third culture container) and the stem cell 30 proliferates, Although the activity is gradually lost, the stem cell 30 is extracted from the culture vessel 35 when the total planar area of the stem cell 30 grows to 88 to 92% with respect to the bottom surface area of the culture vessel 35, so that the activity of the stem cell 30 is retained. The stem cell 30 can be proliferated while maintaining the activity.
 幹細胞30の培養容器35の底面面積に対する総平面面積が第3目標割合に達した場合、培養容器35から培養生成液31を抽出する培養生成液第2抽出工程が行われる。培養生成液第2抽出工程では、活性を有する第2間葉系幹細胞30から分泌された所定の代謝物質を含む培養生成液31を培養容器35から抽出する。培養生成液製造方法は、約1~2時間間隔で総平面面積を観察することで、第2間葉系幹細胞30の培養容器35の底面面積に対する総平面面積を正確に確認することができ、培養容器35の底面面積に対して幹細胞30の総平面面積が第3目標割合に達したことを確実に把握することができる。 When the total planar area of the stem cells 30 with respect to the bottom surface area of the culture vessel 35 reaches the third target ratio, a culture product second extraction step for extracting the culture product 31 from the culture vessel 35 is performed. In the culture product solution second extraction step, the culture product solution 31 containing a predetermined metabolite secreted from the active second mesenchymal stem cell 30 is extracted from the culture vessel 35. The method for producing a culture product solution can accurately confirm the total planar area of the second mesenchymal stem cell 30 relative to the bottom area of the culture vessel 35 by observing the total planar area at intervals of about 1 to 2 hours. It can be ascertained that the total planar area of the stem cells 30 has reached the third target ratio with respect to the bottom surface area of the culture vessel 35.
 医師や看護師、研究者等の担当者は、第2間葉系幹細胞30の培養容器35の底面面積に対する総平面面積が第3目標割合に達したことを確認した後、ディスプレイ16に表示された幹細胞第6観察終了ボタンをクリックする。幹細胞第6観察終了ボタンをクリックすると、コンピュータ11は、工程第13表示画面(図示せず)をディスプレイ16に表示する。工程第13表示画面には、番号1およびドナーデータが表示されるとともに、幹細胞第2採取終了メッセージ、幹細胞第5観察終了メッセージ、幹細胞第6観察終了メッセージ、培養生成液第2抽出ボタンが表示される。 A person in charge such as a doctor, a nurse, or a researcher confirms that the total planar area of the second mesenchymal stem cell 30 with respect to the bottom area of the culture vessel 35 has reached the third target ratio, and then is displayed on the display 16. Click the button for ending stem cell sixth observation. When the stem cell sixth observation end button is clicked, the computer 11 displays a process thirteenth display screen (not shown) on the display 16. On the process 13th display screen, number 1 and donor data are displayed, and a stem cell second collection end message, a stem cell fifth observation end message, a stem cell sixth observation end message, and a culture product second extraction button are displayed. The
 担当者は、幹細胞第6観察工程において培養容器35内に注入した培養液23から変化した培養生成液31を注射器やピペットを利用して培養容器35から吸引し(培養生成液第2抽出工程)、培養生成液31を保存容器32に注入(収容)する。保存容器32に注入された培養生成液31は、不要な間葉系幹細胞が除去された活性を有する特定種類の単一種の間葉系幹細胞(単一種幹細胞)から分泌された所定の代謝物質を含む培養生成液31である。 The person in charge aspirates the culture product solution 31 changed from the culture solution 23 injected into the culture vessel 35 in the stem cell sixth observation step from the culture vessel 35 using a syringe or pipette (culture product solution second extraction step). Then, the culture product solution 31 is injected (stored) in the storage container 32. The culture product solution 31 injected into the storage container 32 contains a predetermined metabolite secreted from a specific type of single-type mesenchymal stem cells (single-type stem cells) having an activity from which unnecessary mesenchymal stem cells have been removed. It is the culture product solution 31 containing.
 担当者は、培養生成液31を保存容器32に注入した後、QRコードが印字された第1コード用紙17を保存容器32の外周面に貼付する。担当者は、ディスプレイ16に表示された第13表示画面の培養生成液第2抽出終了ボタンをクリックし、保存容器32のQRコードをバーコードリーダ12に読み取らせた後、培養生成液31を注入した保存容器32を冷蔵庫34に収納する。培養生成液31は、冷蔵庫34において約3~4℃で保存される。 The person in charge injects the culture product solution 31 into the storage container 32, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 32. The person in charge clicks the culture solution second extraction end button on the thirteenth display screen displayed on the display 16, causes the barcode reader 12 to read the QR code of the storage container 32, and then injects the culture product 31. The stored storage container 32 is stored in the refrigerator 34. The culture product solution 31 is stored at about 3 to 4 ° C. in the refrigerator 34.
 QRコードがバーコードリーダ12からコンピュータ11に送信されると、コンピュータ11は、ディスプレイ16に表示されたドナーデータ(メモリに読み出したドナーデータ)とバーコードリーダ12によって読み取られたQRコードが示すドナーデータとを比較し、それらドナーデータが一致した場合、番号1およびドナーデータをディスプレイ16に表示するとともに、培養生成液抽出終了メッセージ、培養生成液製造終了ボタンをディスプレイ16に表示する。担当者は、培養生成液製造終了ボタンをクリックする。培養生成液製造終了ボタンをクリックすると、コンピュータ11においてシステム10が停止する。 When the QR code is transmitted from the barcode reader 12 to the computer 11, the computer 11 displays the donor data (donor data read into the memory) displayed on the display 16 and the donor indicated by the QR code read by the barcode reader 12. When the data are compared and the donor data match, the number 1 and the donor data are displayed on the display 16, and the culture product extraction end message and the culture product preparation end button are displayed on the display 16. The person in charge clicks the culture production solution production end button. When the culture product production end button is clicked, the system 10 stops in the computer 11.
 培養生成液製造終了ボタンをクリックした場合、培養容器25から幹細胞30を採取する幹細胞採取工程が行われる。幹細胞採取工程では、培養容器35内において増殖(分化)した第2間葉系幹細胞30を培養容器35から採取する。担当者は、培養容器35内をPBSで洗浄した後、トリプシン液を培養容器35内に注入し、トリプシン液の水面に浮上する第2間葉系幹細胞30を注射器またはピペットを利用して吸引し、幹細胞30を注射器またはピペットから保存容器33に注入(収容)する。 When the culture production solution production end button is clicked, a stem cell collection step of collecting the stem cells 30 from the culture vessel 25 is performed. In the stem cell collection step, the second mesenchymal stem cells 30 that have proliferated (differentiated) in the culture vessel 35 are collected from the culture vessel 35. The person in charge cleans the inside of the culture container 35 with PBS, injects a trypsin solution into the culture container 35, and aspirates the second mesenchymal stem cells 30 floating on the water surface of the trypsin solution using a syringe or pipette. The stem cell 30 is injected (accommodated) into the storage container 33 from a syringe or pipette.
 保存容器33に注入された第2間葉系幹細胞30は、不要な間葉系幹細胞が除去された活性を有する特定種類の単一種の間葉系幹細胞(単一種幹細胞)である。担当者は、第2間葉系幹細胞30(単一種の間葉系幹細胞)を保存容器33に注入した後、QRコードが印字された第1コード用紙17を保存容器33の外周面に貼付し、第2間葉系幹細胞30を注入した保存容器33を冷蔵庫34に収納する。第2間葉系幹細胞30(単一種の間葉系幹細胞)は、冷蔵庫34において約3~4℃で保存される。 The second mesenchymal stem cell 30 injected into the storage container 33 is a specific kind of single mesenchymal stem cell (single seed stem cell) having an activity from which unnecessary mesenchymal stem cells are removed. The person in charge injects the second mesenchymal stem cell 30 (single mesenchymal stem cell) into the storage container 33, and then attaches the first code sheet 17 on which the QR code is printed to the outer peripheral surface of the storage container 33. The storage container 33 into which the second mesenchymal stem cells 30 are injected is stored in the refrigerator 34. The second mesenchymal stem cell 30 (single mesenchymal stem cell) is stored in the refrigerator 34 at about 3 to 4 ° C.
 培養生成液製造方法は、第2培養容器25内から培養生成液31を抽出した後に第2培養容器25から第2幹細胞30を採取し、幹細胞30を培養液23とともに培養して幹細胞30を第2培養容器25よりも大きい容量の第3培養容器35の底面27に定着させ、培養容器35内にあらたな培養液23を注入し、幹細胞30を培養しつつ幹細胞30の総平面面積が培養容器35の底面面積に対して第3目標割合に達した場合、幹細胞30の培養過程において増殖した活性を有する単一種の第2幹細胞30から分泌された所定の代謝物質を含む培養生成液31を培養容器35から抽出するから、幹細胞30の培養過程において多種雑多な幹細胞が培養されることはなく、多種雑多な幹細胞から分泌された多種多様な代謝物質が含まれることはなく、活性を有する単一種の第2幹細胞30から分泌された所定の代謝物質のみを含み、所定の疾患や所定の美容に対して唯一特定の効果を発揮する培養生成液31を製造することができ、所定の疾患の治療に有効に使用することが可能な培養生成液31を製造することができるとともに、所定の美容に有効に使用することが可能な培養生成液31を製造することができる。 In the culture product production method, the culture product solution 31 is extracted from the second culture vessel 25, the second stem cells 30 are collected from the second culture vessel 25, the stem cells 30 are cultured together with the culture solution 23, and the stem cells 30 are extracted. 2. Fix to the bottom surface 27 of the third culture container 35 having a larger capacity than the culture container 25, inject a new culture solution 23 into the culture container 35, and culture the stem cells 30, while the total planar area of the stem cells 30 is the culture container. When the third target ratio is reached with respect to the bottom surface area of 35, the culture product solution 31 containing a predetermined metabolite secreted from a single type of second stem cell 30 having an activity proliferated in the course of culturing the stem cell 30 is cultured. Since it is extracted from the container 35, a variety of stem cells are not cultured in the culture process of the stem cell 30, and a variety of metabolites secreted from the variety of stem cells are included. And producing a culture product solution 31 that contains only a predetermined metabolite secreted from a single type of active second stem cell 30 and exhibits a specific effect on a predetermined disease or a predetermined beauty. The culture product solution 31 that can be effectively used for the treatment of a predetermined disease can be manufactured, and the culture product solution 31 that can be used effectively for a predetermined beauty can be manufactured. .
 10  培養生成液製造システム
 11  コンピュータ
 12  バーコードリーダ
 13  電子顕微鏡
 14  キーボード
 15  マウス
 16  ディスプレイ
 17  第1コード用紙
 18  原料骨髄液
 19  ガラス試験管
 20  試験管立て
 21  恒温槽
 22  中間層骨髄液
 23  培養液
 24  第1培養容器(第1扁平培養容器)
 25  第2培養容器(第2扁平培養容器)
 26  第1間葉系幹細胞(第1幹細胞)
 27  底面
 28  遠心分離器
 29  ガラス試験管
 30  第2間葉系幹細胞(第2幹細胞)
 31  培養生成液
 32  保存容器
 33  保存容器
 34  冷蔵庫
 35  第3培養容器(第3扁平培養容器)
 36  試料ホルダ
 37  上面
 38  底部
 39  スペーサー
 40  頂部
 41  注入口
 42  蓋
 43  頂部
 44  底部
 45  注入口
 46  蓋
 47  頂部
 48  底部
 49  注入口
 50  蓋
DESCRIPTION OF SYMBOLS 10 Culture production | generation production system 11 Computer 12 Bar code reader 13 Electron microscope 14 Keyboard 15 Mouse 16 Display 17 1st code paper 18 Raw material bone marrow 19 Glass test tube 20 Test tube stand 21 Constant temperature bath 22 Middle layer bone marrow 23 Culture solution 24 First culture vessel (first flat culture vessel)
25 Second culture vessel (second flat culture vessel)
26 First mesenchymal stem cells (first stem cells)
27 Bottom surface 28 Centrifuge 29 Glass test tube 30 Second mesenchymal stem cell (second stem cell)
31 Culture Product 32 Storage Container 33 Storage Container 34 Refrigerator 35 Third Culture Container (Third Flat Culture Container)
36 Sample holder 37 Upper surface 38 Bottom 39 Spacer 40 Top 41 Inlet 42 Lid 43 Top 44 Bottom 45 Inlet 46 Lid 47 Top 48 Bottom 49 Inlet 50 Lid

Claims (13)

  1.  ドナーから採取した骨髄液から作られる幹細胞を利用して培養生成液を製造する培養生成液製造方法において、
     前記培養生成液製造方法が、前記ドナーから採取した骨髄液を層状に分離する骨髄液分離工程と、前記骨髄液分離工程によって層状に分離した骨髄液のうちの中間層に位置する中間層骨髄液を抽出する骨髄液抽出工程と、前記骨髄液抽出工程によって抽出した前記中間層骨髄液と所定の培養液とを所定容量かつ所定面積の底面を有する第1培養容器に注入し、前記第1培養容器を所定時間静的に放置して前記中間層骨髄液に含まれる第1幹細胞を該第1培養容器の底面に定着させる幹細胞第1定着工程と、前記幹細胞第1定着工程によって前記第1幹細胞を前記第1培養容器の底面に定着させた後、前記第1培養容器内の培養液を排出しつつあらたな培養液を該第1培養容器に注入し、前記第1培養容器を所定時間静的に放置して該第1培養容器の底面面積に対する前記第1幹細胞の総平面面積が第1目標割合に達するまで該第1幹細胞を培養する幹細胞第1培養工程と、前記幹細胞第1培養工程における前記第1幹細胞の培養過程において、前記第1幹細胞の総平面面積が前記第1目標割合に達した場合、前記第1培養容器から前記第1幹細胞を採取する幹細胞第1採取工程と、前記幹細胞第1採取工程によって採取した前記第1幹細胞を層状に遠心分離する幹細胞分離工程と、前記幹細胞分離工程によって層状に分離した前記第1幹細胞のうちの最下層に位置する第2幹細胞を採取する幹細胞第2採取工程と、前記幹細胞第2採取工程によって採取した前記第2幹細胞と所定の培養液とを前記第1培養容器よりも大きい容量かつ大きい底面面積の底面を有する第2培養容器に注入し、前記第2培養容器を所定時間静的に放置して前記第2幹細胞を該第2培養容器の底面に定着させる幹細胞第2定着工程と、前記幹細胞第2定着工程によって前記第2幹細胞を前記第2培養容器の底面に定着させた後、前記第2培養容器内の培養液を排出しつつあらたな培養液を該第2培養容器に注入し、前記第2培養容器を所定時間静的に放置して該第2培養容器の底面面積に対する前記第2幹細胞の総平面面積が第2目標割合に達するまで該第2幹細胞を培養する幹細胞第2培養工程と、前記幹細胞第2培養工程における培養過程において、前記第2幹細胞の総平面面積が前記第2目標割合に達した場合、増殖した単一種の前記第2幹細胞から分泌された所定の代謝物質を含む前記培養生成液を前記第2培養容器から抽出する培養生成液第1抽出工程とを有することを特徴とする培養生成液製造方法。
    In a culture product production method for producing a culture product using stem cells made from bone marrow fluid collected from a donor,
    The culture product production method includes a bone marrow fluid separation step in which bone marrow fluid collected from the donor is separated into layers, and an intermediate layer bone marrow fluid located in an intermediate layer of the bone marrow fluid separated into layers by the bone marrow fluid separation step A bone marrow fluid extraction step for extracting the bone marrow fluid, and the intermediate layer bone marrow fluid extracted by the bone marrow fluid extraction step and a predetermined culture solution are injected into a first culture vessel having a predetermined volume and a bottom area, and the first culture A first stem cell fixing step in which the container is allowed to stand statically for a predetermined time to fix the first stem cells contained in the intermediate layer bone marrow fluid to the bottom surface of the first culture vessel, and the first stem cell by the first stem cell fixing step. Is fixed to the bottom surface of the first culture vessel, and a new culture solution is poured into the first culture vessel while discharging the culture solution in the first culture vessel, and the first culture vessel is allowed to stand for a predetermined time. Leave the first culture A first stem cell culturing step of culturing the first stem cells until the total planar area of the first stem cells with respect to the bottom surface area of the vessel reaches a first target ratio, and a culturing process of the first stem cells in the first stem cell culturing step When the total planar area of the first stem cells reaches the first target ratio, the stem cell first collection step for collecting the first stem cells from the first culture vessel, and the stem cell first collection step, Stem cell separation step for centrifuging first stem cells in layers, stem cell second collection step for collecting second stem cells located in the lowest layer of the first stem cells separated in layers by the stem cell separation step, and the stem cells The second stem cell collected in the second collection step and a predetermined culture solution are poured into a second culture vessel having a bottom having a larger volume and a larger bottom area than the first culture vessel. The second stem cell is allowed to stand statically for a predetermined time to establish the second stem cell on the bottom surface of the second culture vessel, and the second stem cell is fixed by the stem cell second colonization step. After fixing on the bottom surface of the second culture vessel, a new culture solution is poured into the second culture vessel while discharging the culture solution in the second culture vessel, and the second culture vessel is statically fixed for a predetermined time. In the stem cell second culturing step of culturing the second stem cell until the total planar area of the second stem cell with respect to the bottom surface area of the second culture container reaches a second target ratio; In the culturing process, when the total planar area of the second stem cells reaches the second target ratio, the culture product solution containing a predetermined metabolite secreted from the single stem cell that has proliferated is added to the second stem cell. Culture production extracted from culture vessels It has a liquid 1st extraction process, The culture production liquid manufacturing method characterized by the above-mentioned.
  2.  前記幹細胞第1定着工程および前記幹細胞第1培養工程では、前記第1培養容器を所定角度に傾斜させた状態で所定時間静的に放置し、前記幹細胞第2定着工程および前記幹細胞第2培養工程では、前記第2培養容器を所定角度に傾斜させた状態で所定時間静的に放置する請求項1に記載の培養生成液製造方法。 In the stem cell first fixing step and the stem cell first culturing step, the first culture vessel is statically left for a predetermined time in a state inclined at a predetermined angle, and the stem cell second fixing step and the stem cell second culturing step. The method for producing a culture product solution according to claim 1, wherein the second culture vessel is statically left for a predetermined time in a state where the second culture container is inclined at a predetermined angle.
  3.  前記培養生成液製造方法が、前記培養生成液第1抽出工程によって前記第2培養容器内から培養生成液を抽出した後、前記第2培養容器から前記第2幹細胞を採取する幹細胞第2採取工程と、所定容量かつ所定面積の底面を有して前記第2培養容器よりも大きい容量かつ大きい底面面積の底面を有する第3培養容器に前記幹細胞第2採取工程によって採取した前記第2幹細胞とあらたな培養液とを注入し、前記第3培養容器を所定時間静的に放置して前記第2幹細胞を該第3培養容器の底面に定着させる幹細胞第3定着工程と、前記幹細胞第3定着工程によって前記第2幹細胞を前記第3培養容器の底面に定着させた後、前記第3培養容器内の培養液を排出しつつあらたな培養液を該第3培養容器に注入し、前記第3培養容器を所定時間静的に放置して該第3培養容器の底面面積に対する前記第2幹細胞の総平面面積が第3目標割合に達するまで該第2幹細胞を培養する幹細胞第3培養工程と、前記幹細胞第3培養工程における培養過程において、前記第2幹細胞の総平面面積が前記第3目標割合に達した場合、増殖した単一種の前記第2幹細胞から分泌された所定の代謝物質を含む前記培養生成液を前記第3培養容器から抽出する培養生成液第2抽出工程とを含む請求項1または請求項2に記載の培養生成液製造方法。 The culture product production method extracts the culture product solution from the second culture vessel in the culture product solution first extraction step, and then collects the second stem cell from the second culture vessel. And the second stem cells collected by the second harvesting step of the stem cells in a third culture container having a bottom surface with a predetermined volume and a predetermined area and a larger capacity and a larger bottom area than the second culture container. A third stem cell fixing step, in which the third culture vessel is statically left for a predetermined time and the second stem cells are fixed on the bottom surface of the third culture vessel, and the third stem cell fixing step. After fixing the second stem cells on the bottom surface of the third culture vessel, a new culture solution is poured into the third culture vessel while discharging the culture solution in the third culture vessel, and the third culture is performed. Keep the container for a specified time In the stem cell third culture step of culturing the second stem cells until the total planar area of the second stem cells with respect to the bottom surface area of the third culture container reaches a third target ratio, In the culturing process, when the total planar area of the second stem cells reaches the third target ratio, the culture product solution containing a predetermined metabolite secreted from the single stem cell that has proliferated is added to the third culture. The culture product solution production method according to claim 1, further comprising a culture product solution second extraction step of extracting from the culture vessel.
  4.  前記幹細胞第3定着工程および前記幹細胞第3培養工程では、前記第3培養容器を所定角度に傾斜させた状態で所定時間静的に放置する請求項3に記載の培養生成液製造方法。 The method for producing a culture product solution according to claim 3, wherein, in the stem cell third fixing step and the stem cell third culture step, the third culture vessel is statically left for a predetermined time in a state where the third culture vessel is inclined at a predetermined angle.
  5.  前記骨髄液分離工程が、前記ドナーから2~3ccの骨髄液を採取し、前記2~3ccの骨髄液を上下方向へ延びる分離容器に注入し、前記分離容器を体温と略同一の温度で所定時間静的に放置して該骨髄液を該分離容器内において上下方向へ層状に分離させ、前記骨髄液抽出工程が、前記分離容器内において層状に分離した前記骨髄液のうちの中間層に位置する前記中間層骨髄液を抽出する請求項1ないし請求項4いずれかに記載の培養生成液製造方法。 The bone marrow fluid separation step collects 2 to 3 cc of bone marrow fluid from the donor, injects the 2 to 3 cc of bone marrow fluid into a separation container extending in the vertical direction, and the separation container is predetermined at a temperature substantially equal to the body temperature. The bone marrow fluid is left standing statically for time and separated into layers in the vertical direction in the separation container, and the bone marrow fluid extraction step is located in an intermediate layer of the bone marrow fluid separated in layers in the separation container. The method for producing a culture product solution according to any one of claims 1 to 4, wherein the intermediate layer bone marrow fluid is extracted.
  6.  前記第1培養容器の容量が、約20~30ccであり、前記第1幹細胞の初期平面形状が、略円形であり、前記第1幹細胞の変形後の平面形状が、前記略円形を核として該第1幹細胞が一方向へ不定形に伸張した扁平形状であり、前記幹細胞第1定着工程では、前記第1培養容器を体温と略同一の温度で12~24時間静的に放置しつつ、前記12~24時間の間において約1~2時間間隔で前記第1培養容器内の第1幹細胞の初期平面形状からの変形を観察し、前記第1幹細胞が初期平面形状から前記不定形の扁平形状に変形した場合、該第1幹細胞が前記第1培養容器の底面に定着したと判断する請求項1ないし請求項5いずれかに記載の培養生成液製造方法。 The capacity of the first culture vessel is about 20-30 cc, the initial planar shape of the first stem cells is substantially circular, and the planar shape after deformation of the first stem cells is the center of the substantially circular shape as the nucleus. The first stem cell has a flat shape in which the first stem cell is irregularly extended in one direction. In the first stem cell fixing step, the first culture vessel is left statically at a temperature substantially the same as the body temperature for 12 to 24 hours, The deformation of the first stem cells in the first culture vessel from the initial planar shape is observed at intervals of about 1 to 2 hours during 12 to 24 hours, and the first stem cells are deformed from the initial planar shape to the irregular flat shape. The method for producing a culture product solution according to any one of claims 1 to 5, wherein the first stem cells are determined to have settled on the bottom surface of the first culture container when deformed to.
  7.  前記幹細胞第1採取工程では、前記第1培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、前記36~48時間の間において約1~2時間間隔で前記第1培養容器の底面に定着した前記第1幹細胞の該第1培養容器の底面面積に対する総平面面積を観察する請求項1ないし請求項6いずれかに記載の培養生成液製造方法。 In the first stem cell collection step, the first culture vessel is statically left at a temperature substantially the same as the body temperature for 36 to 48 hours, while the first culture container is spaced at about 1 to 2 hours between the 36 and 48 hours. The method for producing a culture product solution according to any one of claims 1 to 6, wherein the total planar area of the first stem cells fixed on the bottom surface of the culture vessel with respect to the bottom surface area of the first culture vessel is observed.
  8.  前記第1培養容器の底面面積に対する前記第1幹細胞の総平面面積の第1目標割合が、70~80%である請求項7に記載の培養生成液製造方法。 The culture product production method according to claim 7, wherein the first target ratio of the total planar area of the first stem cells to the bottom area of the first culture vessel is 70 to 80%.
  9.  前記幹細胞分離工程が、前記第1幹細胞を分離容器に注入し、前記分離容器を遠心分離器に設置して該第1幹細胞を遠心分離させ、前記幹細胞第1採取工程が、前記分離容器内において層状に遠心分離した前記第1幹細胞のうちの最下層に位置する前記第2幹細胞を採取する請求項1ないし請求項8いずれかに記載の培養生成液製造方法。 In the stem cell separation step, the first stem cells are injected into a separation container, the separation container is placed in a centrifuge to centrifuge the first stem cells, and the stem cell first collection step is performed in the separation container. The method for producing a culture product solution according to any one of claims 1 to 8, wherein the second stem cells located in the lowermost layer of the first stem cells centrifuged in a layered manner are collected.
  10.  前記第2培養容器の容量が、約40~60ccであり、前記第3培養容器の容量が、約70~80ccであり、前記第2幹細胞の初期平面形状が、略円形であり、前記第2幹細胞の変形後の平面形状が、前記略円形を核として該第2幹細胞が一方向へ不定形に伸張した扁平形状であり、前記幹細胞第2定着工程および前記幹細胞第3定着工程では、前記第2培養容器および前記第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、前記36~48時間の間において約1~2時間間隔で前記第2および第3培養容器内の第2幹細胞の初期平面形状からの変形を観察し、前記第2幹細胞が初期平面形状から前記不定形の扁平形状に変形した場合、該第2幹細胞が前記第2および第3培養容器の底面に定着したと判断する請求項3ないし請求項9いずれかに記載の培養生成液製造方法。 The volume of the second culture vessel is about 40-60 cc, the volume of the third culture vessel is about 70-80 cc, the initial planar shape of the second stem cell is substantially circular, The planar shape after deformation of the stem cell is a flat shape in which the second stem cell extends indefinitely in one direction with the substantially circular shape as a nucleus. In the stem cell second fixing step and the stem cell third fixing step, The second and third culture vessels are statically left at the same temperature as the body temperature for 36 to 48 hours, while the second and third culture vessels are spaced at about 1 to 2 hours between the 36 and 48 hours. When the deformation of the second stem cell in the container from the initial planar shape is observed and the second stem cell is deformed from the initial planar shape to the irregular flat shape, the second stem cell is converted into the second and third culture containers. Claim to have settled on the bottom of 3 through claim 9 culture product solution producing method according to any one.
  11.  前記幹細胞第2採取工程および前記幹細胞第3採取工程では、前記第2培養容器および前記第3培養容器を体温と略同一の温度で36~48時間静的に放置しつつ、前記36~48時間の間において約1~2時間間隔で前記第2および第3培養容器の底面に定着した前記第2幹細胞の該第2および第3培養容器の底面面積に対する総平面面積を観察する請求項3ないし請求項10いずれかに記載の培養生成液製造方法。 In the stem cell second collection step and the stem cell third collection step, the second culture vessel and the third culture vessel are statically left at the same temperature as the body temperature for 36 to 48 hours, while the 36 to 48 hours. The total planar area of the second stem cells fixed on the bottom surfaces of the second and third culture vessels at a time interval of about 1 to 2 hours is observed with respect to the bottom area of the second and third culture vessels. The method for producing a culture product solution according to claim 10.
  12.  前記第2培養容器の底面面積に対する前記第2幹細胞の総平面面積の第2目標割合が、88~92%であり、前記第3培養容器の底面面積に対する前記第2幹細胞の総平面面積の第3目標割合が、88~92%である請求項3ないし請求項11いずれかに記載の培養生成液製造方法。 The second target ratio of the total planar area of the second stem cells to the bottom area of the second culture container is 88 to 92%, and the second target ratio of the total planar area of the second stem cells to the bottom area of the third culture container is The method for producing a culture product solution according to any one of claims 3 to 11, wherein the 3 target ratio is 88 to 92%.
  13.  前記第1および第2幹細胞が、間葉系幹細胞である請求項1ないし請求項12いずれかに記載の培養生成液製造方法。
     
    The method for producing a culture product solution according to any one of claims 1 to 12, wherein the first and second stem cells are mesenchymal stem cells.
PCT/JP2017/009546 2016-03-10 2017-03-09 Method for manufacturing culture product liquid WO2017155055A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
RU2018131756A RU2751239C2 (en) 2016-03-10 2017-03-09 Method for producing liquid culture product
US16/073,352 US20190032019A1 (en) 2016-03-10 2017-03-09 Method for manufacturing culture product liquid
EP17763395.5A EP3428272A4 (en) 2016-03-10 2017-03-09 Method for manufacturing culture product liquid
SG11201806410PA SG11201806410PA (en) 2016-03-10 2017-03-09 Method for manufacturing culture product liquid
CN201780015560.6A CN108699516A (en) 2016-03-10 2017-03-09 Culture generates liquid manufacturing method
MYPI2018702704A MY185820A (en) 2016-03-10 2017-03-09 Method for manufacturing culture product liquid
PH12018501576A PH12018501576A1 (en) 2016-03-10 2018-07-25 Method for manufacturing culture product liquid

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016-047119 2016-03-10
JP2016047119 2016-03-10
JP2017-044698 2017-03-09
JP2017044698A JP6345826B2 (en) 2016-03-10 2017-03-09 Production method of culture product

Publications (1)

Publication Number Publication Date
WO2017155055A1 true WO2017155055A1 (en) 2017-09-14

Family

ID=59789632

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/009546 WO2017155055A1 (en) 2016-03-10 2017-03-09 Method for manufacturing culture product liquid

Country Status (1)

Country Link
WO (1) WO2017155055A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006109757A (en) * 2004-10-14 2006-04-27 Olympus Corp Method for culturing marrow-derived mesenchymal stem cell
WO2011111787A1 (en) * 2010-03-10 2011-09-15 株式会社ツーセル Cell preparation containing mesenchymal stem cells, and method for producing same
WO2015021189A1 (en) * 2013-08-06 2015-02-12 Regenerative Sciences, Llc Bone marrow adipose portion isolation device and methods
JP2015084686A (en) * 2013-10-29 2015-05-07 オリンパス株式会社 Jig for cell culture, and automatic culture medium exchange system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006109757A (en) * 2004-10-14 2006-04-27 Olympus Corp Method for culturing marrow-derived mesenchymal stem cell
WO2011111787A1 (en) * 2010-03-10 2011-09-15 株式会社ツーセル Cell preparation containing mesenchymal stem cells, and method for producing same
WO2015021189A1 (en) * 2013-08-06 2015-02-12 Regenerative Sciences, Llc Bone marrow adipose portion isolation device and methods
JP2015084686A (en) * 2013-10-29 2015-05-07 オリンパス株式会社 Jig for cell culture, and automatic culture medium exchange system

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GIJUTSU KAIHATSUBU ET AL.: "3 Jido Baiyo Sochi no Kaihatsu = [3 Development of automatic culture device]", INDUSTRY-ACADEMIA-GOVERNMENT JOINT RESEARCH AND DEVELOPMENT PROJECT. RESEARCH RESULT REPORT. AUTOLOGOUS TISSUE-DERIVED STEM CELL DELIVERY SYSTEM. DEVELOPMENT OF EXERCISE EQUIPMENT REGENERATIVE MEDICINE APPLYING, 2006, pages 11 - 18, XP009514103, [retrieved on 20170523] *
See also references of EP3428272A4 *
YUKIO NAKAMURA: "Mokutekibetsu de Eraberu Saibo Baiyo Protocol", EXPERIMENTAL MEDICINE SEPARATE VOLUME, 20 March 2012 (2012-03-20), pages 139 - 146, XP009509903 *

Similar Documents

Publication Publication Date Title
CN105907641B (en) A kind of packaging, many condition parallel culture micro fluidic device and its application method
CN105769911A (en) Hair regeneration method for mesenchymal stem cell-induced alopecia areata and application
CN107746829A (en) A kind of method separated with the mescenchymal stem cell in original cuiture dog placenta source
Turnbull et al. Cardiac tissue engineering models of inherited and acquired cardiomyopathies
JP6401818B2 (en) Method for producing activated stem cells
JP5155530B2 (en) Adult stem cell separation and culture system
CN106434547A (en) Method for preparing umbilical cord mesenchymal stem cells
CN107446884A (en) Human umbilical cord mesenchymal stem cells membrane granule and its preparation and application
Sanchez et al. Generation of self-assembled vascularized human skin equivalents
CN110252440A (en) A kind of excretion body filtering extraction element and excretion body extracting method
JP6345826B2 (en) Production method of culture product
WO2017155055A1 (en) Method for manufacturing culture product liquid
JP2017163979A (en) Culture production solutions
JP6153653B2 (en) Stem cell culture method
CN113604419B (en) Method for extracting mouse primary liver cumic cells
Kim et al. Modularized dynamic cell culture platform for efficient production of extracellular vesicles and sequential analysis
WO2017188370A1 (en) Method for producing activated stem cells
JP2017104106A (en) Single species stem cells
CN101812427A (en) Method for culturing rat airway smooth muscle cells
WO2017099067A1 (en) Stem cell culturing method
US10913931B1 (en) Apparatus and method for harvesting and preparing viable stem cells
CN104845931A (en) Acquisition method for human milk stem cells and construction method for human milk stem cell bank
JP2017200473A (en) Activated stem cells
CN103173405B (en) A kind of simple separation of Human plactnta myofibroblast mother cell and authentication method
CN117903940A (en) Culture apparatus, method for processing incubator, and cell culture method

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 12018501576

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 11201806410P

Country of ref document: SG

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2017763395

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2017763395

Country of ref document: EP

Effective date: 20181010

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17763395

Country of ref document: EP

Kind code of ref document: A1